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Introduction 
 
Drug metabolism is an important item within drug safety research. Not only 
does it determine the remaining time of a drug in the body, it may also be 
cause of the formation of toxic metabolites by bio-activation. Therefore, to 
test the toxicity of new drugs, laboratory animal species should be selected 
that form approximately the same metabolites of a certain compound as 
humans to serve as an optimal model for human drug toxicity. In vitro 
research has been under growing interest for many disciplines within drug 
safety research, but pre-eminently comes in handy for serving the selection 
of adequately metabolizing animal species in late drug discovery and early 
development. In this phase, this is the only way to compare metabolism of a 
particular drug between animals and humans. Additionally, and not 
unimportantly, laboratory animal use can be reduced in this manner.   
Tissue slices are a unique in vitro tool because they closely resemble the 
organ from which they are derived. Because no proteolytic enzymes are 
required for their preparation, cell to cell contacts are maintained in slices, 
as well as cell-matrix interactions and all cell types are present as in the 
whole organ in vivo. The invention of mechanical tissue slicers, like the 
Krumdieck tissue slicer, has facilitated slice preparation enormously 
(Krumdieck et al., 1980). With this equipment, slices from various organs of 
various animal species are prepared under controlled conditions in cooled 
physiological buffer, so minimal trauma is inflicted and slices of consistent 
appearance are produced. Much effort has been put in the optimization of 
preparation and culturing techniques for predominantly liver slices but also 
for lung, kidney and intestinal slices. Amongst factors that are critical for 
maintaining optimal viability of slices are slice thickness, composition of the 
culture medium and the incubation system used. Under optimal conditions, 
tissue slices are kept viable for at least 24 h after preparation. Several 
informative reviews discuss practical considerations that determine tissue 
slice viability and the applicability of slices in pharmaco-toxicological 
settings (Gandolfi et al., 1995; Parrish et al., 1995; Bach et al., 1996; Ekins, 
1996b, Olinga et al., 1997b; Lerche-Lagrand and Toutain, 2000; de Kanter 
et al., 2002b).  
Because of their characteristics, the choice of tissue slices as an in vitro 
tool for several applications in toxicology and drug metabolism research is 
self-evident. Many publications describe the use of precision-cut liver slices 
to study drug metabolism in vitro (see aforementioned reviews). Less focus 
has been put on the use of extra-hepatic tissue slices for drug metabolism 
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research. Some compounds, however, are metabolized extra-hepatically and 
studying metabolism with liver slices alone may give an incomplete view of 
in vivo metabolism. For example, Sandker et al. (1994) and Pahernik et al. 
(1995) compared in vitro metabolism of respectively Org344 and 
pimobendan by isolated hepatocytes with metabolism in vivo and found that 
N-gluronidation of these compounds was underestimated in vitro. It was 
suggested that these metabolites are mainly formed extra-hepatically 
(Sandker et al., 1994). In a recent study by our laboratory we compared 
metabolism of a new drug in development between various in vitro systems 
of both hepatic and extra-hepatic origin. It was indeed found that the N-
glucuronide of this drug, which was the main metabolite in vivo, was formed 
in small amounts by liver slices, while it was produced in relatively large 
amounts by small intestinal slices (de Graaf et al., submitted). Others have 
shown as well that particularly kidney and intestinal slices but also lung 
slices are metabolizing several drugs (Fisher et al., 1994; Vickers et al., 
1995; de Kanter et al., 1999). More importantly, the relative contribution to 
drug metabolism by the different metabolizing organs not only differs 
between compounds but also between animal species (Vickers et al., 1995; 
de Kanter et al., 1999). Consequently, to rightfully predict in vivo 
metabolism for animal species selection, slices of both liver and extra-
hepatic metabolizing organs may be required. 
Cryopreservation of these tissue slices would greatly facilitate their use. 
Basically, by cryopreservation, living material is kept in a state at which 
biological processes are brought to a stand-still after cooling to liquid 
nitrogen temperatures (-196°C), so that storage for infinite years is 
theoretically possible (Mazur, 1984). When damage to cells is prevented 
during cooling and subsequent thawing, slices should remain viable and 
resume their functional activity when brought back to physiological 
temperatures (37°C). Cryopreservation of tissue slices has many 
advantages: In some cases, many more slices are produced from organs 
than can be used directly within an experiment. By cryopreservation, these 
left-over slices could be stored and thawed at any desired time-point. 
Except for these logistic advantages, another benefit of this approach is that 
the number of laboratory animals required is further reduced. Moreover, 
cryopreservation simplifies the use of organ slices of human origin, of which 
the supply is limited, irregular and unpredictable. Ideally, tissue slices of 
human and animal origin could be stored by cryopreservation, forming a 
tissue slice-bank from which slices can be derived and used for species 
comparison studies on drug metabolism and toxicity.  
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Application of several methods for the cryopreservation of liver slices, more 
or less successful, has been reported in the last decade (Fisher et al., 1991; 
Wishnies et al., 1991; Fisher et al., 1993; de Kanter and Koster, 1995; 
Fisher et al., 1996; Ekins, 1996a; Ekins et al., 1996a; Ekins et al., 1996b; 
Glöckner et al., 1996; Glöckner et al., 1998; Glöckner et al., 1999; de 
Kanter et al., 1998; Day et al., 1998; Maas et al., 2000a; Maas et al., 2000b; 
de Graaf et al., 2000b, Sohlenius-Sternbeck et al., 2000; Glöckner et al., 
2001; Vanhulle et al., 2001). Some cryopreservation methods exist for 
precision-cut kidney slices (Fisher et al., 1993; Fisher et al., 1996). To our 
knowledge, cryopreservation methods for other extra-hepatic tissue slices 
are not reported. 
In this chapter, the basic principles and critical issues of 
cryopreservation are discussed. Furthermore, emphasis is put on viability 
and functionality end-points that can be used to determine the 
cryopreservation outcome. Finally, cryopreservation methods for tissue 
slices are reviewed.  
 
 
Cryopreservation by prevention of intracellular ice formation 
 
The basis of the development of most cryopreservation methods is the 
prevention of intracellular ice formation (IIF), which is thought to be 
incompatible with life. Cell dehydration by equilibrium freezing and 
vitrification both prevent IIF, yet have a completely different mechanistic 
principle.   
 
Cell dehydration by equilibrium freezing: critical issues  
When a system containing cells and surrounding medium is cooled below 
0°C, the liquid initially stays unfrozen (supercooled). The formation of ice 
nuclei becomes more probable when the supercooling is persisting longer 
and lower temperatures are reached. Because nucleation is a statistical 
event, it is most probable that the first ice nucleus is formed in the 
relatively high volume of extracellular medium rather than in a cell. 
Because ice crystals subsequently grow from pure water in the extracellular 
medium, the solutes in the unfrozen medium become more concentrated. 
As a result of this, the chemical potential of supercooled water within the 
cell becomes higher than in the external medium and water flows out of the 
cell. When freezing is slow enough to allow sufficient exosmosis of water 
from the cell, the chemical potential of cellular water and unfrozen water 
Chapter 1  
 12
outside the cells remain in equilibrium and the cell completely dehydrates, 
without freezing intracellularly (Mazur, 1984). Numerous publications 
exists that report successful cryopreservation of isolated cell types and 
oligocellular systems using this approach, for example of red blood cells 
(e.g. Pegg, 1981), 1-8 cell mouse embryos (e.g. Whitingham et al., 1972) and 
hepatocytes (e.g. Powis et al., 1987; Condouris et al., 1990; Diener et al., 
1993; Maas et al., 2000a).  
The curve relating viability of a certain type of cell after (slow) freezing to 
the freezing rate is generally bell-shaped: At supra- and suboptimal cooling 
rates, viability is relatively low (Mazur et al., 1972). This suggests that 
survival is determined by two factors, reversibly depending on the cooling 
rate. At supra-optimal cooling rates, there is not enough time for 
intracellular water to diffuse out of the cell to equalize the chemical 
potential of the intra- and extracellular environment and ice crystals are 
formed intracellularly (Mazur, 1984). At sub-optimal rates, low viability is 
probably caused by concentrated solutes: Because cooling is very slow, cells 
are exposed to high intra- and extracellular salt concentrations or changes 
in pH during a relatively long time-period (Lovelock, 1953a; Mazur, 1970). 
Moreover, the more cells dehydrate, the smaller is the volume of the 
unfrozen fraction of liquid remaining within and surrounding the cells. 
Wiest and Streponkus (1978) and Mazur and Cole (1989) have postulated 
that cell death in the course of slow freezing is caused by this latter 
phenomenon. These problems can be circumvented by the addition of 
cryoprotectant agents (CPAs) that decrease the amount of liquid that can 
freeze, thereby lowering intracellular salt concentration and preventing an 
extreme volume decrease of cells (Lovelock, 1953b; Meryman et al., 1977). 
However, only low CPA concentrations are tolerated during equilibrium slow 
freezing (Fahy, 1981), because the elevation of intracellular CPA 
concentrations due to cell dehydration may also contribute to cell damage 
by slow freezing (Fahy, 1986). 
Which cooling rate is optimal for survival is dependent on the cell type. 
Important factors are the surface to volume ratio of the cell and the 
permeability of its membranes, both determining the amount of water that 
can leave the cell per unit of time. Red blood cells for example have, 
because of their disc-like shape, a high surface to volume ratio. Besides of 
this, their membranes are very permeable to water. Therefore, optimal 
cooling rates are higher for red blood cells than for most other cells (Mazur, 
1984). The fact that different cell types have different optimal cooling rates 
has implications for the applicability of slow freezing methods for 
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cryopreservation of tissues and organs: tissues exist of multiple cell types 
that may require different cooling rates for survival and when a tissue is 
frozen with a certain cooling rate, survival of the different cell types may not 
be equally high. Furthermore, although for single cells extracellular ice 
formation during slow freezing is not thought to be deleterious, extracellular 
ice may cause severe damage in tissues, since it concentrates in the 
vascular or interstitial space (Pegg, 1987, Bischof et al., 1997). For these 
reasons, slow freezing of organs and complex tissues (particularly when 
methods are used that are optimized with isolated cells) is usually not 
successful (e.g. Alink et al., 1978; Taylor and Pegg, 1983). 
      
Vitrification: critical issues 
Vitrification is thought to be the most promising starting point for the 
cryopreservation of organs, since by this approach, cell damaging events 
like effects of concentrated salts and CPAs, IIF, intravascular and 
interstitial ice formation, all likely to occur during slow freezing of organs, 
are circumvented (Fahy and Hirsh, 1982). Essentially, vitrification is the 
solidification of a liquid not brought about by crystallization but by an 
extreme elevation in viscosity during cooling, so that the solution becomes a 
glass.  
In principle, every solution (including water) can be vitrified, as long as 
the cooling rates are high enough. For vitrification to occur within ranges of 
cooling rates that are relevant for the cryopreservation of biological 
material, addition of CPAs is necessary. By assessing the critical cooling 
rate, i.e. that cooling rate that is required to prevent ice crystal formation, 
several compounds have been studied in their tendency to form a glass 
when mixed with aqueous solutions. The critical cooling rate of the CPA 
solution depends on the chemical properties of the CPA and on the solution 
that is used to dilute the CPA. For example, to avoid ice crystallization while 
cooling at a rate of 100-400°C/min (rates that are achievable with tissue 
slices), approximately 45% w/w glycerol (Boutron, 1993), 43% w/w DMSO 
(Baudot et al., 2000), 35% w/w 1,2-propanediol (Boutron, 1993) or 30% 
w/w l/d 2,3 butanediol (Boutron, 1993) are required. The critical cooling 
rate of 30% w/w l/d 2,3 butanediol is lowered from 270 to 150°C/min when 
the cryoprotectant is dissolved in Eurocollins (amongst others consisting 
of saline buffer and glucose) instead of water (Boutron, 1993). The critical 
cooling rate of a CPA can be reduced by applying pressure on the sample 
(Fahy and Hirsh, 1982). 
Chapter 1   
 14
Because high concentrations of CPAs are necessary to achieve vitrification, 
their toxicity is a major issue to be dealt with when vitrification protocols 
are designed (Fahy and Hirsh, 1982). CPA toxicity can be both chemical and 
osmotical of origin. One approach to reduce chemical toxicity of a 
cryoprotectant solution, without diminishing its glass forming tendency, is 
to combine different CPAs with different mechanisms of toxicity or that even 
antagonize each others toxic effects (Baxter and Lath, 1971; Fahy, 1984, 
Fahy et al., 1987). Chemical toxicity can also be reduced by introducing the 
CPA at a low temperature. Protocols have been developed that elevate CPA 
concentrations stepwise at temperatures as low as –60°C (e.g. Elford and 
Walter, 1972, Kheirabadi and Fahy, 2000). However, decreasing the 
temperature of CPA introduction increases the probability of the occurrence 
of osmotic effects of CPA exposure. These effects occur, because the cell 
membrane is less permeable for most CPAs than for water. Consequently, 
when a cell is exposed to a certain CPA solution, it will first shrink, because 
of the higher osmolarity of the cryoprotectant solution, and eventually 
return to its normal volume when the CPA enters the cell. Reversibly, if cells 
permeated with CPAs are brought into CPA-free buffer solution for washing, 
water first enters the cell before the CPA gets out, resulting in (extensive) 
cell swelling and ultimately lysis (Levin and Miller, 1984; Pegg and Diaper, 
1990). Osmotic damage may be prevented by introducing and removing the 
CPA stepwise, allowing the cells to regain their original volume before each 
additional step. To prevent cell swelling during CPA removal, washing 
solutions that are made hypertonic by addition of impermeable sugars 
(trehalose, sucrose) can be used (Pegg and Diaper, 1990).   
Besides cryoprotectant toxicity, devitrification is another process that 
needs to be considered when designing a vitrification protocol for 
cryopreservation of biological material. Devitrification is the crystallization 
of water that occurs in samples that were originally vitrified upon cooling, 
when warming is too slow. The occurrence of devitrification can be 
explained by viewing two processes leading to ice crystal formation, i.e. 
nucleation and growth of ice crystals from those nuclei. These processes 
both occur during cooling, however, the formation of ice nuclei is favoured 
at relatively low temperatures. At these temperatures, the growth of ice 
crystals has almost come to a stand-still. So, during cooling the formation 
of ice crystals is less likely than on warming, when the temperature trace 
on which nucleation is favoured comes before the temperature trace of 
maximal ice-crystal growth (MacFarlane, 1987). This is illustrated by the 
difference between the critical cooling and warming rates (i.e. the warming 
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rate required to prevent devitrification during warming) of CPAs: while the 
critical cooling rates of 45% w/w glycerol, DMSO, 1,2-propanediol and l/d-
2,3 butanediol solutions are 380, 14, 10 and 2.5 <°C/min (Boutron, 1993; 
Baudot et al., 2000), the critical warming rates are much higher: 5.6 *108, 
3300, 80 and 80°C/min respectively (Boutron and Mehl, 1990). Therefore, 
for successful cryopreservation by vitrification, emphasis should be put on 
attaining high enough warming rates to prevent IIF upon thawing in 
vitrified samples. Electromagnetic heating has been postulated as a manner 
to achieve this (Burdette, 1972). 
Cells and tissues permeated with CPAs often have lower critical cooling 
and warming rates than bulk CPA solutions (Peridieu et al., 1995; 
Takahashi and Hirsh, 1985). This phenomenon is probably triggered by the 
high protein content of the intracellular matrix, causing it to more or less 
behave as a cryoprotectant (Rapatz and Luyet, 1960). Moreover, in a tissue 
and within cells, liquid is compartmentalized. Compartmentalization of 
water is known to increase supercooling and inhibit crystal formation 
(Yamane et al., 1992). 
 
 
Viability determination of tissue slices   
 
Cryopreservation of tissue slices is considered to be successful when they 
remain (functionally) viable for a sufficiently long period after thawing. A 
number of parameters have been used to determine the integrity of fresh 
and cryopreserved tissue slices. Roughly, commonly used parameters can 
be divided in 1) drug metabolism related parameters (metabolism of model 
substrates, activity of metabolic enzymes, enzyme content, Table 1a), 2) 
functionality parameters other than drug metabolism (urea synthesis, MTT 
reduction, protein synthesis, organic anion transport and gluconeogenesis, 
Table 1b) and 3) parameters that reflect the general cellular condition 
(histomorphological examination, potassium content, ATP content or energy 
charge, retention of cellular enzymes and GSH content, Table 1c). 
 
Drug metabolism related parameters 
The most obvious manner to test biotransformation capacity of a tissue 
slice is to measure metabolite formation of a model compound. Amongst the 
substrates that are often used for this purpose (Table 1a) is testosterone 
which is oxidized to several hydroxyl metabolites and androstenedione. 
Another regularly used model compound is 7-ethoxycoumarin (7-EC), which 
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is mainly O-deethylated to 7-hydroxycoumarin (7-HC) followed by O-
glucuronidation and O-sulfation by liver slices, but mainly hydrolysed to 4-
ethoxy-2-hydroxyphenyl propionic acid (EPPA) by extra-hepatic tissue slices 
(de Kanter et al., 2002a). Other used model substrates are lidocaine (N-
deethylation), naphtol (direct glucuronidation/sulphation) and chloro-
dinitrobenzene (CDNB) (glutathione conjugation). These compounds are 
added to the intact slice and consequently metabolite formation not only 
depends on enzyme activity but also on cofactor content of the slice as well 
as transport of substrates into the slice and of metabolites out of the slice. 
Specific activity of metabolic enzymes of slices is generally measured in 
slice homogenate after addition of cofactors or NADP regenerating system, 
circumventing the role of cofactor availability and transport. Enzyme 
activity assays used for slices include those for several CYPs (e.g. with 7-EC 
(ECOD-activity), 7-ethoxyresorufin (EROD-activity), 7-benzoxyresorufin 
(BROD-activity) or testosterone as substrate), N-acetyltransferases, 
gluthation-s-transferase (GST), glucuronyltransferases and sulfotrans-
ferases (Table 1a).  
Immunochemic assays are often used to measure the presence of 
several metabolic enzymes, without determining their activity (Table 1a). 
 
Functionality parameters other than drug metabolism 
In most terrestial vertebrates urea synthesis is the mechanism to dispose of 
NH4 formed in the breakdown of amino acids and an exclusive property of 
liver tissue. Urea synthesis in the presence of ornithine sets off in the 
mitochondrial matrix of liver cells and is finalized in the cytosol and is a 
highly regulated, ATP-dependent cycle that involves several enzymes. The 
use of urea synthesis as a viability parameter for liver slices has been 
reported by several authors (Table 1b).  
In the MTT (3[4,5-dimethylthiazole-2-yl]2,5-diphenyltetrazoliumbromide) 
test, tetrazolium is converted (at least partly) by succinate dehydrogenase, 
an enzyme linked to the inner mitochondrial matrix and involved in the 
citric acid cycle. Strongly light-absorbing formazan products are formed 
that precipitate in the cell. After extraction, the absorbance is assessed and 
used as a measure of slice functionality (Table 1b). Although MTT reduction 
is often used to determine mitochondrial function, there exist indications 
that MTT reduction is not solely converted by mitochondrial enzymes 
(Berridge and Tan, 1993).  
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Table 1a Drug metabolism related parameters used for viability determination of fresh and 
cryopreserved tissue slices 
 
 
Parameter  
 
References 
 
 
Metabolism of model compounds 
- testosterone 
                          
 
                           
- 7-EC, 7-HC 
                           
                           
 
 
- lidocaine 
 
- naphtol 
 
- CDNB 
 
- paracetamol 
 
Enzyme activity 
- CYPs 
 
 
 
- GsT 
 
- N-acetyl transferases 
 
- glucuronyltransferases 
 
- sulfotransferases 
 
Enzyme content/expression 
 
 
 
 
de Kanter and Koster, 1995; Ekins, 1996c; Ekins et al., 1996b; Olinga et al., 1997a; 
de Kanter et al., 1998; de Kanter et al., 1999; de Graaf et al., 2000b; Maas et al., 
2000a; Maas et al., 2000b; Sohlenius-Sternbeck et al., 2000; Glöckner et al., 2001 
 
Barr et al., 1991a; Barr et al., 1991b; Wishnies et al., 1991; Ekins, 1996a; Ekins, 
1996c; Ekins et al. 1996a; Ekins et al. 1996b; Singh et al., 1996; Olinga et al., 1997a; 
Day et al., 1998; de Kanter et al., 1998; Glöckner et al., 1998; Price, 1998b; de 
Kanter et al., 1999; de Graaf et al., 2000b; Sohlenius-Sternbeck et al., 2000;  
 
Olinga et al., 1997a; de Kanter et al., 1998; de Kanter et al., 1999;  
 
Singh et al, 1996; Sohlenius-Sternbeck et al., 2000 
 
Ekins, 1996c; Maas et al., 2000a; Maas et al., 2000b 
 
Vanhulle et al., 2001 
 
 
Gokhale et al., 1995; Fisher et al., 1995a; Steensma et al., 1994; Drahusnuk et al., 
1996; Lake et al., 1996; Müller et al., 1996; Gokhale et al., 1997; Müller et al., 1998; 
Price et al., 1998a; Vandenbrande et al., 1998; Glöckner et al., 1998;  
 
Toutain et al., 1998; Maas et al., 2000a; Maas et al., 2000b; 
 
Gunawardana et al., 1991 
 
Hashemi et al., 1999; Vandenbrande et al., 1998 
 
Hashemi et al., 1999; Vandenbrande et al., 1998 
 
 
Steensma et al., 1994; Drahusnuk et al., 1996; Lake et al., 1996; Price et al., 1998a; 
Lupp et al., 2001; Vanhulle et al., 2001 
  
 
The active transport of organic anions and cations by proximal tubuli cells 
within the kidney cortex is used as functionality parameter for kidney 
slices. Normally, the slice to medium ratio of radio-labelled model 
substrates such as tetraethylammonium (TEA) and para-amino hippurate 
(PAH) is used as a measure (Table 1b). 
Protein synthesis is a coordinated and complicated interplay of several 
cellular macromolecules and takes place on the ribosomes associated to the 
RER. The synthesis starts with ATP-dependent activation of amino acids. 
The incorporation of 14C-leucine into precipitable protein can be quantified 
as a measure for the capability of a slice to synthesize proteins and is used 
to determine functional activity of liver, kidney and lung slices (Table 1b).
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Table 1b Functionality parameters used for viability determination of fresh and cryopreserved tissue 
slices 
 
 
Parameter  
 
References 
 
 
Functionality parameters  
Urea synthesis 
 
MTT reduction 
 
 
Protein synthesis 
        
  
 
TEA transport 
 
PAH transport 
 
Gluconeogenesis 
 
 
 
Fisher et al., 1993; de Kanter and Koster, 1995; Day et al., 1998; Maas et al., 2000b 
 
Leeman et al., 1995; Olinga et al., 1997a; Obatomi et al., 1998; Maas et al., 2000a; Maas et 
al., 2000b; Sohlenius Sternbeck et al., 2000 
 
Smith et al., 1986; Fisher et al., 1991; Fisher et al., 1993; Fisher et al., 1994; Fisher et al., 
1995a; Fisher et al., 1995b; Ekins, 1996a; Fisher et al., 1996; Glöckner et al., 1998; Toutain 
et al., 1998; Glöckner et al., 1999 
 
Fisher et al., 1993 
 
Fisher et al., 1993 
 
Fisher et al., 1993 
 
Gluconeogenesis is an in vivo characteristic of the liver and to lesser extend 
of the kidney cortex. Glucose is produced under consumption of ATP from 
various non-carbohydrate precursors via pyruvate. Gluconeogenesis is used 
as functionality parameter for liver slices (Table 1 b). 
 
Parameters that reflect general viability of slices 
Histomorphological examination of precision-cut tissue slices is reported by 
several authors to be a sensitive way to examine slice integrity (Table 1 c). 
To be able to study slices microscopically, thin longitudinal or cross 
sections are made that can be stained with standard staining solutions 
(H&E, toluidine blue) or specific or immunohistochemic stainings (e.g. 
glycogen (Lupp et al., 2001); CYPs (Lupp et al., 2001) Connexin32 (de Graaf 
et al., 2000a)). Studying histomorphology is useful to determine cell or site 
specific toxicity of CPAs or damage by cryopreservation. 
The retention or leakage of cellular enzymes with a relatively large 
molecular weight like alanine- or aspartate-aminotransferase (ALT, AST), 
lactate dehydrogenase (LDH), alkalic phosphatase (AP) and gamma-
glutamyl transpeptidase (γGT) is often used to determine membrane 
integrity of cells in a slice (Table 1c). Since there is normally no active 
secretion of these molecules by cells and there is no evidence that cells 
benefit from the loss of these compounds, the release of these enzymes is 
considered to be a pathological manifestation (Danpure, 1984). LDH, AP, 
ALT and AST are relatively abundant in liver and are therefore used as 
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viability parameter for liver slices. For the same reason, LDH, AP and γGT 
retention can be used to determine the quality of kidney slices and LDH and 
AP for lung slices. AP is predominantly located in the mucosa cells of the 
intestines, hence can be of use to determine viability of the epithelium of 
intestinal slices.       
ATP is the universal energy source of cells and loss of ATP has been 
directly associated with influx of extracellular sodium and calcium and 
efflux of intracellular potassium leading to cell swelling and eventually 
necrosis (e.g. Carini, 1999). It should be noticed, however, that directly after 
slice preparation ATP levels of slices are often low probably due to warm 
ischemia upon liver excision and low temperatures during slicing. After 
placing the slices in oxygenated, 37°C medium, ATP levels recover to 
physiological values within 1-4 h (Smith et al., 1986; Smith et al., 1987; 
Dogterom et al., 1993; Toutain et al., 1998; De Kanter et al., 1999; Maas et 
al., 2000a; Maas et al., 2000b), due to a temperature dependent re-
equilibrium phenomenon (Smith et al., 1987). The major ATP consuming 
processes in a cell are protein synthesis and the regulation of cellular ion 
concentrations. Generally, ATP content is considered to be a very sensitive 
viability parameter and can be sensitively measured with luciferine-
luciferase based assays (Gould and Subramani, 1988). The energy status of 
a cell can also be defined by the energy charge (½ADP + 
ATP)/(AMP+ADP+ATP) (Atkinson, 1968), which gives an indication of both 
energy consuming and producing processes in a cell. 
Retention of cellular potassium is determined in slices (Table 1c) by 
several author as (sensitive) measure for membrane integrity but also for 
energy status, since Na+/K+ ATP-ases, directly responsible for intracellular 
ion regulation, are consuming a major part of cellular ATP. For this reason, 
it is not surprising that potassium content often correlates with cellular ATP 
content, showing a similar increase of initial low values upon culturing of 
the slices after preparation (Smith et al., 1986; Smith et al., 1987; Dogterom 
et al., 1993; Maas et al., 2000b).  
Glutathione is measured as oxidized (GSSG) or reduced (GSH) form by 
several authors (Table 1c). The ratio of GSH/GSSG can be used to monitor 
oxidative stress. 
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Table 1c Parameters used for viability determination of fresh and cryopreserved tissue slices that 
reflect general viability   
 
 
Parameter  
 
References 
 
 
Histomorphology 
 
 
 
 
 
Leakage of cellular 
enzymes 
 
 
 
K+ content 
 
 
 
 
 
ATP content 
 
 
 
Energy charge 
 
GSH content 
 
 
 
Smith et al., 1985; Ruegg, 1987; Beamand et al., 1993; Gokhale et al., 1995; Ekins et al., 
1996a; Gokhale et al., 1997; Leeman et al., 1995; Singh et al., 1996; Olinga et al., 1997a; 
Toutain et al., 1998; Hashemi et al., 1999; De Graaf et al., 2000a; de Graaf et al., 2000b; 
Maas et al., 2000a; Maas et al., 2000b; Shigematsu et al., 2000; Lupp et al., 2001; Vanhulle 
et al., 2001 
 
Smith et al., 1985; Miller et al., 1993; de Kanter and Koster, 1995; Fisher et al., 1995a; 
Fisher et al., 1995b; Olinga et al., 1997a; Day et al., 1998; de Kanter et al., 1998; Obatomi et 
al., 1998; Maas et al., 2000a; Maas et al., 2000b; Sohlenius-Sternbeck et al., 2000; 
Glöckner et al., 2001;  Vanhulle et al., 2001 
 
Smith et al., 1985; Smith et al., 1986; Fisher et al., 1991; Fisher et al., 1993; Dogterom, 
1993; Fisher et al., 1995a; Fisher et al., 1995b; Fisher et al., 1996; Baumann et al., 1996; 
Glöckner et al., 1996; Müller et al., 1996 Olinga et al., 1997a; Sidelmann et al., 1996; 
Glöckner et al., 1998; Müller et al., 1998; Price et al., 1998a; Vandenbrande et al., 1998; 
Glöckner et al., 1999; de Graaf et al., 2000b;  Maas et al., 2000b 
 
Smith et al., 1986; Dogterom et al., 1993; Miller et al., 1993; Fisher et al., 1995a; Sidelmann 
et al., 1996; Singh et al., 1996; Toutain et al., 1998; De Kanter et al., 1999; Martin et al., 
2000; Maas et al., 2000a; Maas et al., 2000b; Shigematsu et al., 2000; Vanhulle et al., 2001 
 
Olinga et al., 1997a 
 
Müller et al., 1996; Singh et al., 1996; Toutain et al., 1998; Hashemi et al., 1999; Müller et 
al., 1998; Price et al., 1998a; Maas et al., 2000a; Maas et al., 2000b; Glöckner et al., 2001 
 
 
 
Application of equilibrium slow freezing and vitrification for the 
cryopreservation of tissue slices   
 
For tissue slices, with physical dimensions (8 mm x 200 µm) laying in 
between those of isolated cells and whole organs, a number of 
cryopreservation methods have been published in the past decade. Table 2a 
and 3a give an overview of existing cryopreservation methods that are 
mechanistically based on equilibrium slow freezing and vitrification 
respectively. Table 2b and 3b show the viability of slices after application of 
these methods.   
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Table 2a Slow freezing methods for cryopreservation of tissue slices 
 
  
Fisher et al.  (1991) 
 
Fisher et al.  (1991) 
 
Fisher et al.  (1993) 
 
 
Fisher et al.  (1996) 
 
Maas et al. (2000a) 
Optimization 
Species, organ  
 
Parameters 
optimized  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ultimate method: 
CPA solution 
 
 
CPA introduction 
  
 
 
 
Cooling technique 
 
 
 
Cooling rate 
 
Warming technique 
 
 
Warming rate 
 
CPA outwashing 
 
 
Remarks 
 
 
pig liver  
 
CPA and CPA 
conc. (0.7,1.4, 2.8 
or 4.2 M DMSO or 
0.7, 1.4, 2.8 or 4.2 
M glycerol or 
1.4/1.4, 1.4/2.8 or 
1.4/4.2 M 
DMSO/glycerol), 
CPA carrier 
solution 
(WM/10%FCS, 
KH, FCS, HS,  
NCS), cooling 
rate (0.5, 1, 2, 4 
and 8 and 
12°C/min) 
 
1.4 M DMSO in 
FCS 
 
20 min, 25°C 
 
 
 
 
computer 
controlled, slice 
basket 
  
12°C/min  
 
basket in 37°C 
FCS 
 
“fast” 
 
twice in 37°C FCS 
 
 
 
 
 
 
human liver 
 
cooling rate (0.5, 
1, 2, 4, 8 or 
12°C/min) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4 M DMSO in 
FCS 
 
20 min, 25°C 
 
 
 
 
computer 
controlled, slice 
basket 
 
1°C/min  
 
basket in 37°C 
FCS 
 
“fast” 
 
twice in 37°C 
FCS 
 
variation 
between livers, 
perfused livers: 
better results 
 
human kidney 
 
cooling rate (0.5, 
1, 2, 4, 8 or 
12°C/min) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4 M DMSO in 
FCS 
 
20 min, 25°C 
 
 
 
 
computer 
controlled, slice 
basket 
 
12°C/min  
 
basket in 37°C 
FCS 
 
“fast” 
 
twice in 37°C 
FCS 
 
 
 
 
 
dog liver 
 
cooling rate 
(0.5, 1, 2, 4, 8 
or 12°C/min) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4 M DMSO in 
FCS 
 
20 min, 25°C 
 
 
 
 
computer 
controlled, slice 
basket 
 
 0.5°C/min  
 
basket in 37°C 
FCS 
 
“fast” 
 
twice in 37°C 
FCS 
 
 
 
 
rat liver 
 
cooling rate: 0.5, 1 
or 4°C/min, pre-
incubation period 
(10, 20, 30 or 60 
min), liver 
perfusion (yes or 
no), CPA (10% 
DMSO or 5% 
DMSO/4.1 % 
EG/10% PVP), 
CPA carrier 
solution (WME, 
WME/10% FCS, 
FCS, UW) 
 
 
 
10% DMSO in UW 
 
 
stepwise, 10 min 
5%, on ice, then 
15 min in cryovial 
10% at 0°C 
 
computer 
controlled, 
cryovial 
 
1°C/min 
 
vial in 37°C 
waterbath 
 
“fast” 
 
37°C WME/10% 
FCS 
 
 
 
 
 
WM= Waymouths medium, KH= Krebs-Henseleit buffer, FCS= fetal calf serum, HS= horse serum, 
NCS= newborn calf serum, EG=ethylene glycol, PVP= polyvinylpyrrolidone 
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Table 2b Viability of tissue slices after cryopreservation according to slow freezing methods 
 
 
Author 
 
 
Species, 
organ 
 
 
Incubation 
period 
 
Method of 
 
Viability parameter  (% fresh slice value) 
 
Remarks 
Fisher et al.  
(1991) 
 
 
 
 
 
 
Fisher et al.  
(1993) 
 
 
 
 
 
 
Fisher et al.  
(1996) 
 
 
 
 
 
Maas et al. 
(2000a) 
 
 
 
 
 
 
 
Maas et al. 
(2000b) 
 
 
pig liver 
 
 
 
human liver 
 
 
 
human liver 
 
 
 
human 
kidney 
 
 
dog liver 
 
 
dog kidney 
 
 
 
rat liver 
 
 
 
 
 
 
 
 
rat liver 
4 h 
 
 
 
4 h 
 
 
 
4 h 
 
 
 
4 h 
 
 
 
4 h 
 
 
4 h 
 
 
 
0, 2 h 
 
 
 
 
 
 
 
 
0, 4, 8 h 
 
 
 
 
Fisher et al.  
(1991), method for 
pig liver 
 
Fisher et al.  
(1991), method for 
human liver 
 
Fisher et al.  
(1991), method for 
human liver 
 
Fisher et al.  
(1993) 
 
 
Fisher et al.  
(1996) 
 
Fisher et al.  
(1993), method for 
human kidney 
 
Maas et al. 
(2000a)  
 
 
 
 
 
 
 
Maas et al. 
(2000a) 
K+ content (80 %), protein synth. 
(85%) 
 
 
K+ content (60%), protein synth. (66%) 
 
 
 
K+ content (80%), protein synth. 
(77%), gluconeogenesis (82%), urea 
synth. (112%)  
 
K+ content (78%), protein synth. (70%), 
PAH transport (83%), TEA transport 
(78%) 
 
K+ content (72%), protein synth. (75%) 
 
 
K+ content (67%), protein synth. (65%) 
 
 
 
2 h: MTT conversion (80%), CDNB 
conj. (15%), testost. metab. (60%), 
GsT activity (30%), GSH content 
(40%), LDH leakage (0-2 h: 85% of 
total LDH ), ATP content (15%), 
histomorphology (no living cells). At 0 
h: only ATP content and CDNB conj. 
different from fresh 
 
ATP content (4 h, 8 h:<5%), K+ content 
(4 h, 8 h: <5%), GSH content (4 h: 
30%, 8 h: 20%), LDH leakage (after 4 
h 90% leaked out, after 8 h: 90%), 
GsT activity (4 h, 8 h: 10-20%), CDNB 
conj. (4 h, 8 h: 10%), testost. metab. (4 
h: comparable to fresh values, 8 h: 
50%), urea synth. (0-3 h: 50%, 4-7 h: 
20%, 8-11 h: 20%), histomorphology: 
4 and 8 h: almost no living cells. 0 h: 
50 (ATP content, K+ content) to 100% 
(testost. metab.) of fresh values  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
method 
compared 
with rapid 
freezing 
method: 
rapid 
freezing 
better 
 
Fisher et al. (1991; 1993; 1996) have reported the successful cryo-
preservation of human liver and kidney slices as well as dog and pig liver 
slices by a classical equilibrium freezing approach after permeating the 
slices with 10% DMSO in Fetal Calf Serum (FCS) and optimal freezing rates 
varying between 0.5 (dog liver slices) and 12°C/min (human kidney slices). 
Viability and functionality were all more than 60% of fresh values, as 
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measured by potassium retention, protein synthesis, gluconeogenesis 
(human liver slices), urea synthesis (human liver slices), organic anion 
(PAH) transport (human kidney slices) and cation (TEA) accumulation 
(human kidney slices). However, the authors reported that rat liver slices 
could not be successfully cryopreserved using this approach, with a 
viability of approximately 10-25% compared to fresh slices (Fisher et al., 
1991). Besides this, viability of cryopreserved human liver slices depended 
more than that of fresh slices on the liver condition, determined by the 
duration of warm ischemia and the source from which the liver was derived 
(surgical waste or transplantation liver) (Fisher et al., 1991; Fisher et al., 
2001). Maas et al. (2000a and 2000b) also showed that rat liver slices 
rapidly degenerate after thawing when they are slowly frozen (1°C/min), 
with particularly ATP content, CDNB conjugation and slice histomorphology 
showing marked differences compared with fresh slices. This is in contrast 
with rat hepatocytes that were frozen relatively succesfully with this method 
(Maas et al., 2000a). 
Vitrification of (human) liver slices was first reported by Wishnies et al. 
(1991) using a high molarity solution of 1,2-propanediol (4.7 M) in FCS 
which was introduced to the slices according to a stepwise protocol. Slices 
were subsequently vitrified by placing the stainless steel grids on which 
they were positioned directly into liquid nitrogen. In this manner the 
estimated cooling rate was approximately 5000°C/min and slices had a 
glassy appearance after reaching liquid nitrogen temperatures that is 
typical for vitrified tissue. Slices were reported to maintain both phase I and 
phase II biotransformation to some extent, but results varied considerably 
and seemed to be dependent on the donor liver from which slices were 
derived and on storage time in liquid nitrogen (with unclearified higher 
activity of vitrified and thawed slices after longer storage periods). 
Ekins (1996a), using approximately the same method, found that the 
coupled metabolism of 7-EC to 7-HC and its conjugates was well 
maintained in vitrified and thawed rat liver slices. However, when the slices 
were incubated with 7-HC instead of 7-EC, conjugation was significantly 
lower (approximately 50% of fresh slices). Protein synthesis was only 3-35% 
of fresh slice levels. Vitrified dog liver slices had a very low conjugation 
activity (Ekins et al., 1996b). In a later study, Ekins et al. (1996a) proposed 
the use of ‘antifreeze’ proteins for optimal vitrification of liver slices. 
Allthough results were improved using these proteins, biotransformation in 
thawed slices was still considerably lower than in fresh slices. 
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Table 3a Vitrification methods for tissue slices 
 
  
Wishnies et al.  (1991) 
 
 
Ekins et al.  (1996a) 
 
optimization 
Species, organ  
 
Parameters optimized 
 
ultimate method: 
CPA solution 
 
 
CPA introduction 
  
Cooling technique 
 
Cooling rate 
 
Warming technique 
 
Warming rate 
 
CPA outwashing 
 
Remarks 
 
 
 
human liver 
 
not shown 
 
 
4.7M 1,2 propanediol in FCS 
 
 
stepwise 3x5 min, 0°C 
 
direct exposure to liquid N2 on tray 
 
 5000°C/min. 
 
tray direct in 37°C FCS 
 
5000°C/min. 
 
15 min. in 0°C FCS 
 
unexplained variation between donors and 
different storage periods 
 
 
rat liver  
 
4.7 M 1,2 propanediol in FCS with or without 
antifreeze proteins 
 
4.7M 1,2 propanediol in FCS with antifreeze 
proteins 
 
stepwise 3x8 min, 0°C 
 
direct exposure to liquid N2 on cryocassette 
  
5000°C/min. 
 
cryocassette direct in 37°C FCS 
  
5000°C/min. 
 
15 min. in 0°C FCS 
 
 
 
 
Table 3b Viability of tissue slices after cryopreservation according to vitrification protocols 
 
 
Author 
 
 
Species, 
organ 
 
 
Incubation 
period 
 
Method of 
 
Viability parameter  (% fresh slice value) 
 
Remarks 
 
Wishnies et 
al. (1991) 
 
Ekins, 
(1996a) 
 
 
 
 
Ekins et al.  
(1996a)  
 
 
 
Ekins et al.  
(1996b) 
 
human 
liver 
 
rat liver 
 
 
 
 
 
rat liver 
 
 
 
 
dog liver 
 
0-6 h 
 
 
4 h 
 
 
 
 
 
4 h 
 
 
 
 
1 h, 20 
min. pre-
inc. 
 
Wishnies et 
al. (1991) 
 
Wishnies et 
al. (1991) 
 
 
 
 
Ekins et al. 
(1996a) 
 
 
 
Wishnies et 
al. (1991) 
 
 
total 7-EC metab., 7-HC conj. 
(results very variable) 
 
7-EC O-deethylation 
(>200%), 7-HC conj. (7-EC 
as substrate: 100%), direct 7-
HC conj. (50%), protein 
synth. ( 3-35%) 
 
metabolism 7-EC to 7-HC 
and conjugates retained, 
direct 7-HC conj. (25-40%) 
minor mitochondrial swelling 
 
7-EC O-deethylation 
(>800%), 7-HC conj. (7-EC 
as substrate: <20%) 
 
 
 
 
 
modifications from original 
method: cryocassette instead of 
tray, CPA pre-inc.: 3 x 8 instead 
of 3 x 5 min, results worse after 
24 h storage 
 
 
 
 
 
 
modifications from original 
method: cryocassette instead of 
tray, CPA pre-inc.: 3 x 8 instead 
of 3 x 5 min 
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Rapid freezing as an approach for cryopreservation of tissue slices 
 
De Kanter and Koster (1995) have shown for the first time that rapid 
freezing (250°C/min) after pre-incubation with a low (12%) concentration of 
DMSO maintains viability of rat liver slices better than slow freezing (0.6, 
1.5 or 50 °C/min) (Table 4a and b). This is a remarkable result because 
isolated rat hepatocytes only survive if cooling rates are very low (1°C/min) 
(Powis et al., 1987; Condouris et al., 1990; Diener et al., 1993; Maas et al., 
2000a).  
De Kanter and Koster found that after cryopreservation by rapid freezing 
and thawing, slices of rat and monkey maintained testosterone metabolism, 
ALT retention and urea synthesis at levels >66% of fresh slice values 
between 0 and 3 h post-thawing (Table 4b). The preference for rapid freezing 
for cryopreservation of rat liver slices has been confirmed by Glöckner et al. 
(1996) and Maas et al. (2000b). More recently, de Kanter et al. (1998) 
showed that human liver slices could also be successfully cryopreserved 
with this rapid freezing method, maintaining urea synthesis, ALT retention 
and phase I biotransformation of lidocaine, testosterone and 7-EC on levels 
of >66% of fresh slices. However, marked differences between conjugation of 
7-HC after 7-EC hydroxylation of cryopreserved and fresh slices were 
observed. Particularly sulfate conjugation was decreased. Recently, Maas et 
al. (2000b) examining viability of rapidly frozen rat liver slices after thawing 
and culturing for 4 to 8 h, have shown that the outcome of rapid freezing 
depends on the parameter that is used to determine success. While 
testosterone metabolism, GsT-activity in the slice homogenate in the 
presence of GSH, and urea synthesis were well maintained in fast frozen 
slices for 4 and even 8 h of culturing, other parameters like ATP, GSH and 
potassium (K+) content and slice histomorphology were decreased to levels 
around 20% of fresh slice values (see also chapter 2 of this thesis). Vanhulle 
et al. (2001) also found that P450-dependent drug metabolism and slice 
metabolic enzyme content were not different from fresh slices in rapidly 
frozen rat liver slices permeated with 10% DMSO, while other parameters 
(glycogen content, ATP content and phase II biotransformation), showed a 
progressive decrease compared to fresh slices. Rapidly deterioriating slice 
viability was also reported by Martin et al. (2000), however, they used 
UW/10% DMSO as CPA medium, which has been shown by Maas et al. 
(2000b) to be inadequate for rapid freezing of liver slices.  
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Table 4a  Rapid freezing methods for tissue slices 
 
  
de Kanter and 
Koster (1995) 
 
Glöckner et al. (1996) 
 
Day et al. (1998) 
 
de Graaf et al. (2000b) 
 
Glöckner et al.  (2001) 
 
 
Optimization 
Species, organ  
 
Parameters 
optimized 
 
 
 
 
 
 
 
 
 
Ultimate method 
CPA solution 
 
 
CPA introduction 
  
 
Cooling technique 
 
 
 
 
Cooling rate 
 
Warming technique 
 
 
 
Warming rate 
 
CPA outwashing 
 
 
Remarks 
 
 
rat liver 
 
CPA conc. (0, 6, 
8, 12 or 16% 
v/v), temp. and 
duration of CPA 
pre-incubation 
(2, 20 or 37°C; 0, 
30 or 60 min), 
cooling rate (0.6, 
1.5, 50 or 250 
°C/min) 
 
 
12% (v/v) DMSO 
in WME 
 
in flasks on ice, 
30 min 
 
5 slices + 1 ml 
CPA solution in 
cryovial, direct in 
liq. N2 
 
250°C/min 
 
cryovial in 37°C 
waterbath 
 
 
200°C/90 s 
 
not 
 
 
viability 
decreased when 
slices were 
stored at –80°C 
 
 
 
rat liver 
 
slice thickness 
(0.25 and 0.5 
mm), storage 
prior to 
cryopreservation 
(yes or no) 
cooling rate (1.5 
or >250°C/min) 
 
 
 
 
10% (v/v) DMSO 
in SS  
 
in flask on ice, 15 
min 
 
4-6 slices in 
cryovial without 
medium, direct in 
liq. N2 
 
>250°C/mina 
 
cryovial in 37°C 
waterbath 
 
 
‘fast’  
 
3x in SS, 25°C 
 
 
storage on ice 
prior to freezing 
decreased 
viability 
 
 
 
 
rat liver 
 
cooling and 
warming rateb 
(250 or 
1000°C/min), 
CPA conc. (4.5, 
7, 10, 15 or 22% 
v/v) 
 
 
 
 
 
10% (v/v) DMSO 
in WME 
 
in 40 ml CPA sol. 
on ice, 30 min 
 
5 slices between 
aluminium plates, 
direct in liq. N2 
 
 
ca 1000°C/mina 
 
aluminium plate 
with slices direct 
in 37°C waterbath 
 
200°C/15 s 
 
1x, ice cold HBSS 
 
 
 
 
 
 
rat liver 
 
CPA conc. (0, 
12, 18 or 30% 
v/v), CPA carrier 
solution (WME, 
FCS or UW), 
storage prior to 
cryopreserv. (15 
or 75 min), slice 
thickness (8-23 
cellayers) 
 
 
18% (v/v) DMSO 
in WME 
 
in flasks on ice, 
30 min 
 
5 slices + 0.5 ml 
CPA solution in 
cryovial, direct in 
liq. N2 
 
250°C/mina 
 
cryovial in 370C 
waterbath 
 
 
‘fast’  
 
briefly in WME, 
10% FCS 
 
viability 
decreased by 
storage prior to 
freezing, thin 
slices (10 
cellayers) better 
than thick slices 
(>14 cellayers) 
 
 
rat liver 
 
CPA conc. (10, 
20 or 30% v/v) 
 
 
 
 
 
 
 
 
 
 
30% DMSO in 
SS  
 
in flask on ice, 15 
min 
 
4 slices in 
cryovial without 
medium, direct in 
liq. N2 
 
>250°C/min a 
 
cryovial in 37°C 
waterbath, + 2 ml  
37°C WME 
 
‘fast’  
 
by addition of 2 
ml 37°C WME  
 
prelim. experim. 
showed washing 
1x in 37°C WME 
better than 3x in 
ice-cold SS 
 
 
a
 not actually measured  
b
 cooling and warming rates were varied simultaneously 
SS = Sacks solution, HBSS = Hanks balanced salt solution 
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Table 4b Viability of tissue slices after cryopreservation according to rapid freezing methods 
 
 
Author 
 
 
Species, 
organ  
 
Incubation 
 
Method of 
 
Viability parameter  
% fresh slice value) 
 
 
Remarks 
 
de Kanter 
and Koster 
(1995) 
 
 
 
 
 
Glöckner et 
al. (1996) 
 
de Kanter et 
al. (1998) 
 
 
 
Glöckner et 
al. (1998) 
 
 
 
 
 
Day et al. 
(1998) 
 
 
 
 
 
 
Glöckner et 
al. (1999) 
 
 
Maas et al. 
(2000b) 
 
 
rat liver 
 
 
 
monkey 
liver 
 
 
rat liver 
 
 
human liver 
 
 
 
 
rat liver 
 
 
 
 
 
 
rat liver 
 
 
 
human liver 
 
 
 
human liver 
 
 
 
rat liver 
 
3 h 
 
 
 
3 h 
 
 
 
2h 
 
 
3 h 
 
 
 
 
2, 24 h 
 
 
 
 
 
 
3 h, 1 h 
pre-inc. 
 
 
3 h, 1 h 
pre-inc. 
 
 
2, 6 h 
 
 
 
0, 4, 8 h 
 
de Kanter 
and Koster 
(1995) 
 
de Kanter 
and Koster 
(1995) 
 
Glöckner et 
al. (1996) 
 
de Kanter 
and Koster 
(1995) 
 
 
Glöckner et 
al. (1996) 
 
 
 
 
 
Day et al. 
(1998) 
 
 
Day et al. 
(1998) 
 
 
Glöckner et 
al. (1996) 
 
 
de Kanter 
and Koster 
(1995) 
 
urea synth.(85%), ALT retained (78%), 
testost.metab. (116%) 
 
 
ALT retained (85-87%), urea synthesis 
(82-106%), testost. metab. (60-138%) 
 
 
K+ content (71%), GSH (95%), ECOD 
activity (173%) 
  
urea synth.(78%), testost. metab.(88%), 
7-HC conjug. (7-EC as substr.: 40-
100%), ALT retained (66%), total 7-EC 
metab.(88%), lidocaine metab.(84%) 
 
K+ content (2 h: 40%, 24 h: 20%), 
ECOD and EROD activity in slice 
homogenate (2 h: 99 en 119%), ECOD 
in intact slice (2 h: 150%), protein 
synth.: measurable, inducibility P450 
mRNA: measurable  
 
urea synth. (85%), 7-HC-sulfation (7-EC 
as substrate) (90%). ALT, LDH retained 
(70%, 60%)  
  
urea synth. (35 and 70%, 2 livers), 7-EC 
metab.(55%, 1 liver), LDH retained, ALT 
retained (75%, 1 liver) 
 
K+ content (2 h: 70%, 6 h: no fresh 
values given), protein synth. (2 h: 33%), 
P450-1A1 mRNA inducible 
 
ATP content (4 h: 20%, 8 h: 10%), K+ 
content (4 h: 20%, 8 h: 20%), GSH 
content (4 h: 40%, 8 h 30%), LDH 
leakage (after 4 h 60% leaked out, after 
8 h: 80%), GsT activity (4 h, 8h: 65%), 
CDNB conj.(4 h: 20%, 8 h: 10%), 
testost. metab. (4, 8 h: comparable to 
fresh values), urea synth.(0-3 h: 
unchanged, 4-7 h: 50%, 8-11 h: 40%, 
histomorphology (4 and 8 h: some 
viable foci). 0 h: values unchanged, 
except CDNB conj.   
 
 
 
 
 
fast freezing 
superior to slow 
freezing,  
 
incubation at 
30°C 
 
sometimes no 
sulfate 
conjugates 
found 
 
incubation at 
30°C, one 
human liver 
done but no 
fresh values 
given! 
 
 
 
 
 
 
 
 
 
 
 
 
 
compared with 
slow freezing 
method, fast 
freezing method 
better, WME 
better than UW 
as freezing 
medium 
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Table 4b, continued 
 
 
Author 
 
 
Species,  
organ 
 
Incubation 
 
Method of 
 
Viability parameter  (% fresh slice value) 
 
 
Remarks 
 
de Graaf et al. 
(2000b) 
 
 
Martin et al. 
(2000) 
 
 
 
 
 
Sohlenius-
Sternbeck et 
al. (2000) 
 
 
Glöckner et al. 
(2001) 
 
 
 
 
 
 
 
Vanhulle et al. 
(2001) 
 
 
 
rat liver 
 
 
 
rat liver 
 
 
 
 
 
 
rat liver 
 
 
 
 
rat liver 
 
 
 
 
 
 
 
 
rat liver 
 
4-5 h 
 
 
 
3, 24 h 
 
 
 
 
 
 
2-3 h (1 h 
pre-incub.) 
 
 
 
2, 24 h 
 
 
 
 
 
 
 
 
4h, 24 h 
 
 
de Graaf et al. 
(2000b) 
 
 
de Kanter and 
Koster, (1995) 
 
 
 
 
 
de Graaf et al. 
(2000) 
 
 
 
Glöckner et al. 
(2001) 
 
 
 
 
 
 
 
Glöckner et al. 
(1996) 
 
 
 
 
histomorphology (62%), K+ content 
(66%), testost. metab. (77%), 7-HC 
conj.(67-79%) 
 
MTT reduction (24 h: <15%), ATP 
content (24h: <5%),  antipyrine 
hydroxylation (3 and sulfation (3h: 30-
50%, 24h:<20%) 
 
 
 
MTT reduction (86%), testost. metab. 
(75-100%), ropivacaine metab. (80-
94%), 7-HC conj.(80-100%), naphtol 
conj.(74%) 
 
GSH content (4 h: 50%, 24 h: 40%), 
LDH leakage (0-24 h: 3 x as much in 
cryo slices than in fresh slices), 
testost. metab. (2 and 24 h: 
comparable to fresh), ECOD 
inducibility: comparable to fresh, MUG 
and PNP conj.: measurable up to 24 h  
 
 
paracetamol conj. (4 h: 20-25% , 24 
h: <10%), midazolam metab.(4 h: no 
difference, 24 h: 40-100%), LDH 
leakage (sign. higher in 
cryopreserved slices), ATP content (4 
h: 35% , 24 h:<15%), glycogen 
content (4 h: 25%, 24 h: 15%), 
enzyme content (4, 24 h: not sign. 
different), histomorphology (some 
viable foci) 
 
 
 
 
 
UW, with 50% 
FCS, 10% 
DMSO used 
instead of 
WME/12% 
DMSO 
 
 
 
 
 
fresh slices were 
also exposed to 
30% DMSO,  
washing steps of 
original protocol 
omitted 
Several attempts have led to a significant improvement of rapid freezing 
methods. Day et al. (1998) proposed a novel technique to enhance cooling 
and warming rates during cryopreservation and thawing, using aluminium 
plates with a high thermal conductivity. Results obtained with this device 
were significantly better than with the cryovials, originally used by de 
Kanter and Koster (1995). De Graaf et al. (2000b) showed that increasing 
the DMSO concentration used for pre-incubation of the slices prior to 
freezing, to 18%, improved viability of slices significantly (as measured by 
potassium content, phase I and II biotransformation and by examining slice 
histomorphology). Slices cryopreserved by this improved method remained 
viable and metabolically active up to 24 h post-thawing as reported in a 
later study (chapter 7). Sohlenius-Sternbeck and co-workers as well found 
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that the use of higher DMSO concentrations (18%) enhanced viability as 
measured by parameters that are sensitive for cryopreservation damage, as 
did Glö ckner et al. (2001), who found better results after application of 20 
and 30% DMSO than with 10% DMSO. 
The mechanism explaining the success of rapid freezing methods is not 
understood: the high freezing rates (100-1000°C/min.) will probably not 
result in cell dehydration by equilibrium freezing (Karlsson, 1993, Bischof 
et al., 1997) and the cryoprotectant concentrations used (12-30%) are too 
low to achieve vitrification (Boutron and Kaufmann, 1978; Baudot et al., 
2000). Evidence exists, however, that water within cells/tissue vitrifies more 
readily than in a ‘bulk’ solution. It has been suggested previously that this 
may be caused by the fact that water within tissue behaves as if it were 
compartmentalized like in a hydrogel (Peridieu et al., 1995). Fragmentation 
of a fluid in smaller droplets increases the tendency to supercool and 
therefore facilitates vitrification (Yamane et al., 1992). Within a slice, water 
is compartmentalized in cells and interstitial space and for this reason de 
Kanter et al. (1995) have suggested vitrification within the slices as a 
possible explanation for the success of rapid freezing. 
 
 
Aims and contents of this thesis 
 
A major aim of the research described in this thesis was to develop 
cryopreservation methods for hepatic and extrahepatic tissue slices. 
Furthermore, the mechanism explaining the success of rapid freezing is 
studied. Finally, we aimed to evaluate the predictive value of in vitro 
metabolism by (cryopreserved) tissue slices for in vivo drug metabolism in 
comparison to other in vitro tools.  
 
I  The development of cryopreservation methods for hepatic and extrahepatic 
tissue slices  
 
In chapter 2, a wide range of viability and functionality parameters is used 
to evaluate cryopreservation of rat liver slices by an equilibrium slow 
freezing cryopreservation method, originally developed for the cryopreser-
vation of hepatocytes (Maas et al., 2000a) and a rapid freezing method 
developed by de Kanter and Koster (1995). A full factorial statistical design 
is used to explain the differences in viability found between the two 
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methods including the factors cooling rate, cryopreservation medium, slice 
thickness and stepwise cryoprotectant pre-incubation as variables. 
 
In chapter 3, an attempt is made to improve post-thaw viability and phase I 
and II biotransformation activity of rapidly frozen slices, by varying DMSO 
concentration and DMSO carrier medium, slice thickness and cold storage 
prior to cryopreservation. 
 
In chapter 4, a first step towards cryopreservation of extra-hepatic tissue 
slices is made by using the rapid freezing method, originally developed for 
rat liver slices using 18% DMSO and a cooling and warming rate of 
approximately 200°C/min and by vitrification with high molarity mixtures 
of cryoprotectants, VM3 and VS4. 
 
II  Elucidation of the mechanism of cryopreservation by rapid freezing  
 
In chapter 5 it is determined whether tissue vitrification, promoted by water 
partitioning in the tissue, could be the mechanism explaining high viability 
of rat liver slices, rapidly frozen after pre-incubation with 18% DMSO or 
VS4 (a 7.5M mixture of DMSO, 1,2-propanediol and formamide with weight 
ratio 21.5: 15: 12.4). Differential Scanning Calorimetry (DSC) is used to 
determine the extent to which crystallization or vitrification occurrs in CPA 
solutions (DMSO and VS4) and within liver slices impregnated with these 
solutions. Secondly, these events are related to survival of slices after 
thawing.  
 
In chapter 6, an attempt is made to modify the susceptibility of rat liver 
slices to cryopreservation damage by pre-incubating them at 37°C prior to 
cryopreservation by rapid freezing or vitrification in order to enable them to 
regain physiological metabolism. In this manner, we tend to assess the 
importance of slice condition for cryopreservation outcome.  
 
III  Evaluation of the predictive value of drug metabolism by (cryopreserved) 
tissue slices for in vivo drug metabolism in comparison to other in vitro tools  
 
In chapter 7, various in vitro preparations are compared with respect to 
their ability to mimic in vivo metabolism. For this purpose, S9-liver 
homogenate, microsomes, cryopreserved hepatocytes, fresh and 
cryopreserved liver slices and slices of extra-hepatic metabolizing organs 
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(lung, kidney, intestines) are incubated with three pharmacologically active 
compounds, that are metabolized in vivo by a wide range of metabolic 
routes. Metabolites are identified and quantified with LC-MS/UV from the 
in vitro incubations and compared with metabolite patterns in faeces, urine 
and bile of dosed rats. 
 
Finally, in chapter 8, the most important results and conclusions of this 
thesis as well as future perspectives of tissue slice cryopreservation for 
application in drug metabolism research are discussed. 
Chapter 1   
 32
 
 
 
 
 
  33
 
Chapter 2 
 34
Abstract 
 
A number of studies on the cryopreservation of precision-cut liver slices 
using various techniques have been reported. However, the identification of 
important factors that determine cell viability following cryopreservation is 
difficult because of large differences between the various methods 
published. 
The aim of the present study was to evaluate some important factors 
in the freezing process in an effort to find an optimized approach to the 
cryopreservation of precision-cut liver slices. A comparative study of a slow 
and fast freezing technique was carried out to establish any differences in 
tissue viability for a number of endpoints. Both freezing techniques aim at 
the prevention of intracellular ice formation (IIF) which is thought to be the 
main cause of cell death after cryopreservation. Subsequently, critical 
variables in the freezing process were studied more closely in order to 
explain the differences in viability found in the two methods in the first 
study. For this purpose, a full factorial experimental design was used with 
16 experimental groups, allowing a number of variables to be studied at 
different levels in one single experiment. 
It is demonstrated that ATP and K+ content and histomorphology are 
sensitive  parameters to evaluate slice viability after cryopreservation. 
Subsequently, it is shown that freezing rate and the cryopreservation 
medium largely determine the residual viability of liver slices after 
cryopreservation and subsequent culturing. It is concluded that a 
cryopreservation protocol with a fast freezing step and using Williams 
medium E as cryopreservation medium is the most promising approach to 
successful freezing of rat liver slices of those tested in this study. 
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Introduction 
 
Precision-cut tissue slices are extensively used in studies on toxicity and 
metabolism of xenobiotics (Bach et al., 1996; Olinga et al. 1997b). The use 
of slices for this purpose has several advantages over the use of isolated 
single cells. First, no digestive enzymes are required for slice preparation 
and, consequently, cell to cell contacts and normal tissue architecture 
remain intact. Secondly, slices can be used to study species differences, e.g 
in drug metabolism (Krumdieck et al., 1980), since they can easily be 
prepared with the same method from tissue of numerous species. The use 
of human tissue in this field is of special interest, since it will help 
overcome difficulties with interspecies extrapolation. The supply of human 
tissue for in vitro research, however, is only limited and irregular. 
Successful cryopreservation and storage of tissue slices, without a marked 
loss of viability after thawing, would without doubt expand and facilitate 
experimental possibilities. 
The main concern in cryopreservation is the formation of intracellular 
ice (IIF) both during freezing and thawing. IIF is thought to be the main 
cause of cellular damage and can be prevented or reduced using two 
different approaches. First, slow freezing techniques lead to cellular 
dehydration. Due to ice crystal formation in the extracellular medium, 
solutes concentrate in the nonfrozen phase. As a reaction to maintain 
osmotic equilibrium with their surroundings, cells dehydrate and do not 
freeze intracellularly (Mazur, 1984). Second, rapid freezing techniques, 
generally applied in the presence of high concentrations of cryoprotectant 
(CPA), result in the formation of amorphous instead of crystalline ice in the 
cellular fluid (vitrification) (Fahy, 1990). 
For the cryopreservation of liver slices, both slow and fast freezing 
techniques have been described (for a recent overview see Glö ckner et al., 
1998). Results, however, are highly variable and seem to be dependent on 
the animal species and the viability parameters used (Fisher et al., 1991; 
Wishnies et al., 1991; Fisher et al., 1993; Ekins, 1996; Ekins et al., 1996b). 
The identification of important factors that determine cell viability after 
cryopreservation is difficult due to numerous differences between the 
published methods, including the viability parameters determined, the 
equipment used for freezing and the incubation system for culturing slices. 
For cryopreserving rat liver slices, the applicability of a slow freezing 
method was recently studied, showing that cryopreserved rat liver slices can 
be used for short term (ca 2 h) metabolism studies (Maas et al., 2000a). Also
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recently, a fast freezing technique was described (de Kanter and Koster, 
1995; de Kanter et al., 1998) reporting cryopreserved rat liver slices to be 
viable for 3 h after thawing. The reported time period of cell survival in 
these studies, although promising, may be too short for prolonged 
toxicological and metabolism research. 
The aim of this study was to determine important factors in the freezing 
technique to find an optimized approach towards the cryopreservation of 
liver slices. For this purpose, two cryopreservation protocols that use a slow 
(Maas et al., 2000a) and a fast freezing approach (de Kanter and Koster, 
1995) were compared. The study was performed under identical 
experimental conditions (slices obtained from the same animal, cultured in 
the same incubation system, using the same medium), allowing the most 
direct comparison. A number of different parameters were measured to 
determine which cellular processes were most affected by cryopreservation. 
The two cryopreservation protocols studied differ not only in freezing rate 
but also in the cryopreservation medium, in the slice thickness and in the 
way the CPA is added to the slices. Therefore, in a second study, the 
variables in the two methods were looked at more closely to determine the 
importance of each variable in maintaining slice viability after 
cryopreservation. For this purpose, a set of experiments was performed 
according to a full factorial experimental design, allowing all variables to be 
studied in a single experiment. 
 
 
Materials and methods 
 
Chemicals.  
Chemicals were obtained from the following suppliers; Gibco BRL  (Paisley, 
Scotland): Phosphate Buffered Saline (PBS), William’s Medium E (WME with 
Glutamax I) and gentamycin; PAA Laboratories GmbH (Linz, Austria): Fetal 
Calf Serum (FCS); Sigma Chemical Company (St. Louis, MO, USA): insulin 
(from bovine pancreas), dimethyl sulfoxide (DMSO), 1-chloro-2,4-
dinitrobenzene (CDNB) and the blood urea nitrogen assay kit; Merck 
(Darmstadt, Germany): D-Glucose; Lamepro b.v. (Raamsdonksveer, The 
Netherlands): the University of Wisconsin solution (UW); Omnilabo (Breda, 
The Netherlands): ATP assay kit (Lumac biomass assay kit); Steraloids, Inc., 
(Wilton, NH, USA): testosterone and hydroxylated metabolites; Pierce 
(Oud-Beyerland, The Netherlands): the Coomassie Protein kit No.23200; 
Boehringer (Mannheim, Germany): the lactate dehydrogenase (LDH) kit.
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Slice preparation  
Male Wistar rats were sacrificed by decapitation. After excision, the liver 
was cut into lobules that were stored in washing medium (WME containing 
10 % FCS) on ice. Slices of two different thicknesses were prepared from 8-
mm biopsies in cold WME (pregassed with carbogen (95 % O2, 5 % CO2) for 
approx. 30 min), using a Krumdieck tissue slicer. Slices were washed in 
cold washing medium and stored in fresh washing medium on ice until use. 
The time between the sacrifice of the rat and the start of cryopreservation 
was ca. 2 h. 
 
Culturing 
Slices were cultured under carbogen atmosphere in 25-ml Erlenmeyer 
flasks (1 slice/flask) containing 5 ml culture medium consisting of WME 
with Glutamax I containing 0.1 µM insulin, 5 % FCS, 50 µg/ml gentamycin 
and 25 mM D-glucose, pregassed with carbogen. Flasks were tightly closed 
with a rubber stop. 
 
Cryopreservation 
The slow freezing technique (Maas et al., 2000a) is further referred to as 
method A and the fast freezing technique (de Kanter and Koster, 1995) as 
method B and they are described in detail by the aforementioned authors 
and in Table 1. Method A involves computer-controlled slow freezing using a 
SyLab Icecube 1610 Computer Freezer. Slices were transferred to ice-cold 
UW solution containing 5% DMSO and were stored on ice for approximately 
10 min. Slices were then transferred to cryovials (Costar, Cambridge, MA, 
USA) (5 slices/vial) containing 0.5 ml UW, 10% DMSO and slowly frozen at 
0.5°C/min to -50°C followed by a 1°C/min freezing rate to -80°C, after 
which the vials were submerged in liquid nitrogen. Large temperature rise 
in the sample vial due to the release of heat during crystallization was 
prevented by injecting extra nitrogen into the freezing chamber. Total pre-
incubation time at 0-2 °C was ca. 30 min. 
With method B, slices were pre-incubated before freezing with 5 ml WME 
containing 12% DMSO in a 25-ml Erlenmeyer (maximum 5 slices/flask, 
under carbogen atmosphere) in a shaking waterbath (at ca. 100 rpm, at 2°C 
for 30 min). Slices were then transferred to 2-ml cryovials (4 or 5 slices/vial) 
together with 1 ml of the medium used for pre-incubation and frozen by 
direct immersion into liquid nitrogen. 
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Table 1 Schematic overview of the two cryopreservation methods used in Study I 
 
  
Method A (Maas et al., 2000a) 
 
 
Method B (de Kanter and Koster, 1995) 
 
Wet weight slices (mg) 
Slice thickness (µm) * 
Addition of CPA 
Freezing rate 
Cryopreservation medium 
CPA concentration 
 
16 - 18 
± 200-250 
stepwise addition 
0.5oC/min 
UW 
10% DMSO 
 
19 - 21 
± 250-300 
immediate addition 
± 250oC/min 
WME 
12% DMSO 
 
*) In a calibration study (results not shown), series of slices were cut at different settings of the 
Krumdieck tissue slicer. Wet weight was correlated to slice thickness, that was determined  
morphometrically. In further studies, wet weight of the slices was used to set slice thickness. 
 
Study I 
In this study, methods A and B were compared under standardized 
experimental conditions. A number of viability parameters were studied to 
determine which parameters were most sensitive to cryopreservation. The 
viability parameters studied were ATP and potassium (K+)-levels, 
histomorphology, total glutathione (GSH) levels, leakage of lactate 
dehydrogenase (LDH), total glutathione-S-transferase (GST) activity, urea 
formation and the metabolism of CDNB and testosterone. 
 
Experimental design 
The experimental design of study I is presented in Table 2. Three separate 
experiments were performed. All parameters were determined at three time 
points after slice preparation and thawing and incubation (0, 4 and 8 h) in 
three slices. Leakage of LDH was determined during two successive periods 
of 4 h after isolation or thawing of the slices (three per group). 
 
Viability parameters 
Histomorphology. One half of a slice was fixed in 70 % ethanol at 4°C for at 
least 24 h. After dehydration, slices were vertically embedded in paraffin 
and cross sections (5-µm thickness) were stained with hematoxylin and 
eosin. Histomorphological quality of the slices was scored by estimating the 
percentage of viable cells in the slice cross section by two investigators. For 
this purpose, both nuclear appearance and cytoplasmatic staining were 
taken into account and compared to cell appearance in fixed samples from 
fresh liver. Slice thickness was evaluated by counting the number of cell 
layers.
Critical factors in the freezing technique of liver slices     
 39
Table 2 Experimental setup of Study I 
 
 
 
  
Sampling/incubation time (h) 
 
 
Experiment 
 
Viability parameter 
 
0 
 
4 
 
8 
 
I 
 
 
II 
 
III 
 
GSH, GST activity 
LDH activity 
Urea synthesis 
ATP, K+ and histomorphology 
Testosterone hydroxylation 
CDNB metabolism 
Histomorphology 
 
0 
 
0-3 
0 
0-1 
0-0.15 
0 
 
4 
0-4 
4-7 
4 
4-5 
4-4.15 
4 
 
8 
4-8 
8-11 
8 
8-9 
8-8.15 
8 
 
Note. This study consisted of three independent experiments  
 
ATP content. One half of a slice was quickly rinsed in physiological saline 
and immersed in cold 70% ethanol in potassium-free HPLC water (Baker, 
Deventer, The Netherlands), containing 2 mM EDTA (pH 10.9). The slice 
was homogenized using a Branford sonifier (50 % duty cycle, 5 s). ATP was 
determined using the luciferin, luciferase assay on a Lumac Biocounter 
M500 (Singh et al., 1996). 
Potassium content. In the slice homogenate, potassium content was 
measured using a Beckman 2 electrolyte analyser (Beckman Instruments-
Netherlands division BV, Mijdrecht, The Netherlands). 
GST activity. GST activity in the slice homogenate was determined on a 
Varian Cary IE spectrophotometer using 1 mM CDNB and 1 mM GSH as 
substrates. S-(2,4-Dinitrophenyl)glutathione formation (DNPSG) was 
measured for 3 min at 25°C (detection wavelength: 340 nm). 
Metabolism of testosterone. To determine the metabolism of testosterone, 
slices were incubated for 60 min with 250 µM testosterone in 12-well plates 
(Costar, Cambridge, MA, USA; 2 ml/well) on a gyratory shaker in a 
humidified incubator at 37°C, 40% O2, 5% CO2 at ca. 80 rpm. Testosterone 
metabolites were determined by HPLC on a Hypersil ODS column 
(Chrompack, The Netherlands) according to van ‘t Klooster et al. (1993). 
Metabolism of CDNB. For determining CDNB metabolism, slices were 
incubated for 15 min with 25 µM CDNB in 12-well plates (2 ml/well) on a 
gyratory shaker in a humidified incubator at 37°C, 40% O2, 5% CO2 at ca. 
80 rpm. DNPSG was quantified by HPLC using a Zorbax ODS column 
according to van Iersel et al. (1996).  
GSH content. GSH was determined using a Shimadzu RF1501 
spectrofluorimeter after reacting with o-phtalaldehyde according to Hissin 
and Hilf (1976). 
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LDH activity: LDH activity in the medium and the slice homogenate was 
measured with a BM/Hitachi 911 using a commercially available kit 
(Boehringer, Mannheim, Germany). 
Total protein. To an aliquot of the slice homogenate, 2 M NaOH (25 %v/v) 
was added to dissolve the protein. The protein solution was diluted (1:5 
minimally) with PBS. Subsequently, protein content was measured by a 
Cobas-Bio centrifugal spectrophotometer with a Coomassie Protein kit 
using bovine serum albumin (BSA) as a standard. 
 
Statistical analysis. 
The data were analyzed by pairwise comparisons of mean values for the 
methods A and B, respectively. Comparisons were carried out separately for 
fresh and cryopreserved slices at each of the time points. Statistical 
significance was assessed by t-tests using log transformed data. Standard 
deviations were estimated from pooled data from all groups of slices that 
were treated in the same way. 
 
Study II 
The aim of the second set of experiments was to specify the variables in 
methods A and B that could explain differences in slice viability found in 
Study I. 
 
Experimental design 
The two cryopreservation methods compared in study I differ not only in 
freezing rate but also in the cryopreservation medium, in the slice thickness 
and in the mode of addition of the CPA (see Table 1). A set of two 
experiments was carried out according to a full two-level factorial design. In 
this full factorial design, each of the variables in the two cryopreservation 
methods was studied at all levels of the other variables as illustrated in 
Table 3. The design contained four factors representing the main variables 
in methods A and B. Furthermore, the factor ‘experiment’ was introduced to 
establish the reproducibility of the effects. 
 
Viability parameters 
Four viability parameters were selected from study I based on their 
sensitivity and ability to distinguish between the two cryopreservation 
methods compared. ATP, K+, histomorphology and GST activity were all 
determined in the same slice. Parameters were measured as described for 
Study I. 
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Table 3 Experimental design of Study II 
 
 
 
Factors (variables) 
 
Combination 
 
Medium 
 
CPA addition 
 
Freezing speed 
 
Slice thickness* 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
 
UW 
UW 
UW 
UW 
WME 
WME 
WME 
WME 
UW 
UW 
UW 
UW 
WME 
WME 
WME 
WME 
 
stepwise 
immediate 
stepwise 
immediate 
stepwise 
immediate 
stepwise 
immediate 
stepwise 
immediate 
stepwise 
immediate 
stepwise 
immediate 
stepwise 
immediate 
 
fast 
fast 
fast 
fast 
fast 
fast 
fast 
fast 
slow 
slow 
slow 
slow 
slow 
slow 
slow 
slow 
 
thick 
thick 
thin 
thin 
thick 
thick 
thin 
thin 
thick 
thick 
thin 
thin 
thick 
thick 
thin 
thin 
 
Note. This study consisted of two experiments. In both experiments, four slices were treated 
according to each combination. Directly after thawing and after 4 h of additional culturing, two slices 
were sampled for the determination of slice viability. In addition to the the four factors that represent 
the main variables between method A and B, the factor ‘experiment’ was introduced (see materials 
and methods). 
* The actual difference in thickness between ‘thin’ and ‘thick’ slices was determined at the end of the 
experiments by counting the number of cell layers in the slides that were made for 
histomorphological examination. The average number of cell layers in the slice in two experiments 
was 13.4 for thick slices and 10.7 for thin slices. 
 
Statistical analysis 
Data obtained directly after thawing or after an additional culture period of 
4 h were analyzed separately. Statistical analyses were carried out on the 
natural logarithm of the biochemical parameters and the square root of 
thickness (number of cell layers). For histology scores, the empirical logistic 
transformation was used, defined as: transformed score = log [(score + 0.5)/ 
(100 - score + 0.5)] (Cox, 1970). Statistical analyses were based on the 
mean transformed data from two slices for each parameter (ATP, K+, 
histomorphology and GST activity). The outcome of each of the 
combinations (illustrated in Table 3) is dependent on effects that are caused 
by the four handling factors, the factor 'experiment' and the random 
variation. From the 32 values (mean of two slices) for each parameter (16 
possible combinations in two experiments), a total of 31 effects can be 
calculated (namely, 5 main effects, 10 two-factor interactions, 10 three-
factor interactions, 5 four-factor interactions, and 1 five-factor interaction). 
To illustrate this: the main effect of medium, for example, is calculated as 
the mean of all observations made with the UW medium minus the mean of 
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the observations with the WME medium. Other main effects are calculated 
analogously. Two-factor interactions occur in those cases were the observed 
effect can not be explained solely by the main effects. The interaction 
between medium and freezing, for example, is calculated as the difference 
between the main effect of medium at slow freezing and the main effect of 
medium at fast freezing. This value is divided by 2, causing all interactions 
to have the same standard error as the main effects. The remaining 
interactions are calculated in a way analogous to the calculation of the two-
factor interactions. The design and the calculation of the effects is described 
by Box et al. (1978). Statistical significance of the 31 effects on each 
viability parameter was determined by calculating the standard error of the 
effects with the PSE(45) (Pseudo Standard Error) method as described by 
Schoen and Kaul (2000) and using this standard error to judge the effects. 
Effects were considered significant (α  = 0.05) if they were larger then 2.35 
times their standard error. 
 
 
Results 
 
Study I 
Histomorphological examination  
Directly after preparation of the slices, the average percentage of viable cells 
in the slice was scored 85 ± 5%. After 4 and 8 h in culture, this percentage 
was slightly decreased to 74 ± 4 and 69 ± 5 %, respectively. Immediately 
after thawing, the histomorphogical views of slices frozen according to 
methods A and B closely resembled each other. Compared to freshly 
prepared slices, a slight increase in the number of pyknotic nuclei was 
observed and cytoplasmic staining was slightly more eosinophilic. The 
percentage of viable cells per slice was 63 ± 12%. Differences between slices 
frozen according to methods A and B were more pronounced after an 
additional 4 h of culturing, where the percentage of viable cells per slice 
ranged from 0 to 5 % and 5 to 50 % for methods A and B respectively (Fig. 
1a and b). After 8 h of culturing, the percentage of viable cells frozen 
according to method B was decreased, ranging from 5 to 25 %. In some 
slices, viable cells appeared in small groups in the venal area and at the 
edges of the slice. Many dead cells had fragmented nuclei. In slices frozen 
according to method A, only a few viable cells were observed randomly 
distributed over the slice. Affected cells showed mostly pyknotic nuclei.
Critical factors in the freezing technique of liver slices       
 43
 
 
Fig. 1 Histomorphological view of cryopreserved rat liver slices, 4 h after thawing and subsequent 
culturing (A) Method A, (B) Method B. 
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Data obtained from fresh and cryopreserved rat liver slices are presented in 
Fig. 2. For fresh slices, slice thickness was the only difference between the 
two methods. Data from cryopreserved slices are discussed below. 
 
ATP, K+ and GSH content 
After cryopreserved slices were thawed and subsequent cultured for 4 and 8 
h, ATP and potassium levels in slices cryopreserved according to method B 
were significantly higher than those levels in slices cryopreserved according 
to method A (Fig. 2a and b). No difference was observed in GSH content (Fig 
2c). Potassium content in slices cryopreserved according to method B was 
ca. 20% of that measured in fresh slices, both after 4 and 8 h in culture. 
 
LDH leakage 
LDH leakage from slices cryopreserved according to method A was 
significantly higher than leakage from slices frozen according to method B 
(Fig. 2d). Cryopreservation according to method A and additional culturing 
for 4 h, resulted in 90 % leakage of total LDH.  For slices frozen according 
to method B, leakage of LDH increased from 60 to 80% of total LDH after 4 
and 8 h in culture, respectively. 
 
GST activity 
Total GST activity in the homogenate of slices frozen according to methods 
A and B significantly differed at all time points (Fig. 2e). In slices 
cryopreserved according to method A, GST activity declined to 15% of 
values of fresh slices after 4 h and remained at the same level after 8 h in 
culture. In slices frozen according to method B, respectively 67% (after 4 h) 
and 58% (after 8 h) of total GST activity remained. 
 
Metabolism of CDNB 
In cryopreserved slices, CDNB metabolism decreased with time with only 
limited formation of DNPSG left after 8 h (Fig. 2f). DNPSG formation in 
slices cryopreserved according to method B was only after 4 h of culturing 
significantly higher than DNPSG formation in slices frozen according to 
method A. 
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Fig. 2 Study I: viability parameters determined in fresh and cryopreserved rat liver slices, directly 
after preparation or thawing and after 4 or 8 h of culturing. Statistical analysis was carried out 
separately for fresh and cryopreserved slices at each of the time points. *Significantly different, P < 
0.05.
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Metabolism of testosterone 
No significant difference in the formation of hydroxylated metabolites of 
testosterone (OHT) determined in this study (2 -, 6ß-, and 16 -OHT) was 
found between fresh and cryopreserved slices at any time point (both in 
slices cryopreserved according to methods A and B). The formation of 2 -
OHT is shown in Fig. 2g.  
 
Urea synthesis 
Following cryopreservation, urea synthesis in slices cryopreserved according 
to method B was significantly higher than that in slices frozen according to 
method A at all time points (Fig. 2h): After 8 h in culture, urea synthesis in 
slices frozen according to method A and B was 17% and 44% of fresh 
values, respectively. 
 
Study II 
In this study, variables between the two cryopreservation methods (that is 
freezing rate, cryopreservation medium, slice thickness and the way of CPA 
addition) were studied more closely in order to explain the differences in 
slice viability found in study I. 
 
Determination of critical factors (significant effects) directly after thawing. 
The main effects of all five variables on the selected viability parameters 
directly after thawing are graphically presented in Fig. 3, left side. In slices 
cryopreserved according to method A, relatively high potassium levels were 
measured, resulting in a significant effect of the factor 'medium' (‘WME/UW’ 
in Fig. 3) on the parameter K+. Furthermore, based on the same parameter, 
slice thickness was determined to decisive, with thick slices containing 
slightly higher potassium levels than thin slices. Finally, a significant 
difference was also seen between the two experiments (‘II / I’ in Fig. 3) on 
the parameters ATP and GST activity. 
 
Determination of critical factors (significant effects) after 4 h of culturing 
The main effects of all five variables on the selected viability parameters 
after 4 h of culturing are graphically presented in Fig. 3, right side. The 
choice of the cryopreservation medium appeared to significantly affect the 
outcome of the viability parameters histomorphology, GST activity and 
potassium content. Slices cryopreserved in WME showed better histomor-
phology and higher GST activity and potassium levels, after 4 h of cul-
turing. 
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Fig. 3 Study II: main effects of experimental factors on viability parameters directly after thawing (left) 
and after 4 h of culturing (right). Boundaries between which the effects are nonsignificant (α = 0.05) 
are given with horizontal lines. The Y-axis represents the ratio between geometric means taken at 
both levels of a factor. For histomorphology, effects are represented as differences on a logit scale. 
Step/imm, stepwise addition/immediate addition of CPA. *Potassium content was determined in one 
experiment only. 
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Fig. 4 Study II: joint effects (interactions) of experimental factors (variables) 4 h after thawing and 
subsequent culturing for various viability parameters. Vertical lines indicate the smallest difference 
between variables (fast vs slow freezing and WME vs UW as freezing medium) that is statistically 
significant (least significant difference: α =0.05). 
 
Also, the freezing rate was determined to significantly affect the outcome of 
the same parameters. This finding was consistent in both experiments of 
Study II. 
For ATP, the observed effect could not be explained solely by the effect 
of the main variables. However, a significant interaction was observed 
between freezing rate and medium. This interaction was also found on the 
parameters histomorphology and GST activity. For potassium content, a 
significant (three factor) interaction between freezing, medium and CPA 
addition was observed. These interactions are graphically presented in Fig. 
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4. The use of UW instead of WME caused a decrease in levels of all 
parameter in fast-frozen slices. 
For all viability parameters determined, highest levels were measured in 
slices that had been fast frozen in WME, independent of slice thickness. The 
average potassium level was 0.21 ± 0.03 µmol/mg protein which was ca. 
30% of the value measured in fresh slices. ATP levels in study II showed a 
large variation (as illustrated in Fig. 3), ranging from 2% to 14% in the first 
experiment and from 2% to 25% in the second experiment (both compared 
to fresh slices). Considering histomorphology, the average percentage of 
viable cells was 10 ± 9%. The highest number of viable cells scored in Study 
II was 35%. The average GST activity was 33 ± 15% and 53 ± 18% (both 
compared to fresh slices) in Experiments I and II, respectively. 
 
 
Discussion 
 
The aim of the present study was to evaluate some important factors in the 
freezing process in an effort to find an optimized approach for the 
cryopreservation of precision-cut liver slices. To meet this purpose, a 
comparative study was carried out using two freezing techniques for the 
cryopreservation of rat liver slices (de Kanter and Koster, 1995; Maas et al., 
2000a) to establish any differences in tissue viability for a number of 
endpoints. Subsequently, a second study was performed to identify the 
most important variables between the two cryopreservation methods that 
could explain the differences in slice viability after cryopreservation 
observed in the first study. The second study was performed according to a 
multifactorial experimental design, that has been shown to be an effective 
way to study main effects and interactions of several variables in 
toxicological research with different end-points (Groten et al., 1991; Schoen 
et al., 1996). 
The comparative study between method A and B was performed under 
identical conditions. Directly after thawing, differences between the two 
methods were limited to urea synthesis and GST activity, with method B 
showing significantly higher levels for both parameters. After 4 and 8 h of 
culturing, viability of slices cryopreserved according to method B was 
significantly higher than that of slices frozen according to method A, based 
on all parameters with the exception of GSH content and testosterone 
hydroxylation. 
Chapter 2          
 50
A clear difference between the viability parameters was observed with 
respect to their sensitivity to cryopreservation. Urea synthesis and GST 
activity in the slice homogenate were relatively well maintained with method 
B, while the metabolism of testosterone was maintained by both methods. 
This latter finding is consistent with the report that membrane bound 
enzymes, such as the cytochrome P450 complex, are resistant to freezing 
stress (Ekins et al., 1996b). However, a more pronounced loss of viability 
was apparent when ATP and K+ content and histomorphology were 
considered. 
In the second study we tried to specify the important variables that 
could explain the differences between the two cryopreservation techniques 
that were found in the first study. Directly after thawing, a significant 
medium effect was observed on the parameter K+. Furthermore, a 
significant experiment effect was detected on GST activity and ATP content. 
These effects, however, were considered of less importance since they could 
be explained by the high concentration of potassium in the UW solution 
(that was not complete removed from the slice during washing), or biological 
variation. 
After 4 h in culture, two variables were detected that could explain to a 
large extent the differences between the two cryopreservation methods, 
namely the freezing rate and the cryopreservation medium. Viability of 
slices that were rapidly frozen using WME as cryopreservation medium was 
highest compared to all other groups. This effect was observed on all 
parameters except ATP. 
With slow freezing of rat liver tissue, it was recently shown that in the 
presence of DMSO, cellular dehydration continued below -20°C, until 
maximum dehydration was reached (Smith et al., 1998). In the present 
study, the DMSO concentration was in the same range as used in Smith et 
al. (1998) and slow freezing was continued until -50°C. We therefore expect 
almost maximum cellular dehydration to occur, with minimal IIF. However, 
long term exposure (caused by the low freezing rate) of cellular membranes 
to concentrated intracellular solutes (resulting from cellular dehydration), 
may have caused cellular damage. With the fast freezing approach used 
here, we expect intracellular ice to form, since the freezing rate does not 
allow for cellular dehydration and both freezing rate and CPA concentration 
are too low to allow for vitrification to occur. However, our results indicate 
that fast freezing is still favourable over slow freezing for the 
cryopreservation of rat liver slices. We can speculate that the ice crystals 
formed at least in some of the cells, are small and therefore cellular damage 
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is limited. It can be hypothesized that more rapid freezing and thawing (ice 
crystals tend to be small at high cooling rates (Mazur, 1984)) might 
contribute to higher survival rates. Only recently, it was demonstrated that 
a significant increase in liver slice viability could be achieved when 
aluminium plates instead of cryovials were used for freezing. Due to the 
much higher thermal conductivity of aluminium, higher freezing rates could 
be reached (Day et al., 1998). Preliminary data using small stainless steel 
grids and higher CPA concentrations, confirm these observations (Maas et 
al., de Graaf et al., unpublished results). 
In addition to the freezing rate, the cryopreservation medium was found 
to be an important factor determining the success of cryopreservation: the 
use of WME resulted in higher viability than the use of UW, which is 
successfully used in cold storage of tissue. This finding is unexpected, since 
we believed the effect of the UW solution to be beneficial, by preventing 
cold-induced cell swelling (Southard and Belzer, 1993) leaving less 
unbound water in the cells to crystallize. 
No effect of CPA addition or slice thickness was observed in the present 
study. Due to the much lower cell membrane permeability of DMSO than of 
water, the rapid introduction of CPA in the medium can cause an osmotic 
shock leading to cell damage (Levin and Miller, 1981). In the present study, 
no significant beneficial effect of stepwise addition of the CPA on slice 
viability was observed. Most likely, the CPA concentration used was low 
enough to prevent osmotic damage. 
With respect to slice thickness, this study showed no major effect on 
viability of the slices after cryopreservation. The actual difference between 
‘thin’ and ‘thick’ slices was statistically significant (average difference of ca. 
3 cell layers). Theoretically, slice thickness could be an important factor in 
the success of cryopreservation. Thermal gradients may occur in thick 
slices, leading to differences in freezing rate between the edges and middle 
of the slice. Furthermore, penetration of CPA in thick slices could be 
insufficient. Indeed, in some slices that had been fast frozen in WME, viable 
cells were observed in groups located around venal area or at the edges of 
the slice. This indicates that CPA penetration or freezing rates may have 
been insufficient in cells located deeper in the tissue, and that the use of 
thin slices is favourable. The reason why slice thickness was not found to 
be a determining factor is most likely due to the fact that the difference in 
slice thickness was too small to cause a clear effect on viability. 
In summary, this study shows that hydroxylation of testosterone, urea 
synthesis and GST activity were relatively insensitive to cryopreservation 
Chapter 2 
 52
stress. ATP and K+ content and histomorphology were more clearly affected 
and can therefore be considered more sensitive parameters for evaluating 
slice viability after cryopreservation. Freezing rate and the cryopreservation 
medium were demonstrated to be major determinants of the residual 
viability of liver slices after cryopreservation and subsequent culturing. 
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Abstract 
 
An existing cryopreservation method for liver slices applies 12%  
dimethylsulfoxide and rapid freezing. We previously found that cells in rat 
liver slices, cryopreserved in this manner, deteriorated rapidly upon 
culturing. To improve this cryopreservation method, we varied the 
dimethylsulphoxide concentration (0, 12, 18 and 30%), the cryopreservation 
medium (Williams Medium E, Fetal Calf Serum and University of Wisconsin 
medium), slice thickness and the storage period at 4°C during slice 
preparation prior to cryopreservation. After thawing, slices were cultured for 
4 h at 37°C before their viability was evaluated by their potassium content 
and the number of intact cells determined histomorphologically. The 
biotransformation capacity of liver slices cryopreserved by the improved 
method was assessed by testosterone oxidation, hydroxycoumarine 
sulfation and glucuronidation. 
Best results were obtained with 18% dimethylsulphoxide in Williams 
medium E: the potassium content of cryopreserved slices was higher than 
65% and the number of intact cells was higher than 60% of that in fresh 
slices; with 12% dimethylsulphoxide, potassium content was less than 40% 
and the number of intact cells was less than 30%. Results did not differ 
between the three cryopreservation media. Viability of thin slices (8-10 cell 
layers) was better maintained than that of thicker slices (>14 cell layers). 
Storage at 4°C of slices before cryopreservation decreased viability after 
cryopreservation. Both oxidative and conjugation activities were better than 
60% of fresh values. 
Although results varied, slices cryopreserved with this improved method 
and cultured for 4 h retained viability between 50-80% and biotransfor-
mation activity between 60-90% of fresh slices. 
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Introduction 
 
Precision-cut tissue slices are extensively used as in vitro tool for studies on 
toxicity and biotransformation of xenobiotics (Bach et al., 1996; Olinga et 
al. 1997b). A major advantage of tissue slices over primary cell cultures is 
that cell-to-cell contacts and normal tissue micro-architecture remain 
intact. In addition, tissue slices are prepared according to a rapid, 
reproducible and relatively simple method (Krumdieck et al., 1980). 
Cryopreservation of liver slices can extend their use, for slices from animals 
and man could then be used in a single experiment, facilitating species 
comparison and decreasing the number of laboratory animals required. 
A number of cryopreservation methods for liver slices has been described 
in recent years. Roughly, methods can be divided in those that use 
(computer-controlled) slow freezing (Fisher et al., 1991; Fisher et al., 1993; 
Fisher et al., 1996), those that use vitrification protocols requiring high 
concentrations of cryoprotectants (CPAs) (Wishnies et al., 1991; Ekins, 
1996; Ekins et al., 1996a) and those that apply rapid freezing with low 
concentrations of DMSO (de Kanter and Koster, 1995; Glö ckner et al., 1996; 
Glö ckner et al., 1998; de Kanter et al., 1998). Success of reported methods 
is variable and seems dependent on animal species (Fisher et al., 1991) and 
viability parameters (Maas et al., 2000b). Particularly, phase I 
biotransformation is well preserved by all methods, while phase II 
biotransformation capacity is reported to be preserved to much lesser 
extent or not at all (Wishnies et al., 1991; Ekins et al., 1996a and b; de 
Kanter et al., 1998; Maas et al., 2000b). No publications have reported 
preservation of intact histomorphology of thawed liver slices. 
The rapid-freezing method for cryopreservation, developed in our 
laboratory (de Kanter and Koster, 1995; de Kanter et al., 1998), has the 
advantage of using relatively low and nontoxic concentrations of CPA (12% 
DMSO). Moreover, the method is relatively simple: slices are put in cryovials 
with medium and directly submersed in liquid nitrogen. Using this method, 
slices apparently maintained functional activity (testosterone oxidation, 
urea synthesis) and cell membrane integrity (alanine aminotransferase 
retention) close to levels of fresh slices in the early post-thaw stage (0-3 h 
after thawing). Others, who used rapid-freezing methods have found similar 
results (Glö ckner et al., 1996; Glö ckner et al., 1998) 
Recently, we compared the usefulness of this method, which presumably 
minimizes intracellular ice crystal formation (IIF) by intracellular vitrifica-
tion (Kanter and Koster, 1995) to another method that was designed to 
Chapter 3  
 56
prevent IIF by dehydrating cells by slow freezing (Maas et al., 2000b). 
Although the rapid-freezing method better maintained phase I biotrans-
formation activity and urea synthesis, cell integrity as revealed by 
histomorphological examination was severely affected by either method. 
Moreover, cryopreserved slices had low contents of intracellular potassium 
(potassium) and ATP and were incapable to perform glutathione (GSH) 
conjugation of chlorodinitrobenzene due to cofactor (GSH) loss. 
In the present study, we attempted to improve results on slice viability 
after cryopreservation by rapid-freezing. Two approaches were used for this 
purpose: One approach was to try to inhibit ice-crystal formation and thus 
stimulate vitrification of intracellular and extracellular water. To achieve 
this, we varied the concentration of DMSO, a well-known glass former 
(Boutron and Kaufmann, 1978; Hey and Macfarlane, 1996; Baudot et al., 
1999). Additionally, WME was replaced as CPA carrier medium by 
University of Wisconsin Medium (UW) and Fetal Calf serum (FCS), media 
that contain hydroxyethyl starch (HES) and bovine serum albumine (BSA) 
respectively, that bind water and thus stimulate water vitrification 
extracellularly (Kö rber et al., 1982; Takahashi and Hirsh, 1985). 
The other approach was to alter the susceptibility of slices for 
cryopreservation damage. To that end, slice thickness was varied. Slice 
thickness may be of importance, because ice crystal formation is more likely 
to occur in the cryopreservation medium surrounding the slices during 
freezing than in the tissue itself, where vitrification is favoured (Tahahashi 
and Hirsh, 1985; Peridieu et al., 1995). In very thin slices, therefore, 
relatively more cells might suffer from ice-crystal formation on the outside 
of the cell than in thicker slices (de Kanter and Koster, 1995). In very thick 
slices, on the other hand, CPA diffusion to the inner cell layers may be 
impeded causing a suboptimal cryopreservation condition in these cells.  
In tissues, kept at subphysiological temperatures, intracellular ion 
concentrations change and cells swell (Belzer and Southard, 1988). 
Inevitably, slices are kept for some time in buffer at 4°C before they enter 
the cryopreservation procedure. Therefore, the duration of this step was 
tested for its effect on the cryopreservation result. 
As endpoints for optimization of viability, potassium retention and slice 
histomorphology were used, parameters that have been shown to be highly 
sensitive to cryopreservation damage (Maas et al., 2000b). Slices, 
cryopreserved by an improved protocol, were tested on their phase I 
(testosterone oxidation) and II biotransformation capacity (hydroxycou-
marine sulfation and glucuronidation) subsequently. 
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Materials and methods 
 
Materials 
7-Hydroxycoumarine glucuronide and sulfate were generous gifts of dr. P. 
Olinga, Center for Pharmacy, University of Groningen, The Netherlands; 
Krebs Henseleit buffer, BSA, insulin and gentamycine were obtained from 
Sigma, Axel, The Netherlands; WME+glutamax, FCS and phosphate-
buffered saline (PBS) were from Gibco BRL, Breda, The Netherlands; DMSO 
(>99.9% pure), cryovials were from Greiner, Alphen a/d Rijn, The 
Netherlands; Coomassie Protein kit No. 23200, was from Pierce, Oud-
Beyerland, The Netherlands; testosterone and 11β-Hydroxytestosterone 
were from Fluka, Buchs, Switserland; hydroxytestosterone metabolites were 
from Steraloids Inc., Wilton NH, USA; 7-hydroxycoumarine was from 
Merck-Schuchart, Hohenbrunn, Germany; hematoxylin and eosin were 
from Sigma, St. Louis, MO, USA. glucose, HPLC-water and all other 
chemicals were from Baker, Deventer, The Netherlands. 
 
Preparation of slices 
Male rats (Wistar, obtained from Harlan CPB, Horst, The Netherlands) had 
free access to food and water. They were anesthesized with 65% CO2, 35% 
O2 before the livers were removed. Tissue cores (8 mm) were prepared from 
the freshly excised liver, using an electrical drill (Metabo BSE 5010) with a 
tissue coring tool (Alabama R&D, Munford, AL, USA). Slices were prepared 
subsequently using a Krumdieck tissue slicer (Alabama R&D, Munford, AL, 
USA), filled with oxygenated (95% O2, 5% CO2) ice-cold Krebs Henseleit 
buffer, supplemented with NaHCO3 (25 mM) and CaCl2 (2.5 mM). To 
determine optimal slice-thickness for cryopreservation, the slicer was set to 
produce slices of various thickness. Thickness of slices generated in this 
manner was evaluated by microscopically counting the number of cell 
layers in paraffin cross-sections. 
After preparation, slices were washed and kept on ice in WME with 10% 
FCS until use. To determine the influence of this cold storage period on 
slice viability after cryopreservation, the length of time between slice 
preparation and the start of the cryopreservation method was varied in 
some experiments. 
 
Cryopreservation and thawing of slices 
Before freezing, slices were pre-incubated in a shaking water bath (110 
times/min) for 30 min in a 25-ml Erlenmeyer flask (6 slices/Erlenmeyer) on 
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ice. Each Erlenmeyer flask contained 5 ml oxygenated medium (WME, UW 
or FCS) supplemented with CPA. As CPA, various concentrations of DMSO 
were used. Subsequently, slices were put in 2-ml cryovials with 0.5 ml pre-
incubation medium. Hereafter, the cryovials were directly submersed in 
liquid nitrogen. Following this procedure, slices were cooled at 
approximately 250°C/min to -196°C (de Kanter and Koster, 1995). After 
storing the cryopreserved slices in liquid nitrogen for 30 min1 or more, 
slices were thawed by placing the cryovials in a 37°C waterbath. After 
visible ice was vanished, slices were washed shortly with WME, 10% FCS. 
To determine possible adverse effects of pre-incubation with DMSO on 
the slices, some slices were pre-incubated with DMSO, but not cryopre-
served. The cryopreservation medium was washed away immediately at the 
end of pre-incubation whereafter slices were incubated for viability testing. 
 
Incubation of slices 
Fresh and cryopreserved slices were incubated for 4 h at 37°C, floating in 5 
ml medium in a 25-ml Erlenmeyer flask (1 slice/Erlenmeyer), placed in a 
waterbath shaking back and forth (110 times/min), under humid carbogen 
(95% O2, 5%CO2). This incubation system maintains viability of fresh liver 
slices for at least 24 h (Olinga et al., 1997a). WME+glutamax was used as 
incubation medium, supplemented with FCS (5%), 0.1 µM insulin, 50 mg/l 
gentamycine and D-glucose (25 mM). After 4 h incubation, tests on viability 
and biotransformation capacity were performed. 
 
Potassium content 
To determine potassium content, slices were washed in a physiological salt 
solution (37°C) prepared with potassium-free HPLC-water. Subsequently, 
the slice was cut in two equal parts. One part was used for 
histomorphological examination (see below). The other part was immersed 
in 70% ethanol in HPLC water, containing 2 mM EDTA (pH 10.9), for 
potassium and protein determination. For this purpose, the slice was 
homogenized using a Branford sonifier (50% duty cycle, 5 s). Potassium 
content was measured in the homogenate using a Beckman 2 electrolyte 
analyser (Beckman Instruments, Mijdrecht, The Netherlands). 
                                                          
1
 Theoretically, it is expected that freezing and thawing of slices determine viability after cryopreservation and 
not the storage period in liquid nitrogen (Mazur, 1984). We compared viability of slices stored for 30 min with 
slices from the same liver that were stored for approximately 48 h. Indeed, no differences were found. 
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Protein determination 
To an aliquot of the slice homogenate, 2M NaOH (25% v/v) was added to 
dissolve the protein. Hereafter, the protein solution was diluted (1:5 
minimally) with PBS. Subsequently, protein content was measured by a 
Cobas-Bio centrifugal spectrophotometer with a Coomassie Protein kit, BSA 
was used as a standard. 
 
Histomorphological examination 
After fixation with 70% ethanol at 4°C for at least 24 h, slices were 
dehydrated in a series of ethanol and xylene using a Shandon 2LE 
Processor. Subsequently, slices were vertically embedded in paraffin and 
cross sections (4 µm thickness) were made which were stained with 
haematoxylin and eosin (H&E). Upon microscopical examination, slice 
viability was determined by estimating the percentage of viable cells in the 
slice cross section. For determining viability, nuclear shape and staining 
and cytoplasmatic staining were taken into account. 
 
Testosterone metabolism 
Metabolism of testosterone was determined after 60 min of incubation with 
250 µM testosterone in homogenate extracts by HPLC as earlier described 
(van ‘t Klooster et al., 1993), but using a flow of 0.8 ml/min. 11β-
Hydroxytestosterone was used as internal standard. Of all testosterone 
metabolites peak areas were determined, but only formation of 2α-
hydroxytestosterone (an important hydroxy-testosterone metabolite in rats) 
was quantified (as production in picomoles per slice per min). The formation 
of this metabolite was linear throughout the 60 min incubation with the 
substrate, with R2=0.999. 
 
7-HC conjugation 
Conjugation of 7-HC to 7-HC-glucuronide (7-HC-gluc) and 7-HC-sulfate (7-
HC-sulf) was determined after incubation of 60 min with 100 µM 7-HC. The 
conjugates were determined in the slice homogenate by HPLC with an 
Inertsil ODS-3 (150x2.1 mm) column and a gradient of 100% water with 3 
g/l ammonium acetate to 100% pure methanol in 30 min and 3 min 
isocratic at 100% methanol. Detection was at 325 nm (Walsh et al., 1995). 
Formation of 7-HC-gluc and 7-HC-sulf was linear throughout the 60 min 
incubation with the substrate with R2= 0.995 and 0.998 respectively.
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Statistical analysis 
For the variables DMSO concentration, cryopreservation medium and 
storage time, an analysis of variance (ANOVA) has been applied to the 
viability data, considering data of one experiment as one observation, 
followed by comparisons between data with the t-test. A Bonferroni 
correction of the P values was used where applicable. To study the effect of 
slice thickness, an ANOVA has been applied for the fresh and cryopreserved 
slices separately. Statistical significance of the relation (both with a linear 
and a quadratic fit) between viability and slice thickness was subsequently 
determined with the F-test. For all tests, P<0.05 was considered statistically 
significant. 
 
 
Results 
 
Histomorphology of precision-cut liver slices 
Precision-cut liver slices always have damaged cells at the cutting edges (1-
2 cellayers at each edge). These damaged cells are also taken into account 
with viability scoring. That means that 20-30% of the cells are always non-
viable and, therefore, slices will get a maximal ‘viability’ score of 70-80%. 
 
Effect of DMSO on the viability of fresh slices. 
To discriminate the possible toxicity of DMSO used in the cryopreservation 
procedure from damage caused by cryopreservation itself, the effect of 
DMSO on the viability of fresh slices was determined. To that end, freshly 
prepared slices were subjected to the cryopreservation pre-incubation with 
DMSO and, without actual cryopreservation, cultured for 4 h at 37°C. 
Exposure of slices to DMSO at concentrations up to 18% during pre-
incubation (not followed by cryopreservation) did not cause adverse effects 
on slice potassium content or on slice histomorphology (Fig. 1). The use of 
30% DMSO resulted in a statistically significant reduction in potassium 
content of fresh liver slices and a nonstatistically significant reduction in 
intact cells. 
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Fig. 1 Potassium content [a] and histomorphology [b] of fresh slices in culture for 4 h after pre-
incubation with various concentrations of DMSO. Values are shown as mean of individual 
experiments (6-9 experiments, 3 slices per experiment) +SEM. *values are significantly lower 
(p<0.05) than those of slices that were pre-incubated without DMSO. 
 
 
 
 
 
 
Fig. 2 Potassium content [a] and histomorphology [b] of cryopreserved slices pre-incubated with 
various concentrations of DMSO. Slices were cultured for 4 h after thawing. Values are shown as 
mean of individual experiments (4-10 experiments, 3 slices per experiment) +SEM. a % of value of 
fresh slices (i.e. slices that were not pre-incubated with DMSO or cryopreserved) + SEM.  *values are 
significantly higher (p<0.05) than those obtained with 12% DMSO. 
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Fig. 3 Histomorphology of fresh and cryopreserved liver slices after 4 h in culture (H&E staining) [A] 
fresh slice (not cryopreserved, nor pre-incubated), [B] cryopreserved slice, pre-incubated without 
DMSO.
Biotransformation in cryopreserved rat liver slices     
 63
 
 
Fig. 3, continued [C] cryopreserved slice, pre-incubated with 12% DMSO, [D] cryopreserved slice, 
pre-incubated with 18% DMSO. 
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Cryoprotection by DMSO 
Immediately after thawing, potassium concentration and the number of 
intact cells in cryopreserved slices were comparable to fresh slices, 
independent on DMSO concentration used (12-30%) (data not shown). After 
4 h of culturing, however, 18% (v/v) DMSO better retained viability of slices 
than 12% and 30% (Fig. 2). The potassium content of slices cryopreserved 
with 18% DMSO was over 65% of the content of fresh slices (i.e. slices that 
were not pre-incubated with DMSO or cryopreserved), and higher than the 
results with 12 or 30% DMSO (40 and 55% respectively). 
Histomorphological examination gave similar results. The number of intact 
cells in slices cryopreserved with 18% DMSO was over 60% of that of fresh 
slices and with 12 and 30%, this was considerably lower (Fig. 2a). Without 
DMSO, only few cells were intact, and in most cells pyknosis and 
karyorhexis was observed (Fig. 3a), whereas with 12% DMSO, a number of 
cells with intact nuclei could still be seen. In slices cryopreserved with 18% 
DMSO, the aspect of the cells (Fig. 3d) is hardly distinguishable from that in 
a fresh slice (Fig. 3a). 
 
Influence of cryopreservation medium 
The influence of the medium used as CPA carrier during pre-incubation and 
cryopreservation on viability of slices is shown in Fig. 4. Neither UW nor 
FCS appeared to be a better cryopreservation medium than WME (Fig. 4, a 
and b). 
 
The role of slice thickness  
When slices of various thickness were prepared, the results after 
cryopreservation varied (Fig. 5). Because of this variation, data from each 
experiment are given separately. This shows that the trend in the 
experiments is consistent and statistically significant: both potassium 
content and the number of intact cells were considerably decreased in 
thicker slices. Potassium retention of the cryopreserved slices reached an 
optimum in slices with approximately 10 cell layers. Histomorphological 
examination of slices revealed that damaged cells in relatively thick 
cryopreserved slices are mainly located at the slice edges and in the cell 
layers central in the slice. In thin slices, only the outer cell layers are 
damaged. Potassium retention(Fig. 5a), but not the number of intact cells 
(Fig. 5b), in fresh slices was also related significantly to slice thickness, 
although less marked than in cryopreserved slices. 
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Fig. 4 Potassium content [a] and histomorphology [b] of cryopreserved slices pre-incubated with 
18% DMSO in WME, FCS or UW as pre-incubation medium. Slices were cultured for 4 h after 
thawing. Values are shown as mean of individual experiments (5-7 experiments, 3 slices per 
experiment) +SEM. a % of value of fresh slices (i.e. slices that were not pre-incubated with DMSO or 
cryopreserved) + SEM.  
 
 
 
 
 
 
Fig. 5 Influence of slice thickness on potassium content [a] and histomorphology [b]) of fresh and 
cryopreserved slices. Open symbols: fresh slices not pre-incubated with DMSO, nor cryopreserved 
and closed symbols: cryopreserved slices. Analogous symbol forms represent mean of values of 
individual fresh and cryopreserved slices from the same experiment (6 slices per experiment) +SEM. 
Slices were cultured for 4 h. Potassium content of both fresh and cryopreserved slices is statistically 
significantly related to slice thickness (p<0.05). The % intact cells is only for cryopreserved slices 
statistically significantly related to slice thickness. 
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Fig. 6 Influence of storage time at 4°C after slice preparation on fresh and 18% DMSO treated 
cryopreserved slices, on potassium content [a] and histomorphology [b]. Slices were cultured for 4 h. 
Values are shown as mean values of individual experiments (5-6 experiments, 3 slices per 
experiment) +SEM. a % of value of fresh slices (i.e. slices that were stored at 4°C during the same 
amount of time, but were not pre-incubated with DMSO or cryopreserved) +SEM. 
 
The role of cold storage prior to cryopreservation 
Liver tissue and slices are generally kept on ice for approximately 60 min 
(counting from liver excision) during slice preparation before the 
cryopreservation pre-incubation is started. As shown in Fig. 6, varying this 
time from 15 to 75 min, decreased the number of intact cells and potassium 
content, although not statistically significant. 
 
Biotransformation in liver slices with optimized viability 
In thin slices, cryopreserved according to the improved method (using 18% 
DMSO in WME), biotransformation activity was determined. Results are 
shown in Table 1. Formation of 2  -hydroxytestosterone, an important 
hydroxymetabolite of testosterone in rat slices and a measure for P450-
mediated phase I biotransformation, was maintained at 60-85% of levels of 
fresh slices. Peak areas of other metabolites (6β-OH, 19-OH, 14α-OH, 16α-
OH, 16β-OH and androstenodione) were maintained at similar levels, as 
was the total area of all metabolite peaks. Also phase II biotransformation, 
that is the glucuronidation and sulfation of 7-HC, was maintained at 50-
90% of fresh values, with a relative constant fraction formed of each of the 
two metabolites. The biotransformation capacity of cryopreserved slices 
correlates well with potassium content and slice histomorphology within the 
same experiment. 
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Table 1 Viability and biotransformation capacity of fresh and cryopreserved liver slices after 4 h in 
culture 
 
 
Mean values are given ±SEM, ND=not determined 
a
 metabolite production in pmol/min/slice. Peak areas of other metabolites (6β-OH, 19-OH, 14α-OH, 
16α-OH, 16β-OH and androstenodione) were maintained at 62-114%, 54-71% and 73-117% of fresh 
slices for liver 1, 2 and 3 respectively. Total peak area of metabolites formed was 97%, 59% and 
94% of fresh slices respectively 
b metabolite production in pmol/min/slice 
c µmol/mg protein 
d % intact cells in slice cross section 
 
 
Discussion 
 
In an attempt to improve an existing cryopreservation method for liver 
slices, we found that pre-incubation with 18% DMSO in WME and direct 
immersion in liquid nitrogen maintained cellular integrity and functionality 
of thin slices (8-10 cell layers) at high levels. Since the potassium content, 
the number of intact cells and the functionality/drug metabolism 
parameters are all correlated, the intact cells can be tentatively indicated as 
viable. 
In earlier studies in our laboratory (de Kanter and Koster, 1995) and by 
others (Glö ckner et al. 1996; Glö ckner et al. 1998), high viablity was found 
after fast freezing with lower concentrations of DMSO (10-12%). However, 
the viability parameters (i.e. testosterone oxidation, urea synthesis and 
retention of ALT) used by de Kanter and Koster (1995) to optimize this 
cryopreservation method, were found to be relatively insensitive to 
cryopreservation damage comparing to parameters that indicate cell 
  
2α-OH testosteronea 
 
7-HC-glucb 
 
7-HC-sulfb 
 
K+ contentc 
 
Histomorphologyd 
 
 
liver 1 
 fresh 
 cryopreserved 
 % of fresh 
liver 2 
 fresh 
 cryopreserved 
 % of fresh 
liver 3 
 fresh 
 cryopreserved 
 % of fresh 
mean 
 fresh 
 cryopreserved 
 % of fresh 
 
 
248 ±
 
37 
207 ± 39 
84 ±
 
20 
 
338 ±
 
28 
214 ±
 
20 
63 ±
 
8 
 
156 ±
 
11 
133 ± 16 
85 ± 12 
 
247 ± 52 
184 ± 34 
77 ± 7 
 
 
10 ± 96 
816 ± 11 
79 ± 7 
 
1298 ± 66 
693 ± 110 
53 ± 9 
 
1301 ± 30 
904 ± 26 
70 ± 3 
 
1210 ± 90 
804 ± 52 
67± 8 
 
 
65 ± 8 
52 ± 0 
80 ± 9 
 
63 ± 9 
41 ± 8 
65 ± 16 
 
64 ± 5 
58 ± 3 
90 ± 9 
 
64 ± 1 
50 ± 4 
79 ± 7 
 
 
0.74 ± 0.07 
0.49 ± 0.03 
67 ± 7 
 
ND 
ND 
ND 
 
0.71 ± 0.03 
0.46 ± 0.02 
65 ± 4 
 
0.73 ± 0.01 
0.48 ± 0.01 
66 ± 0.8 
 
 
67 ± 2 
53 ± 8 
79 ± 11 
 
75 ± 0 
32 ± 2 
42 ± 2 
 
72 ± 2 
47 ± 2 
65 ± 3 
 
71 ± 24 
44 ± 6 
62 ± 11 
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integrity like retention of small molecules (GSH, ATP) and potassium and 
preservation of intact histomorphology (Maas et al., 2000b). To prolong 
incubation with thawed slices, it is important to maintain particularly these 
sensitive parameters at high levels. Since the biological machinery of the 
cell is required for the complete expression of cryopreservation damage, 
slices in the present study were cultured at 37°C for 4 h, prior to viability 
testing. Apparently, during a 4 h incubation, 18% DMSO maintains 
sensitive viability parameters better than 12%. 
As shown by other authors, oxidative drug metabolism (i.e. testosterone 
oxidation) is well maintained by cryopreservation (Wishnies et al., 1991; de 
Kanter and Koster, 1995; Ekins, 1996a; Ekins et al., 1996a; Glö ckner et al., 
1996; de Kanter et al., 1998; Glö ckner et al., 1998; Maas et al., 2000b). 
However, phase II metabolism is more sensitive to cryopreservation damage 
(Wishnies et al., 1991; Ekins, 1996a; Ekins et al., 1996a; de Kanter et al., 
1998; Maas et al., 2000b). GSH and sulfate conjugation are more sensitive 
to cryopreservation damage than other metabolic pathways (Steinberg et al., 
1999).  However, in the present study sulfation was maintained at a high 
level. There is evidence that conjugation is impaired by cofactor leakage 
rather than by enzyme inactivation (Maas et al., 2000b). The preservation of 
sulfation in the present study presumably indicates therefore, that small 
molecules like the cofactor for sulfation, phosphoadenosine phosphosulfate, 
are adequately maintained. 
In the present study we selected potassium and histomorphology as end-
points to improve cryopreservation, since we found previously that these 
parameters not only are very sensitive to cryopreservation damage but also 
correlate well with cofactor (ATP/GSH) levels in the slice (Maas et al., 
2000b) and thus we expected these parameters to be reliable predictors of 
biotransformation activity. As expected, the maintenance of cellular 
integrity coincided well with the preservation of oxidation and conjugation 
capacity of cryopreserved slices: 2α-hydroxytestosterone and 7-HC-glucu-
ronidates and 7-HC-sulfates were produced at levels close to that of fresh 
slices. Moreover, production of all metabolites was maintained at similar 
levels, indicating that all metabolic routes of testosterone and hydroxy-
coumarin were maintained. 
The mechanism by which the present procedure protects cells from 
damage remains a subject of speculation: intracellular ice crystal formation 
(IIF) might be (largely) prevented by the higher DMSO concentration or the 
ice crystals may remain smaller. Moreover, DMSO may render the cellular 
membranes less susceptible for ice crystals formed. It is known that high 
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and toxic concentrations of DMSO (>40%) are required to completely 
prevent ice-formation in aqueous solutions (Boutron and Kaufmann, 1978; 
Baudot et al., 1999). Therefore, with 18% DMSO, the cryopreservation 
medium surrounding the slices will not vitrify during freezing. An even 
higher concentration, 30% DMSO, did not further increase viability after 
cryopreservation, probably because of its toxicity. 
Other attempts to stimulate vitrification, for example replacing WME by 
other cryopreservation media (FCS and UW) that contain substances that 
can behave as CPA (BSA and HES respectively) did not improve viability. 
Since these substances remain extracellular, they will only influence 
extracellular vitrification, which, with this method, does not seem to have 
an added value. 
It should be noticed that viability varied within experiments and even 
more so  between the experiments, in contrast to fresh slices. This could be 
caused by differences between slices derived from different parts of the liver 
and between livers from different animals. Moreover, the starting conditions 
of the slices may be critical. We found, for example, that storage time prior 
to cryopreservation influences slice viability after cryopreservation. 
It can be concluded from the present study that the cryopreservation 
method improved here, using thin slices pre-incubated in WME with 18% 
DMSO as CPA, offers a simple way to store liver slices and can maintain 
their viability and biotransformation activity close to that of fresh slices. 
Variability between slices cryopreserved from different livers, may be of 
concern, but for in vitro metabolism studies, slices from successful 
cryopreservation experiments can be easily selected by measuring the 
potassium content of a few cryopreserved slices of that particular liver. 
Because both phase I and II metabolism are maintained quantitatively 
comparable to fresh slice levels, and more importantly, because even in less 
successful cryopreservation experiments, metabolite patterns are similar to 
that of fresh slices, cryopreserved slices seem to be a promising tool to 
study in vitro metabolism both qualitatively as (semi-) quantitatively. 
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Abstract 
 
Precision-cut tissue slices of both hepatic and extra-hepatic origin are 
extensively used as in vitro system to assess drug metabolism in vivo. 
Cryopreservation would greatly facilitate their use. In the present study, 
attempts are made to cryopreserve precision-cut rat liver, intestinal and 
renal cortical and medullary slices (1) by using 18% DMSO and a cooling 
and warming rate of approximately 200°C/min and (2) by vitrification with 
high molarity mixtures of cryoprotectants, VM3 and VS4. 
Contrary to rat liver slices, intestinal and kidney slices were found not 
to survive cryopreservation by rapid freezing. Vitrification of liver slices with 
VS4 by ultra-rapid cooling and warming (800°C/min) was reasonably 
successful, but cryopreservation damage still occurred, despite the fact that 
cryoprotectant toxicity was low and no ice was formed during cooling or 
warming. Vitrification of kidney cortical slices with VS4 was not successful, 
partly because of cryoprotectant toxicity. Viability of kidney medullary slices 
was completely maintained after vitrification with VS4. Viability of intestinal 
slices was severely decreased by VS4 toxicity and no further attempts were 
made to actually vitrify them.  
The protocol for pre-incubation with VM3 was optimized to decrease 
cryoprotectant toxicity and tissue slices were vitrified with varying cooling 
rates. It appeared that viability of both kidney cortical slices and liver slices 
increased gradually with decreasing cooling rate. A cooling rate of ca. 
1.5°C/min resulted in viability close to that of fresh slices. 
     In conclusion, vitrification is a promising approach to cryopreserve 
tissue slices. However, contrary to prevailing thoughts, cooling rate dete-
rmines cell survival, even when water crystallization is prevented. 
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Introduction 
 
Precision-cut liver slices are increasingly used as in vitro tool to serve as a 
model for in vivo drug metabolism (for review see: Gandolfi et al.,1995; 
Parrish et al., 1995; Ekins, 1996b; Bach et al., 1996; Olinga et al., 1997b; 
Lerche-Lagrand and Toutain, 2000; de Kanter et al., 2002b). 
Cryopreservation would offer a possibility to store slices of human and 
animal origin, forming a tissue slice-bank from which slices can be derived 
and used for studies on drug metabolism and toxicity at any desired time-
point. A number of cryopreservation methods for liver slices have been 
developed, amongst others by our laboratory (Fisher et al., 1991; Wishnies 
et al., 1991; Fisher et al., 1993; de Kanter and Koster, 1995; Fisher et al., 
1996; Ekins, 1996a; Ekins et al., 1996a; Glö ckner et al., 1998; Day et al., 
1998; Maas et al., 2000a; de Graaf et al., 2000b, Glö ckner et al., 2001). 
There is an increasing awareness that extra-hepatic organs contribute 
substantially to drug metabolism and studying metabolism with liver slices 
alone may give an incomplete view of in vivo metabolism (Sandker et al., 
1994; Pahernik et al., 1995; Fisher et al., 1994; Vickers et al., 1995; de 
Kanter et al., 1999; de Graaf et al., submitted-see also chapter 7). However, 
the cryopreservation of precision-cut slices of extra-hepatic origin has not 
received much attention, with only a method for dog and human kidney 
slices reported (Fisher et al., 1993; Fisher et al., 1996).   
In the present study, attempts were made to cryopreserve slices from rat 
liver, kidney medullary and cortical slices, and small intestinal slices. Two 
approaches were used for this purpose. The first approach was rapid 
freezing. For liver slices, we have developed a simple, rapid (200°C/min) 
freezing method (de Kanter and Koster, 1995; de Kanter et al., 1998; de 
Graaf et al., 2000b), using 18% DMSO and showed that post-thaw viability 
and phase I and II biotransformation activity of cryopreserved rat liver slices 
were maintained at least during 4 h after thawing (de Graaf et al., 2000b). 
The second approach used was vitrification. Essentially, vitrification is the 
solidification of a liquid not induced by crystallization but by an extreme 
elevation in viscosity during cooling, so that the solution becomes a glass 
(Fahy et al., 1984). Previously, with liver slices some success was reported 
when vitrification was used as starting point for cryopreservation (Wishnies 
et al., 1991; Ekins, 1996a; Ekins et al., 1996a; de Graaf and Koster, 2001). 
In the present study, highly concentrated cryoprotectant (CPA) mixtures, 
VS4 and VM3, were used for vitrification of tissue slices. VS4 consists of 1,2 
propanediol, DMSO and formamide in buffered saline with glucose, with a 
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total molarity of 7.5. VM3 is a low toxic high molarity mixture of CPAs as 
well, however the composition can not be given because of proprietary 
reasons, but it is expected to be commercially available soon. The cooling 
rate required to provoke vitrification (critical cooling rate, Vcrc) of VS4 in liver 
slices is ca. 10°C/min (de Graaf and Koster, 2001). The warming rate 
required to prevent devitrification of liver slices (critical warming rate, Vcrw) 
varies between 40 and 1600°C/min, depending on the liver from which the 
slices were derived (de Graaf and Koster, 2001). These rates can be reached 
by freezing and thawing slices between aluminium foil sheets (de Graaf and 
Koster, 2001). The Vcrc and Vcrw of VM3 are lower than of VS4, respectively 
<1°C/min and <10°C/min (dr. Greg Fahy, personal communication).  
The viability of slices was tested by measuring the ATP content of the 
kidney and liver slices, alkaline phosphatase (AP) retention in the intestinal 
slices and by evaluating the histomorphology of all. Both ATP content and 
slice histomorphology have been shown to be sensitive to cryopreservation 
damage (Maas et al., 2000b) and to correlate with phase II biotransforma-
tion activity in cryopreserved slices (unpublished data). AP retention was 
chosen over ATP content as a parameter for the intestinal slices, because 
this protein is predominantly located in the mucosa, which is the 
metabolizing part of the intestine, thus preventing a possible influence of 
the muscle cells on the viability tests.  
 
 
Materials and methods 
 
Chemicals 
Formamide, 1,2-propanediol, Krebs Henseleit (KH) buffer, HEPES buffer, 
insulin, gentamycine, low melting agarose, adenine, trehalose and 
glutathione were obtained from Sigma, Axel, The Netherlands; William’s 
Medium E (+glutamax) (WME), phosphate buffered saline (PBS) and fetal 
calf serum (FCS) were from Gibco BRL, Breda, The Netherlands; University 
of Wisconsin medium (UW) was from Lamepro b.v., Raamsdonkveer, The 
Netherlands; VM3 was kindly provided by dr. Greg Fahy (21st Century 
Medicine, Charleston, USA), the exact composition cannot be given because 
of proprietary reasons. The Celsis Biomass assay kit was derived from 
Omnilabo, Breda, The Netherlands. The IL Test™ Alkaline Phosphatase test 
kit was derived from Instrumentation Laboratory (Lexington, USA). DMSO 
(>99.9% pure) and all other chemicals were from Baker, Deventer, The 
Netherlands.
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Table 1 Stepwise CPA impregnation and removal 
 
 
VS4 pre-incubation  
 
VS4 out washing 
 
25%VS4 a 
 
50% VS4 
 
75% VS4 
 
100% VS4  
 
75% VS4 
 
50% VS4 
 
25% VS4 
15 min 15 min 15 min 30 min  10 min 10 min 10 min 
 
VM3 pre-incubation  
 
VM3 out washing 
 
8% Pre-Vb  
 
15% Pre-V  
 
26% Pre-V  
 
VM3  
 
26% Pre-V  
 
15% Pre-V  
 
8% Pre-V 
15 min 15 min 15 min 30 min  10 min 10 min 10 min 
 
Note. Values in the table represent the time span of each step, given in min with each row 
representing consecutive pre-incubation or washing steps   
a % VS4 in VS4 buffer (v/v) 
b% Pre-V in VS4 buffer (g/v) 
 
Preparation of liver kidney and small intestinal slices  
Male rats (Wistar, obtained from Harlan CPB, Horst, The Netherlands) had 
free access to food and water. They were anaesthetised with 65% CO2, 35% 
O2 before the small intestine and/or kidneys and liver were removed.  
Precision-cut intestinal slices were made according to de Kanter et al. 
(submitted). From the small intestine, a part of ca. 10 to 20 cm, starting ca. 
10 cm from the stomach was taken and flushed with ice-cold UW and 
subsequently filled with 37°C low-melting agarose. After the agarose had 
solidified, the filled intestine was carefully cut into pieces of ca. 1 cm. These 
pieces were then put into a cooled 8 mm diameter tissue core holder of the 
Krumdieck tissue slicer (Alabama R&D, Munford, AL, USA), which was then 
filled with low-melting agarose. In later experiments a tissue-embedding 
tool (Alabama R&D) was used for this purpose. Slices were then made 
perpendicular to the intestinal wall.  
For the liver and kidney, 8 mm cores were produced using a 9 mm 
tissue-coring tool (Alabama R&D) attached to a mechanical drill (Metabo, 
The Netherlands). Sometimes from the kidney 5 mm cores were produced 
using a 6 mm coring tool to better be able to make separate medullary and 
cortical slices. Subsequently, these cores were sliced using a Krumdieck 
tissue slicer (Krumdieck et al., 1980) filled with ice-cold oxygenated KH 
buffer. After slicing, kidney medullary and cortical slices were separated. All 
slices were stored in ice-cold oxygenated WME with 10% FCS until further 
use.   
 
Pre-incubation with the CPA  
Slices were pre-incubated in 25 or 100-ml Erlenmeyer flasks (until 6 slices 
in a 25-ml flask, until 18 slices in a 100-ml flask) placed in a gently shaking
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waterbath filled with ice. Each Erlenmeyer flask contained 5 (25-ml flask) or 
15 ml CPA (100-ml flask) mixed in various proportions with oxygenated 
medium. As CPA DMSO, VS4 or VM3 were used. VS4 consists of DMSO, 
1,2-propanediol and formamide (weight ratio 21.5: 15: 12.4) mixed with 
buffered saline, glucose, adenine and glutathione (for the exact composition 
see Fahy and Ali, 1997). The mixture has a total concentration of 7.5 M. 
VS4 buffer has the same composition as VS4, but without formamide, 1,2-
propanediol and DMSO. VM3 is a CPA mixture under development for 
commercial sales and kindly provided by 21st Century Medicine. Because 
both VS4 and VM3 are highly concentrated CPA solutions, pre-incubation 
was executed stepwise with the intention to limit osmotic damage. For this 
purpose, VS4 was mixed to various concentrations with VS4 buffer. For 
VM3 impregnation, a special pre-incubation solution (called ‘pre-V’) was 
mixed in various proportions with VS4 buffer (the exact pre-incubation 
schedule is given in Table 1). In some experiments we deviated from this 
protocol, to further decrease CPA toxicity, by shortening the last pre-
incubation step (with undiluted VS4 or VM3) from 30 to 15 min. 18% 
DMSO (v/v), used for rapid freezing was applied to the slices in one single 
step of 30 min on ice. In some experiments, the effect of this protocol on 
viability of the slices was compared to that of a two-step protocol, with the 
intention to limit osmotical damage. In that case, the slices were incubated 
for 15 min in 10% DMSO before the last step of 15 min in 18% DMSO.       
 
Cryopreservation  
For rapid freezing with 18% DMSO, 3-6 slices were placed in 2-ml cryovials 
(Greiner, Alphen a/d Rijn, The Netherlands) with 0.5 ml 18% DMSO. 
Hereafter, the cryovials were directly submersed in liquid nitrogen (de 
Kanter and Koster, 1995, de Graaf et al., 2000b).  
 To prevent ice-crystal formation during cooling and warming with VS4, 
higher cooling and warming rates were required than were reached with the 
cryovials (de Graaf and Koster, 2001). Therefore, slices pre-incubated with 
VS4 were cryopreserved after placing them between pads of aluminium foil 
followed by direct immersion in liquid nitrogen. Cooling rates than were ca. 
800°C/min (de Graaf and Koster, 2001). VM3 has a lower Vcrc and Vcrw than 
VS4, i.e. <1°C/min and <10°C/min respectively, so cooling rates of slices 
could be varied: depending on the experiment, some VM3 pre-incubated 
slices were cooled in cryovials with 0.5 ml VM3 by direct immersion in 
liquid nitrogen (-200°C/min), others were frozen in cryovials placed in a 
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polystyrene box in a –80°C freezer for 1 h (cooling rate approx. 1.5°C/min 
(de Kanter and Koster, 1995)), followed by freezing in liquid nitrogen.  
 
Thawing and CPA removal 
Slices in cryovials were thawed by placing the cryovials in a 37°C waterbath 
(18% DMSO) or on ice-water (VM3) until ice was no longer visible (or for 
VM3, the glass became fluid again). VS4 and VM3 pre-incubated slices that 
were vitrified after being sandwiched between aluminium foil were thawed 
by placing the foil in 100% VS4 or VM3 on melting ice. After thawing, VS4 
and VM3 were washed away according to the stepwise protocol in Table 1. 
In some experiments we deviated from this protocol with the intention to 
further decrease osmotic damage by adding 300 mM trehalose, an im-
permeable sugar, to the washing medium. Slices that were rapidly frozen in 
18% DMSO were normally directly incubated at 37°C after thawing and 
quick washing in WME, 10% FCS. In some experiments, a two-step washing 
protocol was used, with the intention to limit osmotic damage. In that case, 
the slices were incubated for 10 min in 10% DMSO before incubation at 
37°C.  
To determine possible adverse effects of pre-incubation with the CPAs on 
the slices, some slices underwent the procedure of pre-incubation with out-
washing of the CPA and subsequent incubation, but were not cryopre-
served. 
 
Incubation and viability testing  
Slices were incubated in a 25-ml Erlenmeyer flask (1 slice/flask for 8 mm 
liver and kidney slices or 2 slices per flask for 5 mm kidney slices or 
intestinal slices) in a shaking water bath (110 strikes/min), under humid 
carbogen (95% O2, 5%CO2) in 5 ml WME, supplemented with FCS (5%), 0.1 
µM insulin, 50 mg/l gentamycine and d-glucose (to a medium concentration 
of 25 mM). After incubation for 4 h at 37°C viability was determined. 
The ATP content of liver and kidney slices was determined as follows: 
Slices were cut in two equal parts. One part was used for histomorpho-
logical examination (see below). The other part was immersed in 70% 
ethanol in HPLC water, containing 2 mM EDTA (pH 10.9). In case 5 mm 
kidney slices were used instead of 8 mm ones, one of the slices from an 
Erlenmeyer flask was used for the determination of ATP content and the 
other for histomorphology examination. Then, slices were homogenized 
using a Branford sonifier (50% duty cycle, 5 s). An aliquot of the 
homogenate was taken and mixed 1/1 with Nucleotide Releasing Medium
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from the assay kit. Thereafter, the solution was diluted 1/10 with 0.025M 
HEPES buffer to decrease the ethanol concentration. Subsequently, to 100 
µl of the solution, 50 µl luciferin/luciferase solution from the assay kit was 
added and the amount of luminescence as a measure of ATP content was 
measured using a Lumac Biocounter M500 (Lumac, The Netherlands). ATP 
content was determined relative to the protein content of the slices. 
Slice protein and potassium content were determined in the slice 
homogenate as described previously (de Graaf et al., 2000b), except that 
now an I-lab 600 automatical spectrophotometer (Instrumentation 
Laboratory, Lexington, USA) was used for the measurements. 
For histomorphological examination slices were fixed in 70% ethanol and 
further processed as described in de Graaf et al. (2000b). Slice integrity was 
determined in the haematoxylin and eosin stained cross sections by 
estimating the percentage of viable cells. It should be noted that also slice 
edges (1-2 cellayers at each edge in case of liver and kidney slices) that are 
damaged by cutting the slices during slice preparation were taken into 
account with viability scoring.  
AP retention in the mucosa of intestinal slices was determined as 
follows. After 4 h of incubation, the agarose was stripped from intestinal 
slices. Subsequently the slices were blotted dry, put into 0.5 ml PBS, 
homogenized using a Branson sonifier (50% duty cycle, 5 s) and 
subsequently centrifuged at 600 rcf. The AP content was subsequently 
measured in the supernatant and the slice incubation medium with the 
ILab 600, using IL Test™ Alkaline Phosphatase test kit. Then the 
percentage retention per slice was determined by dividing the amount of AP 
in the slice by the amount of AP in the incubation medium that leaked out 
of the slices + the amount of AP in the slice.  
 
Differential Scanning Calorimeter Measurements 
A differential scanning calorimeter (DSC7, Perkin Elmer, Oosterhout, The 
Netherlands) was used for determination of Vcrw of slices pre-incubated with 
the CPAs for 2 purposes a) to monitor whether or not optimal equilibration 
with a CPA had taken place (in case of optimal equilibration the Vcrws of the 
slices does not further decrease with increasing pre-incubation time) and b) 
to determine whether or not the feasible warming rate of 800°C/min was 
higher than the Vcrw of the pre-incubated slices, so that devitrification was 
prevented. For detailed description of DSC measurements on slices, see de 
Graaf and Koster (2001).  
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Fig. 1 Viability of tissue slices after pre-incubation with 18% DMSO (v/v) and rapid freezing. (a) liver 
slices, (b) kidney cortical slices, (c) kidney medullary slices (d) small intestinal slices. Untreated 
slices were not pre-incubated with 18% DMSO or cryopreserved, 18% DMSO treated slices were 
only pre-incubated with 18% DMSO, but not cryopreserved. 18% DMSO pre-incubation and out-
washing was performed stepwise with kidney slices. All slices were incubated for 4 h prior to viability 
testing. Histomorphologic appearance of slices is quantified as the percentage of intact (not necrotic) 
cells in the slice cross section. AP retention is quantified as the percentage of the initial AP content of 
the slices. The number of experiments (n) is given in the bars, 2 or 3 slices were used per 
experiment. Values are given +SD where appropriate. ND=no (intact cells) detected. 
 
 
Results 
 
Tissue slice viability after pre-incubation with 18% DMSO and rapid freezing.  
Previously, we have reported that viability and functionality of liver slices 
were maintained close to fresh slices levels for at least 4 h after thawing. 
Results in the present study are consistent with this observation (Fig. 1a). 
Both the amount of viable cells in cryopreserved slices (see also Fig. 7b), 4 h 
after thawing, and the ATP content were approximately 70% of fresh slice 
levels. Also in accordance with previous studies, viability of fresh liver slices 
was not affected by pre-incubation with 18% DMSO.   
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Preliminary studies with kidney slices showed that pre-incubation with 18% 
DMSO significantly decreased viability (data not shown). For this reason, a 
protocol was developed to minimize DMSO toxicity by pre-incubating 
stepwise (15 min in 10% DMSO, 15 min in 18% DMSO). Moreover, while 
liver slices were washed in WME, 10% FCS directly after thawing, kidney 
slices were first placed in 10% DMSO for 15 min before washing. Treated in 
this manner, both fresh cortical and medullary slices were unaffected by 
18% DMSO (Fig. 1b and c). Nevertheless, ATP levels of kidney slices that 
were treated in this way and then cryopreserved by rapid freezing were very 
low, <20% of fresh levels for cortical slices and <40% for medullary slices, 
while few unaffected cells were found upon histomorphological examination 
either cortical or medullary slices (see also Fig. 8b and 9b).  
 Viability of intestinal slices was deteriorated by rapid freezing as well: 
after thawing and subsequent culturing for 4 h, only 40% of alkalic phos-
phatase (AP) was retained in the slice, which is close to levels of slices that 
were cryopreserved without CPA, used as negative control (Fig. 1d). The 
decreased viability was not caused by 18% DMSO toxicity, since the 
amount of AP retained was equal in slices that were treated with DMSO and 
untreated slices.  
 
Tissue slice viability after pre-incubation with VS4 and vitrification   
Initially, to vitrify kidney and intestinal slices with VS4, a method was used  
that was found to maintain viability of rat liver slices at acceptable levels 
(de Graaf and Koster, 2001). However, Fig. 2 shows that viability of fresh 
kidney and intestinal slices already decreased markedly by treatment with 
VS4 without vitrification. Viability of liver slices after VS4 treatment was 
maintained at levels >75% of those of untreated slices (Fig. 2a), while that of 
kidney slices was reduced to approximately 50% (Fig. 2b). Data are given for 
kidney slices as a whole, but upon histomorphological examination it 
appeared that particularly the cortex was affected by VS4 treatment. Small 
intestinal slices retained only 45% of their AP after VS4 treatment, slightly 
more than slices used as negative control, that were cryopreserved without 
CPA and retained approximately 35% of their AP. Upon histomorphological 
examination of the intestinal slices it appeared that all mucosal cells 
became necrotic after VS4 treatment.  
As shown in Fig. 3a, reducing the duration of the pre-incubation with 
100% VS4 from 30 to 10 min increased viability of kidney cortical slices. 
Shortening pre-incubation did not improve the AP retention of intestinal 
slices.    
Cryopreservation of tissue slices by rapid freezing and vitrification           
 81
 
 
Fig. 2 Toxicity of VS4 to tissue slices. (a) liver slices, (b) kidney slices (not separated), (c) small 
intestinal slices. Untreated slices were not pre-incubated with VS4 or vitrified, VS4 treated slices 
were pre-incubated with VS4 but not vitrified. All slices were incubated for 4 h prior to viability testing. 
Histomorphologic appearance of slices is quantified as the percentage of intact (not necrotic) cells in 
the slices cross section. AP retention is quantified as the percentage of total AP content of the slices. 
The number of experiments (n) is given in the bars, 3 slices were used per experiment. Values are 
given +SD.  
 
 
 
Fig. 3 The effect of shortening VS4 pre-incubation on viability of tissue slices. (a) kidney cortical 
slices and (b) small intestinal slices. All slices were incubated for 4 h prior to viability testing. 
Histomorphologic appearance of slices is quantified as the percentage of intact (not necrotic) cells in 
the slices cross section. AP retention is quantified as the percentage of total AP content of the slices. 
Data points are labeled with the number of experiments performed (n), 3 slices were used per 
experiment. Values are given + SD where appropriate.    
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Fig. 4 Viability of tissue slices after treatment and vitrifcation with VS4. (a) liver slices, (b) kidney 
cortical slices and (c) kidney medullary slices. Untreated slices were not pre-incubated with VS4 or 
vitrified, VS4 treated slices were pre-incubated with VS4 but not vitrified. *Vcrws measured were 
below feasible warming rates, **Vcrws were higher than feasible warming rates. The final pre-
incubation step with 100% VS4 was 30 min with liver slices and 10-15 min with kidney slices. All 
slices were incubated for 4 h prior to viability testing. Histomorphologic appearance of slices is 
quantified as the percentage of intact (not necrotic) cells in the slices cross section. The number of 
experiments (n) is given in the bars, 3 slices were used per experiment. Values are given +SD. 
 
De Graaf and Koster (2001) have shown that the critical warming rate (i.e. 
the warming rate required to prevent devitrification, Vcrw) of liver slices is in 
most cases near the warming rate that can be reached when slices are 
vitrified and warmed between aluminium foil sheets (800°C/min, from now 
on called feasible warming rate). When equilibration with VS4 is sub-
optimal, the Vcrw is expected to be above this level. To ensure that 
shortening of the pre-incubation period did not cause incomplete 
penetration of VS4, kidney and intestinal slices were pre-incubated for 10, 
20 or 30 min with VS4 and Vcrws determined. With kidney slices, Vcrws were 
not changed by shorter pre-incubation, indirectly indicating that VS4 
penetration in all cases was complete. With intestinal slices, Vcrws gradually 
increased from 216 to 595 and 1291°C/min for pre-incubation periods of 
30, 20 and 10 min respectively. Nonetheless, even for 10 min pre-
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incubation, Vcrws were still close to the feasible warming rate of 800°C/min. 
Nonetheless, because of the high sensitivity of intestinal slices for VS4 
toxicity, no further attempts were made to actually vitrify them. 
 After optimization of the pre-incubation protocol for VS4, liver and 
kidney slices were vitrified. Results are shown in Fig. 4. Of each individual 
experiment (organ), one slice was used to check whether the Vcrw was lower 
than the feasible warming rate of 800°C/min. Measured Vcrws varied 
between 350 and 3500°C/min for liver slices and were 298 and 194°C/min 
for kidney cortical and 2578 and 498°C/min for medullary slices. So, for 
part of the liver and kidney medullary slices the Vcrws were higher that the 
feasible warming rates and some crystallization may have occurred upon 
warming. In Fig. 4, the results of experiments with Vcrws lower than the 
feasible warming rates and of experiments with higher Vcrws than the 
feasible warming rates are shown separately. It appears that VS4 vitrified 
liver slices had a viability of (only) 35-60% of that of untreated slices, 
despite of the fact that VS4 toxicity was low and no ice was formed either 
during cooling or warming (see Fig. 7c for histomorphology of liver slices 
that were treated and vitrified with VS4). The same holds true for kidney 
cortical slices: although Vcrws were well below the feasible warming rates, 
viability after vitrification decreased to approximately 10% (histomorpho-
logy, see also Fig. 8c) or <40% (ATP content) of untreated slices. Only a part 
of this decrease can be attributed to VS4 toxicity. Kidney medullary slices 
were well preserved by vitrification with VS4 (see also Fig. 9c). Remarkably, 
viability of liver and kidney medullary slices that had Vcrws higher than the 
feasible warming rates did not differ much of those with Vcrws below the 
feasible warming rates.  
 
Vitrification of liver and kidney slices with VM3 
Initially, to pre-incubate slices with VM3, a stepwise protocol was used with 
a 30 min pre-incubation period with VM3 as final step. As with VS4 
however, the viability of kidney cortical slices was decreased by VM3 
treatment, while liver slices and kidney medullary slices were barely 
affected. To increase viability of VM3 treated cortical slices, several 
variations were made in the pre-incubation protocol. As shown in Fig. 5, 
slices incubated with VM3 for 15 min instead of 30 min and washed with 
300 mM trehalose added to the washing medium with the intention to 
decrease osmotic effects, had the highest viability. 
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Fig. 5 The effect of shortening VM3 pre-incubation and adding 300 mM trehalose to the washing 
medium on viability of kidney cortical slices after VM3 treatment. Untreated slices were not pre-
incubated with VM3 or vitrified, VM3 treated slices were pre-incubated with VM3 for 15 or 30 min, not 
vitrified and washed with or without 300 mM trehalose in the washing medium. Slices were incubated 
for 4 h prior to viability testing. Histomorphologic appearance of slices is quantified as the percentage 
of intact (not necrotic) cells in the slice cross section. ATP content is given relative to untreated slices 
of the same experiment because of the great variation in absolute values between experiments 
(absolute values for untreated slices were 10.3, 5.6 and 3.4 nmol ATP/mg protein). The number of 
experiments (n)  is given in the bars, 3 slices were used per experiment. Values are given +SD.  
 
Because the critical cooling rate (Vcrc) and the Vcrw (respectively <1 and 
<10°C/min) of VM3 are much lower than of VS4, it was possible to vary 
cooling rates of VM3 pre-incubated slices. Cooling rates of 800, 200 and 
1.5°C/min were used. In preliminary experiments it was noticed that the 
glass that was formed from VM3 in the cryovials was susceptible to 
cracking, leading to fragmentation. This pheno-menon is probably caused 
by temperature stress within the sample. It is known that cracking in a 
glass at low temperatures can be avoided by lowering the cooling rate 
around the glass transition point (Baudot et al., 2001). Optimization of the 
freezing technique for VM3 has led to the following protocol: Cryovials 
containing VM3 and slices were initially cooled to –80°C with 200 or 
1.5°C/min and then placed in a piece of polystyrene floating on liquid 
nitrogen in a small tank. The vials were not in direct contact with the liquid 
nitrogen or the nitrogen gas. Then, the tank was closed and after 40 min 
(the temperature of the samples was than around –140°C), the vials were 
submerged directly in liquid nitrogen. In this manner, the obtained glass 
was virtually unfractured and the slices were not fragmented after thawing.
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Fig. 6 The effect of cooling rate on normalized viability of vitrified tissue slices after VM3 pre-
incubation. (a) liver, (b) kidney cortical slices and (c) kidney medullary slices. Slices were pre-
incubated with VM3 for 15 or 30 min, vitrified with various cooling rates, thawed rapidly and washed 
with 300 mM trehalose in the washing medium. All slices were incubated for 4 h prior to viability 
testing. Viability is given relative to VM3 treated slices, to normalize for CPA toxicity. The number of 
experiments (n) is given in the bars, 3 slices were used per experiment. Values are given +SD, 
where appropriate. 
 
Fig. 6 shows that viability, normalized for CPA toxicity, of both liver and 
kidney cortical slices decreased with increasing cooling rate. With a cooling 
rate of approximately 1.5°C/min, normalized viability of kidney cortical 
slices (Fig. 6b) was nearly completely maintained by vitrification. Also liver 
slices (Fig. 6a) were virtually unaffected by vitrification at 1.5°C/min, but 
only when they were incubated for 30 min with VM3, indicating that pre-
incubation for 15 min possibly caused incomplete penetration with the CPA. 
Viability of renal medullary slices (Fig. 6c), pre-incubated for 30 min with 
VM3, was not clearly affected by the cooling rate.  
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Fig. 7 Histomorphology of liver slices (A) untreated slice (B) slice cryopreserved by rapid freezing 
after pre-incubation with 18% DMSO.  
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Fig. 7, continued (C) slice vitrified with VS4 (D) slice vitrified with VM3. All slices were incubated for 4 
h.
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Fig. 8 Histomorphology of kidney cortical slices (A) untreated slice (B) slice cryopreserved by rapid 
freezing after pre-incubation with 18% DMSO.  
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Fig. 8, continued (C) slice vitrified with VS4 (D) slice vitrified with VM3. All slices were incubated for 4 
h.
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Fig. 9 Histomorphology of kidney medullary slices (A) untreated slice (B) slice cryopreserved by 
rapid freezing after pre-incubation with 18% DMSO.  
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Fig. 9, continued (C) slice vitrified with VS4 (D) slice vitrified with VM3. All slices were incubated for 4 
h. 
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Fig. 10 Viability of tissue slices after vitrification with VM3 (a) liver slices, (b) kidney cortical slices 
and (c) kidney medullary slices. Slices were pre-incubated with VM3 for 15 or 30 min, vitrified with 
1.5°C/min, thawed rapidly and washed with 300mM trehalose in the washing medium. All slices were 
incubated for 4 h prior to viability testing. Histomorphologic appearance of slices is quantified as the 
percentage of intact (not necrotic) cells in the slices cross section. Data are the average of 3 slices 
from 1 experiment, +SD. 
 
In Fig. 10, results are shown of the ‘best’ vitrification method we obtained 
with VM3 for liver (Fig. 10a) and renal cortical (Fig. 10b) and medullary 
slices (Fig. 10c), i.e. the method resulting in the highest viability of vitrified 
slices regarding the effect of both CPA toxicity and actual vitrification. 
Kidney cortical slices were incubated for 15 min with VM3 and liver and 
kidney medullary slices for 30 min. All slices were slowly cooled with 
approximately 1.5°C/min while avoiding fracturing as described above. 
After fast thawing, slices were washed with 300 mM trehalose in the 
washing medium. With this protocol, both kidney cortical and medullary 
slices and liver slices maintained viability 80-100% of that of untreated 
slices. Fig. 7d, 8d and 9d show histomorphology of respectively liver, kidney 
cortical and kidney medullary slices that were treated and vitrified with 
VM3.
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Discussion 
 
Rapid freezing with moderately concentrated DMSO solutions has been 
proposed by our laboratory as a simple and adequate way to cryopreserve 
rat liver slices, maintaining viability and phase I and II biotransformation 
activity of cryopreserved rat liver slices for at least 4 h after thawing. Others 
who have used rapid freezing for the cryopreservation of liver slices (using 
18% DMSO or more) have found similar results (Sohlenius-Sternbeck et al., 
2000; Glö ckner et al., 2001). With this method, we also obtained a 
satisfying cryopreservation outcome with cynomolgus monkey liver slices, 
maintaining ATP content, slice histomorphology and drug metabolism on 
levels comparable to fresh slices (unpublished data). Others have reported 
short-term maintenance of phase I and II biotransformation in cryopre-
served liver slices of beagle dogs, mice, monkeys and humans (Monshouwer 
et al., 2000). In the present study, liver slices again remained viable after 
cryopreservation by rapid freezing, but kidney and intestinal slices were 
severely damaged.  
The mechanism by which rapid freezing maintains viability of liver slices 
is not completely clear. De Kanter and Koster (1995) have proposed that 
vitrification within the slice promoted by partitioning of water within the 
tissue could possibly explain the success of rapid freezing. Recent studies 
by DSC measurements, however, have pointed out that with 18% DMSO 
and rapid freezing ice was formed in liver slices in the same amount as in 
bulk cryopreservation solution, with ice crystals probably formed both 
within the liver cells and in the intercellular space (de Graaf and Koster, 
2001). A number of authors have reported examples of cell types that 
survive intracellular ice formation caused by freezing rapidly (MacKenzie, 
1970; Mazur et al., 1972; Zieger et al., 1996; Acker and McGann, 2000), 
provided that these cells were rapidly thawed as well. It was proposed that 
small intracellular ice crystals would re-arrange during slow warming, 
growing to a size deleterious to the cells (Mazur et al., 1972). With liver 
slices, slow warming after rapid freezing also results in loss of viability 
(unpublished data) indicating that the same mechanism plays a role. The 
question arises why kidney and intestinal slices do not survive rapid 
freezing. Possibly, they are more susceptible for ice crystals formed 
intracellularly. Studies to compare the exact location and size of ice-crystals 
in rapidly frozen liver, kidney and intestinal slices may illuminate our 
observations.
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Vitrification overcomes the problems of intra- (or inter-)cellular ice 
formation since it allows ice-free cooling to liquid nitrogen temperatures. 
When vitrification is chosen as an approach for cryopreservation, the main 
problem to conquer is the toxicity of the CPAs that are used in high 
concentrations (Fahy and Hirsh, 1982). In the present study we noticed that 
the various tissue types are unequally affected by CPA toxicity. Particularly 
kidney cortical slices and small intestinal slices were highly sensitive to VS4 
exposure. CPA toxicity can be both chemical and osmotically of origin. One 
approach to reduce chemical toxicity of a CPA solution, without diminishing 
its glass-forming tendency, is to combine different CPAs with different 
mechanisms of toxicity and that may even antagonize each others toxicity 
(Baxter and Lath, 1971; Fahy, 1984, Fahy et al., 1987). This is the scientific 
base of the development of high molarity mixtures of CPAs like VS4 and 
VM3. Another manner to reduce chemical toxicity is to reduce the exposure 
time to the CPA. When decreasing the exposure time, one should affirm that 
the tissue is still fully equilibrated with the CPA. The use of a DSC can be of 
help for this purpose, monitoring possible elevation of critical cooling and 
warming rates when the exposure time is reduced. In the present study, we 
indeed found that reducing the exposure time to VS4 and VM3 reduces 
toxicity, but may also elevate critical warming rates of the tissue, as 
measured by DSC. Reducing exposure time of liver slices to VM3 from 30 to 
15 min resulted in a higher viability of VM3 treated slices, yet viability 
(normalized for toxicity) of vitrified slices was lower, which can be explained 
by incomplete penetration of VM3. Similar observation were reported with 
human corneas treated with VS41a (Bourne and Nelson, 1994), confirming 
the necessity to optimize loading protocols for different tissues regarding 
both toxicity and tissue penetration of the CPA.   
 Osmotic effects of CPA exposure occur, because the cell membrane is 
less permeable for most CPAs than for water. Consequently, when a cell is 
exposed to a certain CPA solution, it will first shrink, because of the higher 
osmolarity of the CPA solution, and eventually return to its normal volume 
when the CPA enters the cell. Reversibly, if cells permeated with CPAs are 
brought into CPA free buffer solution for washing, water first enters the cell 
before the CPA gets out, resulting in (extensive) cell swelling and eventually 
lysis (Levin and Miller, 1984; Pegg and Diaper, 1990). In the present study 
we tended to diminish osmotic damage by introducing and removing the 
CPA stepwise, with the intention to allow the cells to recover their volume 
before each additional step. The use of impermeable sugars is known to 
prevent cell swelling during CPA removal, because it elevates osmolarity of 
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the washing medium (Pegg and Diaper, 1990). In agreement with this, we 
found that the use of 300 mM trehalose in the washing medium increased 
viability of VM3 treated kidney cortical slices.  
Vitrification has been put forward by Fahy and Hirsh (1982) as a 
mechanism to avoid all damaging events associated with freezing, as long as 
CPA toxicity would be prevented. Furthermore they state that with 
vitrification, there is no need to worry about finding optimal cooling and 
warming rates for different cell types in an organ. Of course, this statement 
only holds true if cooling and warming rates are rapid enough to avoid ice 
crystal formation during freezing and thawing. The cooling rate to provoke 
vitrification of 10 mg medium samples of VS4 (approximately 10°C/min) is 
easily achievable with slices. The warming rate to prevent devitrification of 
VS4-medium samples has been found to be much higher (1500-
6990°C/min) (de Graaf and Koster, 2001). The feasible warming rate of 
slices is approximately 800°C/min, hence too low to prevent ice-formation 
in medium samples. However, we have found that liver slices in general 
have less tendency to devitrify than bulk medium (de Graaf and Koster, 
2001). In the present study we also found that tissue slices in general had 
lower Vcrws than VS4-medium samples. In most tissue samples 
devitrification is prevented using warming rates of 800°C/min, but not in 
all. Remarkably, viability of liver and kidney medullary slices that had Vcrws 
higher than the feasible warming rates did not differ much of those with 
Vcrws below the feasible warming rates.  
Nevertheless, according to the proposition of Fahy and Hirsh (1982), in 
slices with a Vcrw lower than the feasible warming rate, vitrification should 
not further decrease viability. In the present study, with VS4 pre-incubated 
kidney medullary slices, this was indeed the case. However, both liver and 
kidney cortical slices had a clearly lower viability after vitrification at 
800°C/min than slices that were treated with VS4 but not vitrified. In slices 
vitrified with high cooling rates after pre-incubation with VM3, we noticed 
the same. With VM3 however, it was possible to vary the cooling and 
warming rates because it has much lower critical cooling and warming rates 
than VS4. In slices slowly cooled after pre-incubation with VM3, viability 
was maintained at high levels. So, despite of the fact that the cooling rate 
does not determine whether ice formation is prevented or not in VM3 
solutions (as long as those rates are >1°C/min), it yet seems to determine 
slice viability, at least in the case of liver and kidney cortical slices. Similar 
observations have been done by Greg Fahy’s group (Greg Fahy, personal 
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communication). As yet, we have no explanation for this observation, but 
possibly thermal stresses induced by high cooling rates play a role. 
In conclusion, rapid freezing after pre-incubation with 18% DMSO 
maintains viability of liver slices as determined by measuring ATP content 
and examining slice histomorphology. Yet for unclearified reasons, rapid 
freezing is deleterious for rat kidney and small intestinal slices. Vitrification 
with relatively non-toxic, high molarity mixtures as VS4 and particularly 
VM3 is a promising approach for cryopreservation of tissue slices, 
maintaining viability of these slices on levels comparable to those of fresh 
slices. However, preventing toxicity and ice formation is not sufficient to 
maintain viability of particularly liver and kidney cortical slices by 
vitrification: the use of slow cooling rates, preventing thermal stress in the 
sample, seems to be a prerequisite.  
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Abstract 
 
The present study examines whether tissue vitrification, promoted by 
partitioning in the tissue, could be the mechanism explaining the high 
viability of rat liver slices, rapidly frozen after pre-incubation with 18% 
DMSO or VS4 (a 7.5M mixture of DMSO, 1,2-propanediol and formamide 
with weight ratio 21.5: 15: 12.4). 
To achieve this, we first determined the extent to which crystallization 
or vitrification occurred in CPA solutions (DMSO and VS4) and within liver 
slices impregnated with these solutions. Secondly, we determined how these 
events were related to survival of slices after thawing. Water crystallization 
was evaluated by Differential Scanning Calorimetry and viability was 
determined by histomorphological examination of the slices after culturing 
at 37°C for 4 h. 
VS4 pre-incubated liver slices indeed behaved differently from bulk VS4 
solution, because, when vitrified, they had a lower tendency to devitrify. 
Vitrified VS4 pre-incubated slices that were warmed sufficiently rapid to 
prevent devitrification had a high viability. When VS4 was diluted (to 75%) 
or if warming was not fast enough to prevent ice formation, slices had a low 
viability. With 45% DMSO, low viability of cryopreserved slices was caused 
by CPA toxicity. Surprisingly, liver slices pre-incubated with 18% DMSO or 
50% VS4 had a high viability despite the formation of ice within the slice. 
In conclusion, tissue vitrification provides a mechanism that explains 
the high viability of VS4 pre-incubated slices after ultra-rapid freezing and 
thawing (>800°C/min). Slices that are pre-incubated with moderately 
concentrated CPA solutions (18% DMSO, 50% VS4) and cooled rapidly 
(100-200°C/min) survive cryopreservation despite the formation of ice 
crystals within the slice. 
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Introduction 
 
A major goal for cryobiologists is the prevention of ice crystal formation 
when cryopreserving biological samples. With single cells, this goal may be 
achieved by freezing sufficiently slowly to allow equilibrium freezing (Mazur, 
1984). For whole organs, equilibrium freezing is not an option, since ice 
that is formed in the intercellular space may harm the cells from the 
outside. Therefore, cryopreservation of organs is focussed on the promotion 
of vitrification, in which an amorphous glassy state is formed (Fahy et al., 
1984; Armitage and Rich, 1990). 
Precision-cut liver slices are becoming increasingly popular as an in vitro 
tool for metabolic and toxicity studies in drug research, because their 
micro-architecture resembles the liver architecture in vivo, (Bach et al., 
1996; Olinga et al., 1997). Liver slices have physical dimensions (8 mm x 
200 µm) that are intermediate between those of isolated cells and whole 
organs. A number of cryopreservation methods for liver slices have been 
published in the past decade. These methods are based either on 
equilibrium freezing using low cooling rates and cryoprotectant (CPA) 
concentrations (Fisher et al., 1991; Fisher et al., 1993; Fisher et al., 1996, 
Maas et al., 2000a) or on vitrification protocols with highly concentrated 
CPA solutions and (ultra-) rapid freezing (Wishnies et al., 1991; Ekins, 
1996a; Ekins et al., 1996a). 
A third group of methods has been published more recently, including 
some from our laboratory. These methods are successfully combining rapid 
freezing (100-1000°C/min) with moderately concentrated CPA solutions 
(12-30% dimethylsulfoxide (DMSO)) (de Kanter and Koster, 1995; Glö ckner 
et al., 1996; Glö ckner et al., 1998; de Kanter et al., 1998, Day et al., 1999; 
de Graaf et al., 2000b; Sohlenius-Sternbeck et al., 2000, Glö ckner et al., 
2001), and maintain the viability of slices at relatively high levels, even 24 h 
after thawing (Glö ckner et al., 2001 and own unpublished research). The 
mechanism that explains the success of this approach is not understood: 
the high cooling rates do not allow prevention of intracellular ice formation 
(IIF) by equilibrium freezing (Karlsson, 1993). With the applied cooling rates 
the CPA concentration is too low to achieve vitrification (Boutron and 
Kaufmann, 1978; Baudot et al., 2000). Evidence exists however, that cells 
or tissues that are impregnated with a CPA vitrify more readily than bulk 
solutions of the same CPAs and that the amorphous state also has a higher 
stability (Takahashi and Hirsch, 1985; Peridieu et al., 1995). It has been 
suggested previously that this may be caused by the fact that liquid within 
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a tissue behaves as if it were compartmentalized like in hydrogels (Peridieu 
et al., 1995). Partitioning of liquids increases the tendency to supercool and 
therefore facilitates vitrification (Yamane et al., 1992). Therefore, the liquid 
within the slice may vitrify while the CPA medium surrounding the slice 
crystallizes. This would explain why liver slices survive rapid freezing when 
relatively low CPA concentrations are used. 
Preliminary studies within our laboratory showed that (ultra) rapid 
freezing of slices impregnated with a relatively non-toxic CPA called 
Vitrification Solution 4 (VS4) gave similar survival rates as 18% DMSO. VS4 
is composed of DMSO, 1,2-propanediol and formamide (weight ratio 21.5: 
15: 12.4) with a total concentration of 7.5 M (Fahy and Ali, 1997; 
Kheirabadi and Fahy, 2000) and vitrifies as a bulk solution under pressure. 
The experiments performed in the present study try to clarify whether or 
not tissue vitrification is the mechanism responsible for the maintenance of 
viability by either method. To achieve this, we first used Differential 
Scanning Calorimetry (DSC) to determine the extent to which crystallization 
and vitrification occurred in CPA solutions (DMSO and VS4) and within 
liver slices that were impregnated with these solutions. Secondly we 
determined how these events were related to the viability of slices after 
thawing. 
Slice viability was determined by histomorphological examination. This 
parameter was selected because previous studies have shown that this 
correlated with results obtained with other viability parameters (e.g. slice 
ATP- and potassium content) and with slice functionality (e.g. metabolism of 
testosterone and 7-hydroxycoumarin). The latter parameters even appeared 
to be less readily affected by cryopreservation than slice histomorphology 
(de Graaf et al., 2000b, Maas et al., 2000b). The relative insensitivity of 
functionality parameters to tissue damage in comparison with 
histomorphology is also reported by Gokhale et al. (1995). The thawed slices 
were incubated for 4 h at 37°C prior to microscopic examination of 
morphology, to allow sufficient time for damage caused by CPA toxicity or 
cryopreservation to be expressed. 
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Materials and Methods 
 
Chemicals 
Formamide, cyclohexane, insulin, gentamycine, adenine and glutathione 
were obtained from Sigma, Axel, The Netherlands; William’s Medium E + 
glutamax (WME) and Fetal calf serum (FCS) were from Gibco BRL, Breda, 
The Netherlands; DMSO (>99.9% pure) and all other chemicals were from 
Baker, Deventer, The Netherlands. 
 
Preparation and incubation of liver slices and viability testing 
Male rats (Wistar, obtained from Harlan CPB, Horst, The Netherlands) had 
free access to food and water. They were anaesthetised with 65% CO2, 35% 
O2 before the livers were removed. Subsequently tissue slices (thickness 
200-250 µm) were prepared from 8 mm tissue cores with a Krumdieck 
tissue slicer (Krumdieck et al., 1980). Slices were incubated at 37°C in 
WME-medium, supplemented with FCS (5%), 0.1 µM insulin, 50 mg/l 
gentamycine and D-glucose (to a medium concentration of 25 mM) using a 
shaking flask incubation system (de Kanter and Koster, 1995; de Graaf et 
al., 2000b; Olinga et al., 1997b). Slice viability was evaluated by 
histomorphological examination after 4 h of incubation at 37°C. To examine 
histomorphology, a 5 µm cross-section of the slice was made and stained 
with haematoxylin and eosin. Cells were considered to be viable if they did 
not show signs of degeneration such as hydropic cell swelling, pyknotic 
nuclei, karyolysis or karyorhexis. The percentage of intact cells was the 
number of viable cells divided by the number of viable plus non-viable cells 
x 100.   
 
Pre-incubation with the CPA and cryopreservation  
Slices were pre-incubated in 25-ml Erlenmeyer flasks (6 slices/Erlenmeyer) 
placed in a shaking water bath (110 strikes/min) on ice. Each Erlenmeyer 
flask contained 5 ml CPA (DMSO or VS4) mixed in various proportions with 
oxygenated medium (WME or VS4 buffer). VS4 buffer has the same 
composition as VS4, but without formamide, 1,2-propanediol and DMSO. 
Pre-incubation with 10 or 18% v/v DMSO and 25% v/v VS4 was executed 
in one single step, during 30 min. When higher concentrations of DMSO or 
VS4 were used, the CPA was added stepwise with the intention of limiting 
possible osmotic damage, according to the empirically derived protocol 
shown in Table 1.  
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Table 1  Stepwise cryoprotectant impregnation and removal 
 
 
 
 
Pre-incubation medium concentrationa 
  
Washing medium concentrationa 
 
End-concentration 
VS4 
 
0% 
 
 
25% 
 
50% 
 
75% 
 
100% 
  
100% 
 
75% 
 
50% 
 
25% 
 
0% 
 
0% 
25% 
50% 
75% 
100% 
 
10 
 
 
 
 
 
 
30 
15 
15 
15 
 
 
 
30 
15 
15 
 
 
 
 
30 
15 
 
 
 
 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 
10 
10 
 
 
 
10 
10 
10 
 
 
10 
10 
10 
10 
 
 
 
Pre-incubation medium concentrationb 
  
Washing medium concentrationb 
 
End-concentration 
DMSO 
 
0% 
 
10% 
 
18% 
 
30% 
 
45% 
  
45% 
 
30% 
 
18% 
 
10% 
 
0% 
 
0% 
10% 
18% 
30% 
45% 
 
10 
 
 
 
 
 
 
30 
 
 
 
 
 
 
30 
15 
15 
 
 
 
 
30 
15 
 
 
 
 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 
10 
10 
 
 
 
 
 
 
 
10 
10 
10 
10 
 
Values in the table represents the time span of each step, given in min with each row represen-ting 
consecutive pre-incubation or washing steps   
a % VS4 in VS4 buffer (v/v) 
b % DMSO in WME (v/v) 
 
Immediately after pre-incubation, slices were cryo-preserved by placing 3-6 
slices in 2 ml cryovials (Greiner, Alphen a/d Rijn, The Netherlands) with 0.5 
ml of the CPA solution. The cryovials were then submerged directly in liquid 
nitrogen. Some slices that were pre-incubated in 100% VS4 or 45% DMSO 
were cryopreserved by placing them between aluminium foil followed by 
direct immersion in liquid nitrogen. The aim of this procedure was to 
increase cooling and warming rates as described by Day et al. (1999). 
After storing the cryopreserved slices in liquid nitrogen for 30 min or 
more, slices were thawed by placing the cryovials in a 37°C waterbath until 
ice was no longer visible. The slices that were sandwiched between 
aluminium foil were thawed by placing the foil in VS4 or 45% DMSO on 
melting ice. After thawing, the cryopreservation medium was washed away, 
depending on the cryopreservation medium used, according to Table 1, 
immediately followed by 4 h incubation at 37°C prior to viability determina-
tion. 
To determine possible adverse effects of pre-incubation with the CPAs on 
the slices, some slices underwent the same procedure of pre-incubation and 
washing, but were not cryopreserved. Other liver slices were only pre-
incubated with CPA and subsequently used to determine the ‘liquid 
fraction’ (see below) of the slice or for DSC measurements. 
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Determination of slice ‘liquid fraction’  
The slice liquid fraction is the relative liquid content (cellular water and 
CPA) of a slice by weight, and is determined as follows: The slice wet weight 
(Massw) was measured after carefully removing CPA solution attached to the 
slice with paper tissue. The slice was then dried overnight in a 60°C oven. 
After measuring the dry weight (Massd) the liquid fraction (g/g) was 
determined by Eq. [1]. 
 
 
liquid fraction (g/g) = (Massw-Massd)/ Massw   [1]  
 
 
Determination of cooling and warming rate in cryovials  
The cooling rate of cryovials filled with 0.6 ml medium was determined by 
placing the temperature sensor of an Icecube 1610 computer freezer (Sylab) 
in the vial, followed by direct submersion of the vial in liquid nitrogen. The 
sensor was calibrated with ice-water (0°C) and liquid nitrogen (-196°C). 
Warming rates were measured during the warming of the vials (with the 
sensor) in a 37°C water bath. Cooling rates of slices that were sandwiched 
between aluminium foil after pre-incubation with 45% DMSO or VS4 were 
determined by including the sensor between two slices in the aluminium 
foil sandwich. Warming rates were determined in VS4 or 45% DMSO on 
melting ice, during warming with the sensor in between the aluminium foil 
pads. 
 
Determination of sample cooling rate in the Differential Scanning Calorimeter 
A small adaptation in the Differential Scanning Calorimeter (DSC-7) (Perkin 
Elmer, Oosterhout, The Netherlands) made it possible to determine both the 
programmed and the actual sample warming and cooling rates from the 
diagrams. For this purpose, in the Thermal Analyser Controller (TAC-7) of 
the DSC-7, the PIN 6 from IC U8 (which is located on the motherboard of 
the TAC-7) was disconnected from its socket. For further information 
consult Perkin Elmer (Oosterhout, The Netherlands). 
 
DSC measurements 
DSC measurements were performed using a DSC-7. The apparatus was 
calibrated with cyclohexane and pure water. 
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Sample preparation 
At the end of pre-incubation with the CPA, a part of a slice (weighing 5-9 
mg) was transferred into a 50 µl DSC sample pan (Perkin Elmer, 
Oosterhout, The Netherlands). Cryopreservation medium attached to the 
slice was carefully removed with a paper tissue before the pan was closed 
hermetically. From the pre-incubation medium used, approximately 9 mg 
was pipetted into another sample pan. To prevent evaporation, the pan was 
directly closed tightly and kept at 4°C until use. 
 
Determination of the percentage of a sample water that crystallised  
From DSC thermograms, the heat of crystallization and the heat of melting 
were determined from the area of the crystallization and melting peaks. 
From these values q (in %), which can be defined as the percentage of a 
sample that crystallized as pure ice (Boutron, 1986), was calculated by 
dividing the liberated heat of crystallization per gram sample by the specific 
crystallization heat of pure water that freezes at 0°C (*100%). For liver 
slices, q was corrected for the solid matter of the slice by dividing q by the 
liquid fraction (see above) of the slice. When water only crystallized on 
cooling (i.e. no devitrification occurred), the melting peak was used to 
calculate q, since this peak was better shaped and therefore more reliably 
quantified than the crystallization peak. 
 
Determination of critical cooling rates in slices and CPA solutions  
For determination of the critical cooling rate (Vcrc) of a sample, i.e. that 
cooling rate just high enough to almost prevent crystallization in the 
sample, q (in %) was determined on cooling with the DSC cooling rate (v) set 
at 2.5, 5, 10, 20, 40, 80 or 160°C/min. Subsequently, q was plotted against 
the logarithm of v. The theoretical relation between q and v was described 
by Boutron (1986) in the fourth semi-empirical model of Boutron. We used 
this model to calculate the theoretical curves, fitting the experimental 
values in our experiments. Vcrc was then determined from the theoretical 
curves by calculating v when q = 0.2%. The value of 0.2% for q was chosen 
by Boutron for practical reasons. It was assumed that this minimal amount 
of ice would not damage cells (Boutron, 1986). 
 
Determination of critical warming rates in slices and CPA solutions 
The stability of the vitrified state was assessed in samples that vitrified 
during cooling, by determining the critical warming rates Vcrw. For this 
purpose, the samples were warmed with the DSC warming rate (v) set at 5, 
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10, 20, 40 or 80°C/min after cooling with the DSC set at 300°C/min. From 
the thermograms the temperature at the end of melting (Tm) and the 
temperature of the devitrification peak (Td) were determined. A linear 
relationship exists between Tm/Td and the logarithm of the warming rate 
(Boutron and Mehl, 1990). The critical warming rate (Vcrw), i.e. the warming 
rate just high enough to prevent devitrification, can be determined by 
extrapolating the curve, determining v when Td = 0.95 Tm (Boutron and 
Mehl, 1990; Boutron, 1993, Boutron and Peridieu, 1994) 
To assess Vcrc and Vcrw in an individual sample, various cooling and 
warming scans were required. The impact of these multiple freeze and thaw 
cycles on the sample was minimized by first scanning with the highest 
cooling and warming rates (at which the lowest amount of ice was 
expected). The effect of the repetitive freeze-thaw cycles on the 
devitrification temperature (Td) of a VS4 pre-incubated slice was tested by 
repeating a cycle of cooling with 300°C/min and warming with 20°C/min 3 
times. No difference was found between the Td of the first and the 
subsequent cycles. The same was done for the crystallization peak while 
repeatedly cooling the slice with 5°C/min and warming with 80°C/min. In 
this case also, no significant change in the size of the crystallization peak 
was seen (data not shown). 
 
Determination of q in slices that were pre-incubated with various CPA 
solutions and subsequently cryopreserved 
In slices pre-incubated with aqueous solutions of DMSO (0, 10, 18, 30 and 
45% v/v in WME) or VS4 (0, 25, 50, 75 and 100% v/v in VS4 buffer) the 
amount of ice (q, in %) formed during cryopreservation (freezing and 
thawing) was determined. For this purpose, the cooling rates in the 
cryovials during cryopreservation had to be determined first (see above). 
Subsequently for each sample a cooling program was written in the DSC, 
mimicking the cooling rates in the cryovials. For samples that did not 
devitrify on thawing (because all crystallizable water had already 
crystallized on cooling), the warming rate in the DSC was set to 80°C/min. 
For vitrified samples that devitrified during thawing, q was calculated from 
the devitrification peak. In this case, q was dependent on the warming rate 
and therefore the DSC was also programmed to mimic the warming rates as 
measured in the cryovials. 
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Table 2 Critical cooling and warming rates in liver slices impregnated with VS4 and in a sample of 
VS4 solution taken at the end of pre-incubation in the same experiment 
 
  
VS4 impregnated liver slices 
  
VS4 solution 
 
   
Vcrc  (°C/min) 
 
Vcrw (°C/min) 
 
  
Vcrc (°C/min) 
 
Vcrw  (°C/min) 
 
Liver 1 (slice 1) 
          (slice 2) 
          (slice 3) 
Liver 2 (slice 1) 
Liver 3 (slice 1) 
Liver 4 (slice 1) 
Liver 5 (slice 1) 
Liver 6 (slice 1) 
 
 
<2.5 
23 
9.5 
11 
22 
12 
 
 
26 
29.5 
 
238 
354 
1589 
351 
634 
 
 
 
9 
 
 
9 
8 
4 
12 
 
6856 
 
 
2400 
2412 
1570 
6991 
3472 
 
 
Results 
 
Determination of critical cooling and warming rates in slices and bulk CPA 
solutions 
To determine the critical cooling rates, the quantity of ice formed within a 
sample (q) was measured at various cooling rates (v). When slices were 
impregnated with 18% v/v DMSO, q did not vary with the cooling rate (Fig. 
1). Moreover, there was no difference between slices and the CPA solution. 
However, in VS4 bulk solution and in slices that were pre-incubated with 
VS4, q did depend on the cooling rate (a typical example is shown in Fig. 2). 
For both slices and solutions, there was a good correlation between the 
experimental data points and the theoretical curves, calculated with the 
fourth semi-empirical model of Boutron. In Table 2, for liver slices from 6 
different livers, the critical cooling rates required to achieve (almost) 
complete vitrification of the sample (Vcrc), are shown. The Vcrcs of slices and 
the CPA solutions are in the same range (2.5-23°C/min and 4-12°C/min 
respectively). 
Critical warming rates (Vcrws), however, did differ between slices, pre-
incubated with VS4, and VS4 bulk solution (Fig. 3). Although Vcrws varied 
considerably, they were lower for slices than for medium in 5 out of 6 
experiments. In one experiment there was no difference between the Vcrws. 
To prevent devitrification, slices that were vitrified after pre-incubation with 
VS4 had to be warmed at 26 to 1589°C/min, while the prevention of 
devitrification of vitrified CPA solutions required warming rates between 
1570 and 6991°C/min. 
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Fig.1 Relation between the cooling rate and q (the percentage of a sample that crystallized as pure 
ice) in an 18% (v/v) DMSO solution and in a slice impregnated with 18% DMSO. Data-points 
represent the mean of 3 experiments (livers), 1 sample (medium or slice) per experiment.   
 
 
 
 
 
 
 
Fig. 2 Relation between the cooling rate and q (the percentage of a sample that crystallized as pure 
ice) in a VS4 solution and in a slice impregnated with VS4. Data-points represent one sample 
(medium or slice), from one representative experiment (liver). Solid lines represent semi-empirical 
curves calculated according to the fourth model of Boutron. Critical cooling rates were calculated by 
extrapolating the theoretical curves to q=0.2% (Boutron, 1986).   
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Fig. 3 Relation between the warming rate and Tm/Td in a VS4 solution and in a slice impregnated 
with VS4. Data-points represent one sample (medium or slice), from one representative experiment 
(liver). Solid lines are theoretical regressions used to calculate the critical warming rates. To calculate 
critical warming rates, theoretical regression curves were extrapolated to Td =0.95 Tm (Boutron and 
Mehl, 1990; Boutron, 1993; Boutron and Peridieu, 1994). 
 
 
 
 
 
 
 
Fig. 4 Relation between critical cooling and warming rates in VS4 solutions and in slice 
impregnated with VS4. Data are derived from 5 different experiments (livers), each data-point 
represents one sample (medium or slice).   
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For both slices and CPA solution, there is a correlation between the critical 
cooling and warming rates of the same sample (Fig. 4). For slices, warming 
rates required to prevent devitrification of a vitrified sample were on the 
average 50 times higher than the cooling rates required to achieve 
vitrification. For the CPA solutions, critical warming rates were approxi-
mately 500 times higher than the critical cooling rates. 
 
Determination of cooling and warming rates during cryopreservation 
To make an accurate comparison between the crystallization of ice in a liver 
slice during cryopreservation and liver slice viability, it is essential to use 
approximately the same cooling rates and warming rates with the DSC as 
those that are normally reached during cryopreservation and warming. For 
this reason, we first measured cooling and warming rates in cryovials with 
CPA solution and of slices sandwiched between aluminium foil pads, 
following the normal cryopreservation procedure. As shown in Fig. 5a (VS4) 
and 5b (DMSO), cooling rates in cryovials are dependent on the composition 
of the cryoprotective solution and on the state of the sample (fluid or 
frozen): the highest maximum cooling rates were 200-300°C/min and 
occurred in samples that were frozen with low CPA concentrations. Freezing 
of VS4 and 45% DMSO pre-incubated slices sandwiched between 
aluminium foil increased the cooling rate from 100 to at least 800°C/min. 
The cooling rate of all samples decreased as the liquid nitrogen temperature 
was approached. It should be noted that the cooling rates in the cryovials 
were measured in the CPA solution without slices. However, the addition of 
slices did not alter the cooling rates (data not shown). 
The warming rate was also determined in order to quantify 
crystallization accurately. However, since q in non-vitrified samples is 
dependent only on the cooling rate, Fig. 5c shows just the warming rates for 
slices that were vitrified in cryovials or clamped between aluminium foil 
pads after pre-incubation with 45% DMSO or 100% VS4. Warming of 
sandwiched slices was at least 8 times more rapid than of slices in 
cryovials. 
The DSC was set to match the cooling rates of the slices under normal 
cryopreservation circumstances. For vitrified slices the warming rate was 
also mimicked since ice formation in these slices occurred particularly 
during warming (devitrification) and was dependent on the warming rate. 
For some samples the cooling rates of the samples after crystallization 
under normal cryopreservation conditions, was somewhat faster than the 
maximum sample cooling rates in the DSC. 
Chapter 5 
 110
 
 
Fig. 5 (a) Sample temperature at various time points after direct immersion in liquid nitrogen of 
various VS4 solutions in cryovials or of aslices sandwiched between aluminium foil after pre-
incubation with 100% VS4 (b) Sample temperature at various time points after direct immersion in 
liquid nitrogen of various DMSO solutions in cryovials or of aslices sandwiched between aluminium 
foil after pre-incubation with 45% DMSO. (c) Sample temperature at various time points after placing 
cryovials with 45% DMSO or 100% VS4 in a 37°C waterbath or after aplacing the alumnium foil 
sheets containing slices pre-incubated with 45% DMSO or 100% VS4 in 4°C 45% DMSO or VS4. 
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Relation between the amount of ice formed in a slice and viability 
The relation between the amount of ice (q) formed within a slice and slice 
viability is presented in fig. 6a for VS4 as the CPA and in Fig. 6b for DMSO. 
These figures also show the influence of pre-incubation with the CPA, 
without cryopreservation, on the viability of fresh slices (closed symbols). To 
determine viability, the slices were histomorphologically examined. Our 
experience is that within 4 h of culturing eventual damage by cryopreser-
vation or by CPA toxicity becomes evident using this parameter. 
For VS4, a slight decrease in viability can be seen at the highest 
concentrations, compared to the viability of slices that were not exposed to 
VS4 (Fig. 6a). According to Fig. 6b, DMSO was not toxic to rat liver slices at 
concentrations up to 30% v/v but no cells survived exposure to 45% DMSO. 
Even in slices that were not exposed to CPAs, no more than 75% of the cells 
in a cross section were viable. It should be noted, however, that because of 
the procedure of slice preparation, 1 or 2 outer cell layers are always 
damaged, leading to a maximal ‘viability score’ of approximately 80% for 
very good slices. 
For slices cryopreserved after pretreatment with VS4 (Fig. 6a), two 
optima in the curve relating q to viability occurred. Because of the low 
toxicity, 58% of the cells in a slice were still intact after pre-treatment with 
100% VS4 and subsequent culturing for 4 h. After cryopreservation and 
thawing of these slices between aluminium foil sheets, and 4 h of culturing, 
45% of the cells on average were still intact. It should be noted that the 
amount of ice formed in the slices that were cryopreserved and thawed 
between aluminium foil was not actually measured, because the cooling 
and warming rates (ca. 800°C/min) required were too high to simulate with 
the DSC. We may assume, however, that with these rates all slices vitrified 
on cooling, but some devitrified during warming and (a small amount of) ice 
was formed after all (see Fig. 3 and Table 2). Just a few cells in a slice pre-
incubated with 100% VS4 survived cryopreservation in cryovials (cooling 
and warming rate approximately 100°C/min, q= ca. 8%). Surprisingly, 
despite the fact that ice does form during cryopreservation, viability of slices 
pre-treated with 50% VS4 (q= ca. 40%) was relatively high after thawing. 
Slices permeated with VS4 buffer, 25% VS4 or 75% VS4 and then 
cryopreserved had a very low viability. 
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Fig. 6 Relation between q (the percentage of a sample that crystallised as pure ice) and viability as 
determined by histomorphological examination. (a) Slices were pre-incubated with VS4 and 
cryopreserved in cryovials except for a, these slices were cryopreserved between aluminium foil. 
Data-points are labeled with the used VS4 concentrations and represent 3-4 experiments, 2 or 3 
slices per experiment.. Fresh slices were only pre-incubated with VS4, but not cryopreserved. (b) 
Slices were pre-incubated with DMSO and cryopreserved in cryovials except for a, these slices were 
cryopreserved between aluminium foil. Fresh slices were only pre-incubated with DMSO, but not 
cryopreserved. Data-points are labeled with the used DMSO concentrations and represent 3 
experiments, 2 or 3 slices per experiment. Data are given +/- SD. 
 
Despite the fact that no ice was formed during the cooling or warming of 
45% DMSO pre-incubated slices, no cells survived cryopreservation (Fig. 
6b). In this case however, the low viability was caused by CPA toxicity. 
Therefore, only one viability optimum was observed, namely when 18% 
DMSO (q= ca. 50%) was used as CPA. With a higher q, obtained with 0 or 
10% DMSO, more ice was formed and few cells survived. Surprisingly, with 
30% DMSO, despite the facts that less ice was formed than with 18% 
DMSO and that toxicity appeared to be low, no cells survived. 
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Discussion  
 
Calorimetric studies performed in the present study showed that ice was 
formed within slices that were rapidly frozen after pre-incubation with 18% 
DMSO and therefore, the relatively high viability of these slices cannot be 
explained by the occurrence of tissue vitrification. The total amount of ice 
formed within these slices was equal to that formed in the CPA solution, 
indicating that the crystallization of water was maximal for the given DMSO 
concentration. Also, the cooling rates needed to achieve vitrification in VS4 
treated slices were the same as in VS4 bulk solution and, hence, no effect of 
water partitioning in the tissue was evident. 
The critical cooling rate for VS4 bulk solution found in the present study 
was approximately 10ºC/min, however, to achieve vitrification of VS4 when 
cooling at 10ºC/min, Kheirabady and Fahy (2000) had to apply a high 
hydrostatic pressure to the sample. This discrepancy can be explained by 
the fact that different methods were used to assess Vcrc. Fahy and 
coworkers used a macroscopic method and defined Vcrc as that rate at 
which no visible ice crystals or nuclei were formed during cooling (Fahy and 
Hirsh, 1982). The method of Boutron, which is used in the present study, 
allows 0.2% of the sample volume to crystallise at the Vcrc. Moreover, Fahy 
and coworkers used a sample of approximately 8 ml to assess Vcrc (Fahy 
and Hirsh, 1982), so the chance of nucleation was much higher than in our 
sample, which was approximately 10 µl. The effect of a smaller sample 
volume was also shown by Mehl (1993): With a 15-30 mg sample of VS41A, 
which should vitrify at 10ºC/min under atmospheric pressure according to 
Fahy, he found a Vcrc of less than 1ºC/min. 
In agreement with data of Peridieu et al. (1995) and Takahashi and Hirsh 
(1985), the vitrified state in slices appeared to be more stable than in the 
cryoprotective solutions, with critical warming rates up till 200 times lower 
in slices than in CPA solutions. The Vcrws varied considerably between slices 
incubated with VS4, by a factor 50. We do not believe that the 
measurement itself and the subsequent calculation introduced this 
variation, because the Vcrws varied only by a factor of 4 in the 
cryopreservation solutions from the same experiments. Furthermore, slices 
with high Vcrws also had high critical cooling rates. It is not likely that 
insufficient equilibration of slices with the CPA caused the variation, since 
the maximal amount of water that crystallized, which is dependent on the 
CPA concentration, did not vary substantially between the different slices. 
So, the variation found may be caused by differences in the intrinsic 
Chapter 5 
 
 114
properties of the slices such as vascularization, collagen content and 
glycogen content, initiating differences in the extent of partitioning. 
Variation of critical warming rates between kidney samples was also 
reported by Peridieu et al. (1995). They found a correlation between Vcrw and 
the degree of vascularization in samples from different parts of the kidney. 
The critical warming rates of slices (26-1600°C/min) are sufficiently low 
to prevent devitrification in the majority of VS4 treated slices that were 
warmed between aluminium foil sheets (warming rate at least 800°C/min). 
In some slices, however, the Vcrws were so high that devitrification occurred. 
Indeed, slices from liver 4 (see Table 2), which had the highest Vcrw 
(>1500°C/min), appeared to be less viable than slices in all the other 
experiments. However, DSC measurements and viability testing could not 
be done with the same slice and so it was not possible to directly correlate 
the amount of ice generated by devitrification to the slice survival. In slices 
that were cooled and warmed in cryovials at only 100°C/min after pre-
incubation with VS4, devitrification on warming lead to the death of even 
more cells. 
The question arises why slices remain relatively viable when they are 
treated with 18% DMSO (or to less extent, 50% VS4) and cryopreserved by 
rapid freezing (100-200°C/min), since a considerable amount of ice was 
formed in these slices. One explanation could be that the liver cells 
(partially) dehydrated and vitrified internally after reaching intracellular 
DMSO levels high enough to achieve this. Ice would then be formed mainly 
extracellularly. Karlsson (1993), however, has shown that collagen-
sandwiched hepatocytes in culture should not be cooled faster than about 
10°C/min in order to allow enough time for the extrusion of sufficient water 
by the cells to enable them to reach vitrifiable concentrations of CPA 
intracellularly. Equilibrium freezing rates required for optimal survival of 
hepatocytes are often even lower than this (Powis et al., 1987; Condouris et 
al., 1990; Diener et al., 1993; Maas et al., 2000a). Cooling rates applied to 
slices treated with 18% DMSO in the present studies (100-200°C/min) are 
well above these levels and we know that the application of cooling rates of 
at least 800°C/min (by placing the slice between aluminium foil sheets) 
does not decrease the viability of slices cryopreserved after pre-incubation 
with DMSO (Wilfred Maas, personal communication and own unpublished 
research). Moreover, when higher, non-toxic CPA concentrations are used 
(30% DMSO or 75% VS4) and therefore less water has to leave the cell to 
obtain vitrifiable concentrations, slices do not survive cryopreservation. For 
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these reasons, we do not expect cells within the slices to dehydrate 
sufficiently to avoid IIF. 
Hence, when tissue vitrification and cellular dehydration are eliminated 
as possible mechanisms to explain the viability of slices permeated with 
18% DMSO and cryopreserved, it seems that the cells within the slice are to 
some extent resistant to IIF. Indeed, some evidence exists that cells can 
survive when a fraction of their volume exists of ice (Mazur et al., 1972; 
Karlsson, 1993). Cellular resistance to ice seems to be dependent on the 
warming rate, which must be high enough to avoid the re-arrangement of 
small ice crystals to form larger crystals (recrystallization) (Mazur et al., 
1972), and on whether the cells are in a suspension or connected to other 
cells (Acker and McGann, 2000). Nevertheless, the low survival of slices 
permeated with 30% DMSO or 75% VS4 seems to be contradictory to this 
proposal, since q is lower for these concentrations and thus even less ice, or 
smaller ice-crystals will have to be resisted. One might speculate that the 
characteristics of the CPAs underlie the existence of two optima in the curve 
relating q to viability. It may be possible, that DMSO (whether or not in 
combination with 1,2-propanediol and formamide in VS4) in an optimal 
concentration (18% DMSO/50% VS4) protects cellular membranes and 
proteins by stabilizing them, while in higher concentrations these cellular 
components are slightly damaged by exposure to these compounds. This 
damage may be sublethal and therefore no signs of toxicity may be seen in 
fresh slices, but it may make slices more susceptible to subsequent damage 
by ice crystals. With the second optimum the high concentration of 
cryoprotective agent may allow vitrification so that the eventual decrease in 
viability is the result of CPA toxicity and no additional damage by ice 
crystals occurs. 
In conclusion, liver slices pre-incubated with VS4 behave differently 
from the bulk CPA solution because, when vitrified, they have a lower 
tendency to devitrify. Slices that are vitrified and warmed sufficiently 
rapidly to prevent devitrification have a high viability. However, liver slices 
permeated with 18% DMSO also have a high viability after cryopreservation, 
despite of the fact that ice is formed within the slice. The exact mechanism 
that might explain the survival of these slices remains a subject of 
speculation and requires further research. 
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Abstract 
 
Precision-cut liver slices are to some extent resistant to ice formation 
induced by rapid freezing. Susceptibility to rapid freezing damage has been 
shown to be (partly) dependent on intrinsic properties of cells. In the 
present study an attempt was made to decrease the susceptibility of rat 
liver slices to rapid freezing damage: to recover from low ATP levels, 
impaired ion regulation and cell swelling induced by their preparation, the 
slices were pre-incubated at 37°C under oxygen, prior to cryopreservation.  
 It was shown that unexpectedly recovery of cellular homeostasis prior to 
the cryopreservation procedure by the 37°C pre-incubation markedly 
decreased viability of rapidly frozen slices (in which ice was formed), but not 
of vitrified slices (in which no ice was formed), in a time- and temperature 
dependent manner. UW was found to protect slices from this ‘warm pre-
incubation phenomenon’. Apparently, pre-incubation prior to freezing 
causes certain cellular alterations, that render slices more susceptible to ice 
crystals. 
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Introduction 
 
A considerable number of relatively successful methods for the 
cryopreservation of precision-cut liver slices have been developed in the 
past decade, with the goal to facilitate the use of these slices in in vitro drug 
metabolism and pharmaco-toxicological research (Fisher et al., 1991; 
Wishnies et al., 1991; Fisher et al., 1993; de Kanter and Koster, 1995; 
Fisher et al., 1996; Ekins, 1996a; Ekins et al., 1996a; Glö ckner et al.,1998; 
Day et al., 1998; Maas et al., 2000a; de Graaf et al., 2000b, Glö ckner et al., 
2001). Many of these cryopreservation methods are based on ‘rapid’ (200-
1000°C/min) freezing and thawing of the slices after pre-incubation with 
moderately concentrated (12-30% v/v) DMSO solutions (de Kanter and 
Koster, 1995; Glö ckner et al.,1998; Day et al., 1998; de Graaf et al., 2000b, 
Glö ckner et al., 2001). An interesting feature of these methods is that 
reasonably high survival of the liver slices is obtained, even though the 
formation of inter- or even intracellular ice is most probably not prevented 
(de Graaf and Koster, 2001). 
The resilience of cells to ice has been discussed by other authors. 
Survival of cells despite of exposure to ice crystals has been shown to be 
dependent on extrinsic (physical) factors, like the size and location of ice 
crystals (MacKenzie, 1970; Mazur, 1977; Hunt, 1984; Zieger et al., 1996), 
but also on intrinsic (biological) factors. The presence of intercellular 
connections is one of the intrinsic factors of cells reported to determine 
their survival after rapid freezing: isolated cells seem more prone to rapid 
freezing damage (and intracellular ice formation associated with it) than 
cells of the same type that are integrated within a tissue or monolayer  
(Zieger et al., 1996; Acker and McGann, 2000). Other intrinsic factors that 
determine the outcome of cryopreservation of liver slices involve the 
condition of the slices prior to cryopreservation, influenced by for example 
cold storage (Glö ckner et al., 1996; de Graaf et al., 2000b) or the quality of 
liver donor material (Fisher et al., 2001)      
 In cryobiology research, focus is normally put on influencing extrinsic 
factors that determine cryopreservation outcome, like prevention of 
intracellular ice formation or of cryoprotectant (CPA) toxicity. With the 
knowledge in mind that cells seem to be able to resist ice crystals under 
certain conditions, we decided to examine to which extent modification of 
intrinsic factors, like tissue condition, could influence cryopreservation 
outcome. Our hypothesis was that improving the condition of slices prior to 
cryopreservation would positively influence survival of those slices after 
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thawing.  In liver slice preparation, a period of warm ischemia during liver 
excision and low temperatures during preparation and storage of the slices 
is known to lead to an initially low cellular ATP content, disturbed cellular 
ion levels and cell swelling in freshly cut slices (Smith et al., 1986; Smith et 
al., 1987; Dogterom et al., 1993; Toutain et al., 1998; De Kanter et al., 
1999; Maas et al., 2000a; Maas et al., 2000b and own unpublished 
observations). Upon subsequent incubation at physiological temperatures, 
cellular homeostasis is normally regained within 1-4 h. In the present study 
we attempted to improve slice condition by pre-incubating them at 37°C 
prior to cryopreservation. In this manner we allowed the slices to regain 
cellular homeostasis. Subsequently, slices were rapidly frozen after 
impregnation with 18% DMSO. 
 On the other hand, if improvement of slice condition indeed reduces its 
susceptibility to ice crystal damage, one would expect that this effect would 
be absent when slices are cryopreserved by vitrification (thus no ice crystals 
are formed within the slice). To confirm this, in the present study, some 
37°C pre-incubated slices were vitrified after treatment with VS4 (a high 
molarity mixture of CPAs; (Fahy and Ali, 1997)) instead of rapidly frozen. 
 Viability of slices was assessed after 4 h of culturing after treatment by 
measuring intracellular potassium and/or ATP levels and by examining 
slice histomorphology, parameters that are considered to be very sensitive 
to cell damage (Maas et al., 2000b). We will show that, unexpectedly, pre-
incubation prior to the cryopreservation procedure, markedly decreased 
viability of rapidly frozen slices, but not of vitrified slices, in a time- and 
temperature dependent manner. We will discuss what possible alterations 
within the liver slices could be inflicted during this warm pre-incubation 
period and how these alterations could render the slices more susceptible to 
ice crystal damage. 
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Materials and methods 
 
Chemicals 
Formamide, Krebs Henseleit (KH) buffer, HEPES buffer, insulin, genta-
mycine, adenine and glutathione were obtained from Sigma, Axel, The 
Netherlands; William’s Medium E/glutamax (WME), Phosphate buffered 
saline (PBS) and Fetal calf serum (FCS) were from Gibco BRL, Breda, The 
Netherlands; University of Wisconsin medium (UW) was from Lamepro b.v., 
Raamsdonkveer, The Netherlands; The Celsis Biomass assay kit was 
derived from Omnilabo, Breda, The Netherlands. The Coomassie Protein kit 
No. 23200, purchased from Pierce (Oud-Beyerland, The Netherlands). 
DMSO (>99.9% pure) and all other chemicals were from Baker, Deventer, 
The Netherlands.  
 
Preparation of slices 
For a more detailed description of the preparation and incubation of the 
slices, we refer to previous publications (de Graaf et al., 2000b; de Graaf 
and Koster, 2001). Shortly, the liver was excised from male rats (Wistar, 
obtained from Harlan CPB, Horst, The Netherlands) that had free access to 
food and water, after anaesthesia with 65% CO2, 35% O2. Depending on the 
experiment, sometimes the liver was perfused with UW prior to further 
treatment. Precision-cut liver slices were made from 8 mm tissue cores 
using a Krumdieck tissue slicer (Krumdieck et al., 1980) filled with ice-cold 
oxygenated KH buffer. In some experiments, other media were used for 
slicing. After preparation, slices were stored in ice-cold oxygenated WME 
with 10% FCS (or other media, dependent on the experiment) for 
approximately 45 min until further use. 
To study the influence of regaining cellular homeostasis on 
cryopreservation outcome, slices were pre-incubated at 15, 25 or 37°C in 
oxygenated WME+supplements (for the description of the supplements, see 
the slice culturing section), for various time periods prior to the 
cryopreservation procedure. To study the influence of the pre-incubation 
medium, in some experiments UW was used instead of WME. In other 
experiments calcium chelators, allopurinol or oxygen radical scavengers 
were added to WME.  
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Cryopreservation and thawing 
Slices were cryopreserved and thawed as previously described (de Graaf et 
al., 2000b). First, slices were impregnated with 18% DMSO in oxygenated 
WME on ice for 30 min under gentle shaking. Subsequently, they were 
brought over to cryovials together with 0.5 ml of the pre-incubation 
medium, and directly submerged into liquid nitrogen (cooling rate 
approximately 200°C/min). After storing the cryopreserved slices in liquid 
nitrogen, they were thawed by placing the cryovials in a 37°C waterbath 
until ice was no longer visible (warming rate approximately 200°C/min).  
In some experiments, slices were vitrified instead of rapidly frozen. For 
this purpose, slices were impregnated stepwise with increasing 
concentrations of oxygenated VS4 solutions, like previously described (de 
Graaf and Koster, 2001). VS4 consists of DMSO, 1,2-propanediol and 
formamide (weight ratio 21.5: 15: 12.4 with a total concentration of 7.5M) 
mixed with saline, glucose, adenine and glutathione (for the exact 
composition see Fahy and Ali (1997)). Slices were vitrified by placing them 
between pads of aluminium foil followed by direct immersion in liquid 
nitrogen (cooling rate approximately 800°C/min (de Graaf and Koster, 
2001)). Vitrified slices were thawed by placing the foil with the slices in ice-
cold VS4 (warming rate approximately 800°C/min (de Graaf and Koster, 
2001)). Subsequently, slices were washed stepwise in solutions with 
decreasing VS4 concentrations. To detect any adverse effects of VS4 on the 
slices, some slices were treated with VS4, not vitrified but directly 
incubated at 37°C for 4 h to test viability. In each experiment, one VS4 
impregnated slice was taken and measured by Differential Scanning 
Calorimetry (DSC) as previously described (de Graaf and Koster, 2001) in 
order to determine whether the slices actually vitrified upon cooling and 
devitrification was prevented upon warming (thus the critical cooling and 
warming rates (Vcrc and Vcrw) were lower than the attained cooling and 
warming rates of  800°C/min).  
 
Slice incubation and viability testing 
Fresh and thawed slices were incubated in a 25-ml Erlenmeyer flask (1 
slice/flask) in a shaking waterbath (110 times/min), under humid carbogen 
(95% O2, 5%CO2) in WME+glutamax, supplemented with FCS (5%), 0.1 µM 
insulin, 50 mg/l gentamycine and D-glucose (to a medium concentration of 
25 mM). After culturing for 4 h at 37°C viability was determined. 
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The ATP content of liver and kidney slices was determined using a Celsis 
Biomass Assay kit, as follows: Slices were cut in two equal parts. One part 
was used for histomorphological examination (see below). The other part 
was immersed in 70% ethanol in HPLC water, containing 2 mM EDTA (pH 
10.9). Then, slices were homogenized using a Branford sonifier (50% duty 
cycle, 5 s) for determination of ATP and potassium content. For 
determination of the ATP content, an aliquot of the homogenate was taken 
and mixed 1/1 with Nucleotide Releasing Medium from the assay kit. If 
necessary, the homogenate was subsequently diluted in 70% ethanol/2 mM 
EDTA to ensure the values were in the range of the counter. Thereafter, the 
solution was diluted 1/10 with 0.025M HEPES buffer to decrease the 
ethanol concentration. Subsequently, to 100 µl of the solution, 50 µl 
luciferin/luciferase solution from the assay kit was added and the amount 
of luminescence as a measure of ATP content was determined using a 
Lumac Biocounter M500 (Lumac, The Netherlands). ATP content was 
determined relative to the protein content of the slices. Slice protein and 
potassium were determined in the slice homogenate as described previously 
(de Graaf et al., 2000b), except that now an I-lab 600 automatical 
spectrophotometer (Instrumentation Laboratory, Lexington, USA) was used 
for the measurements. 
For histomorphological examination, liver slices were fixed in 70% 
ethanol and further processed as described by de Graaf et al. (2000b). Slice 
viability was determined in the haematoxylin and eosin stained cross 
sections by estimating the percentage of viable cells. For determination of 
viability upon microscopical examination, nuclear shape and staining and 
cytoplasmatic staining were taken into account. It should be noted that also 
slice edges (1-2 cellayers at each edge) that are damaged by cutting the 
slices during slice preparation were included in viability scoring.  
Hypothermic cell swelling can be assessed in slices by determination of 
the total tissue water (TTW) of the slice (Sundberg et al., 1991). TTW is 
defined as (the wet weight-slice dry weight)/dry weight (Little, 1964). The 
slice wet weight was measured after carefully removing medium attached to 
the slice with paper tissue. The slice was then dried overnight in a 60°C 
oven and hereafter the dry weight was measured. 
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Fig. 1 The influence of incubation at 37°C on cellular parameters prior to cryopreservation (closed 
symbols) and after cryopreservation (open symbols). (a) ATP content, (b) K+ content, (c) TTW and 
histomorphology. Parameters of slices were monitored after 37°C pre-incubation and CPA 
impregnation, so directly prior to freezing (closed symbols). Cellular parameters of cryopreserved 
slices were determined after 37°C pre-incubation, CPA impregnation, rapid freezing, thawing and 4 h 
of culturing (open symbols). Data-points represent the mean of 3 slices from one liver (+SD). For 
comparison: control slices (which were directly incubated for 4 h and not pre-incubated, treated with 
CPAs or cryopreserved) had a mean ATP content of 24.6 ± 1.3 nmol/mg protein, a K+ content of 0.68 
± 0.05 µmol/mg protein and 72.5 ± 3.5 % intact cells in the slice cross section. 
 
 
 
Fig. 2 The influence of duration and temperature of pre-incubation prior to cryopreservation on 
viability of rapidly frozen slices after 4 h of culturing after thawing. (a) histomorphology (% of intact 
cells) and (b) ATP content. Bars represent the mean of 3-7 livers + SD, 3 slices were used per liver. 
Values are given as relative to those of control slices of the same experiment. Control slices were 
cultured for 4 h, but not impregnated with CPA or cryopreserved. Mean ATP content of fresh controls 
after 4 h of culturing: 19.05 ± 6.1 nmol/mg protein (7 livers), mean % of intact cells in slice cross 
section: 70.1 ± 6.4 (7 livers). 
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Results and Discussion 
 
We hypothesized that allowing the slices to regain normal cellular 
homeostasis prior to freezing would improve cryopreservation results. 
Surprisingly, the opposite is true: 37°C incubation prior to cryopreservation 
actually allowed slices to regain cellular homeostasis, but at the same time 
deteriorated the viability of slices after cryopreservation by rapid freezing. 
Indeed the restoration of cellular homeostasis during pre-incubation at 
37°C (Fig. 1, closed symbols) is shown by the cellular ATP and potassium 
levels gradually increasing and reaching levels after 2 h of incubation that 
are close to the maximum values reported by other authors to be reached 
after re-equilibration of slices at physiological temperatures (Miller et al., 
1993; Maas et al., 2000b). As shown in Fig. 1c, in the wake of ATP and 
potassium levels, cellular water content is recovered to near physiological 
levels (2.08 gram water/gram dry weight as reported by Sundberg et al. 
(1991)). Slices that were cryopreserved after regaining homeostasis during 
the 37°C incubation, had a very low viability compared to slices that were 
not pre-incubated prior to freezing (compare open symbols after 120 min of 
pre-incubation with those at 0 min of pre-incubation). While viability of 
non-pre-incubated cryopreserved slices was reasonably high (approximately 
40% (histomorphology) to 70% (potassium content), in slices that were pre-
incubated for only 15 min at 37°C prior to freezing, no viable cells were 
detected after thawing and subsequent culturing and ATP and potassium 
levels were only 10-25% of fresh slice levels (compare Fig. 1, open symbols 
at t=0 with those at t=15 min). Remarkably, slices that were not pre-
incubated prior to freezing, managed to increase their initially low ATP 
content from 7 nmol/mg protein at the moment of freezing (Fig 1a, closed 
symbols, t=0) to 12 nmol/mg protein after thawing and culturing (Fig. 1a, 
open symbols, t=0). Correspondingly, slice potassium content was increased 
from 0.12 µmol/mg protein directly prior to freezing (Fig 1b, closed symbols, 
t=0) to 0.5 µmol/mg protein after thawing and culturing (Fig. 1b, open 
symbols, t=0). On the opposite, slices that were pre-incubated at 37°C prior 
to freezing, lost most of the regained ATP and potassium after freezing, 
thawing and culturing. 
Fig. 2 shows that the impact of the pre-incubation prior to freezing is not 
only time-, but also temperature-dependent. If a 15 min pre-incubation 
took place at 15°C, it even seemed to be beneficial to the slices. If the 15°C 
pre-incubation was persisted for more than 60 min, viability was decreased. 
A 25°C pre-incubation during 15 min decreased the percentage of intact
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cells after cryopreservation, but not the ATP content. If pre-incubation was 
carried out at 37°C, both parameters showed a dramatic loss of viability of 
thawed slices. 
Based on the foregoing, we may conclude that pre-incubation prior to 
freezing in a time- and temperature-dependent manner causes certain 
cellular alterations, that render slices more susceptible to cryopreservation 
by rapid freezing. The question rises whether the pre-incubation sets the 
slices to be more susceptible to ice formed within the slice or, alternatively, 
to other factors that are related to cryopreservation (such as CPA toxicity or 
chilling injury). To answer this question, we set up an experiment in which 
37°C pre-incubated slices were either impregnated with 18% DMSO and 
rapidly frozen or impregnated with VS4 and vitrified by ultra-rapid freezing 
(cooling rate at least 800°C/min (de Graaf and Koster, 2001); DSC 
measurements confirmed that the Vcrc and Vcrws of the VS4 treated slices 
were near or below the feasible cooling and warming rate of 800°C/min and 
negligible ice crystal formation occurred, data not shown). If the deleterious 
effect of warm pre-incubation prior to freezing indeed rendered slices more 
susceptible to ice crystal damage, this effect should only occur in rapidly 
frozen slices but not in vitrified slices. Fig. 3 shows the result of this 
experiment: Viability of slices that were cryopreserved directly after 
preparation and CPA impregnation by either rapid freezing or vitrification 
had a reasonably high viability after thawing. Viability of vitrified slices was 
not affected by 37°C pre-incubation, but viability of rapidly frozen slices 
was again markedly decreased. Hence, it can be concluded that warm pre-
incubation renders slices more susceptible to ice crystal damage. 
    
Possible explanations for the ‘warm pre-incubation phenomenon’ 
The question remains what possible alteration is provoked during 37°C pre-
incubation that renders slices more susceptible to ice crystal damage. 
Remarkably, alterations caused by warm pre-incubation are lethal to slices 
after cryopreservation, but not to fresh slices. Since the effect of the pre-
incubation is depending on temperature and is most pronounced if pre-
incubation takes place at 37°C, obviously, activation of the cellular 
machinery is required for this phenomenon to occur.  
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Fig. 3 The effect of 37°C pre-incubation prior to cryopreservation on viability of rapidly frozen or 
vitrified liver slices after thawing and 4 h of culturing.  (a) histomorphology (% of intact cells)  and (b) 
ATP content. Bars represent the mean values + SD of 4 (ATP) or 6 (histomorphology) livers, 3 slices 
were used per liver. Values are given as relative to those of control slices of the same experiment. 
Control slices were cultured for 4 h but not impregnated with CPA or cryopreserved. Mean ATP 
content of fresh controls: 20.1 ± 6.4 nmol/mg protein, mean % of intact cells was 71.9 ± 6.4. Pre-
incubation with VS4 decreased ATP content of (37°C pre-incubated) fresh slices by approximately 
25% and the % of intact cells by 5%.   
 
From transplantation research it is known that if organs are re-oxygenized 
at physiological temperatures after a period of (cold) ischemia, 
‘reperfusion’/reoxygenation injury may occur. Pre-incubation at 37°C 
(under 95% O2) could have caused a similar effect in the slices in the 
present study. Reperfusion injury is often associated with oxygen radical 
production leading to lipid peroxidation. Production of free radicals is 
associated with ATP catabolism and calcium influx leading to activation of 
xanthine oxidase. Since ATP levels are low after slice preparation and the 
low potassium content indicates that regulation of ion concentration is 
impaired, free radicals are likely to be produced leading to lipid peroxidation 
during the 37°C pre-incubation. Peroxidation of lipids in cellular 
membranes decreases their fluidity (Garcia et al., 1997) and a decrease in 
membrane fluidity is associated with increased mortality of spermatozoa 
after cryopreservation (Giraud et al., 2000). So we may hypothize that lipid 
peroxidation during warm pre-incubation may predispose the slices for 
additional cryopreservation damage. 
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Fig. 4 The effect of 37°C pre-incubation in either UW or WME prior to cryopreservation on viability of 
rapidly frozen liver slices after thawing and 4 h of culturing. (a) slice histomorphology (% of intact 
cells) and (b) ATP content. For this experiment, livers were perfused in situ with UW and slices were 
cut and stored in UW as well. Bars represent the mean values + SD of 2 livers, 3 slices were used 
per liver. Values are given as relative to those of control slices of the same experiment. Control slices 
were cultured for 4 h but not impregnated with CPA or cryopreserved. Mean ATP content of fresh 
controls: 22 ± 4.5 nmol/mg protein, mean % of intact cells was 69.9 ± 2.6. There was no effect of 
37°C pre-incubation in UW on fresh slices. 
 
UW, an organ preservation solution, is known to prevent reperfusion injury. 
Critical components of this solution are allopurinol, that inhibits xanthine 
oxidase, and GSH, an oxygen radical scavenger. Furthermore, UW has an 
‘intracellular’ ion composition thus preventing calcium influx during 
ischemia (Southard and Belzer, 1993). With this in mind we hypothized that 
perfusion of the liver with UW, followed by slice preparation and storage in 
UW might prevent the warm pre-incubation phenomenon. Fig. 4 shows 
viability of rapidly frozen slices of livers that were perfused in situ with UW. 
Slices were cut and stored in UW and subsequently either impregnated with 
18% DMSO and cryopreserved (0 min pre-incubation), or pre-incubated at 
37°C for 15 or 60 min in either UW or WME and than impregnated and 
cryopreserved. Apparently, UW completely protects slices from the warm 
pre-incubation effect, but only if it is used for all phases of slice preparation 
and the warm pre-incubation itself. However, the use of WME without 
calcium or WME with added calcium chelators did not prevent the pre-
incubation effect, neither did the addition of allopurinol to WME, or the 
oxygen radical scavengers GSH, vitamin E and C (data not shown). Since 
these modifications of WME should prevent lipid peroxidation during 37°C
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pre-incubation but did not prevent the deleterious effect of warm pre-
incubation on cryopreservation outcome, the proposed oxygen free radical 
theory to explain the pre-incubation effect seems not to hold true.   
 
Concluding remarks 
In agreement with other reports we found that influencing the intrinsic 
properties of a tissue prior to cryopreservation can determine cryopreser-
vation outcome. In the present study it was shown that pre-incubation 
under oxygenated conditions at physiological temperatures prior to 
cryopreservation renders slices more susceptible to ice crystal damage. UW 
apparently protects slices from the deleterious effects of warm pre-
incubation, but probably not by prevention of oxygen free radical formation. 
Which cellular alteration is provoked by 37°C pre-incubation is not yet 
clear. Further research to this phenomenon seems worth the effort, since it 
may provide further insight into the mechanism of survival of cells that are 
cryopreserved at so called ‘supra-optimal’ cooling rates and may support 
the optimization of rapid freezing protocols for slices and other tissues.   
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Abstract 
 
Various in vitro preparations were compared with respect to their ability to 
mimic in vivo metabolism. For this purpose, S9-liver homogenate, 
microsomes, cryopreserved hepatocytes, cryopreserved liver slices and fresh 
liver, lung, kidney and intestinal slices were incubated with three drugs in 
development, which are metabolized in vivo by a wide range of 
biotransformation pathways. Metabolites were identified and quantified 
with LC-MS/UV from the in vitro incubations and compared with metabolite 
patterns in feces, urine and bile of dosed rats. 
In vitro systems with intact liver cells produced the same metabolites as 
the rat in vivo and are a valuable tool to study drug metabolism. Phase I 
metabolites were almost all conjugated in intact cells, whereas S9-
homogenate only conjugated by sulfation and N-acetylation. Microsomes 
and S9-homogenate are useful to study phase I metabolism, but not for the 
prediction of in vivo metabolism. Extra-hepatic organ slices did not form 
any metabolites that were not produced by liver cells, but the relative 
amounts of the various metabolites differed considerably. Small intestinal 
slices were more active than liver slices in the formation of the N-
glucuronide of compound C, which is the major metabolite in vivo. When 
the relative contribution of liver and small intestinal slices to the 
metabolism of this compound was taken into account, it appeared that the 
in vivo metabolite pattern could be well predicted. Results indicate that for 
adequate prediction of in vivo metabolism, fresh or cryopreserved liver slices 
or hepatocytes in combination with slices of the small intestines should be 
used.  
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Introduction 
 
In vitro research has been under growing interest for many disciplines 
within drug safety research, but pre-eminently for the selection of animal 
species as models for human drug toxicity in late drug discovery and early 
development. In this phase, this is the only way to compare metabolism of a 
particular drug between animals and humans. From such a species 
comparison study, the animal species could be selected of which the 
metabolism of the tested compound resembles metabolism by humans. A 
prerequisite for making an adequate selection is that the used in vitro 
system reliably predicts in vivo biotransformation of the drug, i.e. in vivo 
and in vitro patterns of the major metabolites should be comparable.  
The in vitro approach in early drug development is normally very 
straightforward to serve speed. In our lab, normally a low and a high drug 
concentration are used, that are hopefully not too high such that toxicity 
occurs but high enough to produce detectable amounts of metabolite(s). In 
this phase, linearity in relation to drug concentration of the metabolite 
production is not studied and other possible incubation variables are not 
optimized, like cell number used and incubation times. Only the major 
human metabolites are studied for their production by animal preparations. 
As in vitro tool, both subcellular fractions and intact cells are intensively 
used. Subcellular fractions (i.e. S9-homogenates and microsomes) from 
various animal species and humans are commercially available and can be 
easily preserved for long periods of time. Disadvantages are the necessity of 
cofactor addition to facilitate metabolism and the lability (e.g. flavine mono-
oxygenases) (Ekins, 1999), absence (e.g. cytosolar enzymes with micro-
somes) or inaccessibility (e.g. glucuronyl-transferases) of some metabolic 
enzymes.   
In contrast, in vitro preparations with intact cells (hepatocytes, tissue 
slices) possess the ‘complete’ cellular machinery and have the ability for an 
integrated phase I and phase II metabolism of xenobiotics. A disadvantage 
of the use of hepatocytes is that isolation needs to be optimized for livers of 
every different animal species and involves collagenase digestion for 
disrupting cell-cell contacts. These problems are overcome when precision-
cut tissue slices are used, which can be easily prepared from organs from 
various animal species, while the tissue architecture remains intact 
(Krumdieck et al., 1980). Several informative reviews discuss the 
applicability of liver slices in pharmaco-toxicological settings (Bach et al., 
1996; Ekins, 1996b, Olinga et al., 1997b; Lerche-Langrand and Toutain, 
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2000). Recent studies have shown that extra-hepatic organ slices (lung, 
kidney and intestinal slices) are almost as actively as liver slices 
metabolizing some drugs (Vickers, 1994; Vickers et al., 1995; de Kanter et 
al., 1999; Vickers et al., 2001, de Kanter et al., in press) 
Long-term storage of slices and hepatocytes is more complicated than 
storage of subcellular fractions. Recently, we have developed a simple rapid 
freezing method for liver slices (de Kanter and Koster, 1995; de Kanter et 
al., 1998; de Graaf et al., 2000b) and showed that post-thaw viability and 
phase I and II biotransformation activity of cryopreserved rat liver slices 
were maintained at least during 4 h after thawing. More complicated 
cryopreservation protocols exist for hepatocytes (Powis et al., 1987; 
Condouris et al., 1990; Diener et al., 1993). Cryopreserved hepatocytes are 
now commercially available. 
In the present study rat liver microsomes, S9-homogenate, cryopre-
served hepatocytes, cryopreserved liver slices and fresh liver, lung, kidney 
and intestinal slices are compared in their ability to predict in vivo 
metabolism. Furthermore, the metabolite patterns of precision-cut slices of 
liver, kidney, lung and small intestine are combined on the base of the 
relative contribution of these slices to the metabolism of the compound. 
Metabolites formed by the in vitro preparations are compared with those 
found in feces and urine of dosed rats. In addition, comparisons are made 
with the metabolite profile in bile, because some of the conjugates formed 
are deconjugated by microflora in the gut in vivo. The in vitro preparations 
are considered to be adequate predictors of in vivo metabolism if they meet 
two criteria: 1) they should produce the same metabolites as the intact 
animal 2) they should produce these metabolites in approximately the same 
relative amounts as in vivo.  
Three compounds from Solvay Pharmaceuticals Research, from here 
called Compound A, B and C were selected as model compounds, since 
these are metabolized in vivo via a wide range of metabolic routes. 
Metabolites were analyzed by LC-MS/UV.   
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Materials and methods 
 
Materials 
Compound A, B and C are products of Solvay Pharmaceuticals Research, 
UDPGA, PAPS, NADP+, NADPH, isocitrate, isocitrate dehydrogenase, Phenyl-
methylsulfonyl fluoride (PMSF), glycerol, glutathione, Acetyl CoA, Triton X-
100, Krebs Henseleit buffer, insulin, gentamycine and low melting agarose 
were obtained from Sigma, Axel, The Netherlands; William’s Medium E 
(WME), Fetal calf serum (FCS) and phosphate buffered saline (PBS) were 
from Gibco BRL, Breda, The Netherlands; DMSO (>99.9% pure), The 
Netherlands; Haematoxylin and eosin were from Sigma, St. Louis, MO, USA. 
D-glucose, HPLC-water and all other chemicals were from Baker, Deventer, 
The Netherlands. 
 
Preparation of S9-homogenates and microsomes of rat liver and slices of rat 
liver, lung, kidney and small intestine 
For preparation of S9-homogenates, microsomes and slices, male rats 
(Wistar, obtained from Harlan CPB, Horst, The Netherlands) were used. 
Rats had free access to food and water. They were anesthetized with 65% 
CO2, 35% O2 before the organs were removed.  
For preparation of liver S9-homogenates, freshly excised liver was 
homogenized on ice using a Potter-Elvehjem homogenator. Subsequently, 
homogenates were ultracentrifuged at 9000g for 20 min at 2-4 0C. To the 
supernatant PMSF (final concentration 100 µM) was added. The S9-
homogenate was stored at -80°C until use. 
For preparation of microsomes, the S9-homogenate was subsequently 
centrifuged at 100.000g for 30 min (Williams and Wilson, 1978). The pellet 
was resuspended in KCl-Tris-EDTA buffer with a volume corresponding to 
that of 80% of the original volume of the liver. Then, the pellet was 
homogenized again using a Potter-Elvehem homogenator (400 rpm). Finally, 
a volume glycerol corresponding to 20% of the original volume of the liver 
was added to the microsomal suspension. The microsomes were frozen in 
liquid nitrogen and stored at -80°C until use.  
Tissue cores (8 mm) from freshly excised kidneys and livers were 
prepared using an electrical drill (Metabo BSE 5010) with a tissue-coring 
tool (Alabama R&D, Munford, AL, USA). For preparation of lung tissue 
cores, the lung was filled with 37°C 1.5% (w/v) low melting agarose with 
0.9% (w/v) NaCl in distilled water and kept on ice for up to 1 h prior to 
coring. Cores from small intestines were prepared as follows: a 10 to 20 cm
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piece of the small intestine, starting 10 cm from the stomach was dissected, 
directly flushed with ice-cold UW-medium and subsequently filled with 
37°C 3% (w/v) low melting agarose with 0.9% (w/v) NaCl in distilled water. 
Both ends were tied and the filled intestine was submerged in ice-cold UW 
medium for 5 to 10 min. After the agarose had solidified, the intestine was 
carefully cut into pieces of approximately 2 cm. Subsequently, the bottom of 
the sample holder of the tissue-slicer was sealed with a piece of parafilm 
and filled with 37°C agarose. A piece of the intestine was quickly submerged 
into the liquid agarose and the sample holder was then stored at 4°C for 
about 15 min until the agarose had solidified. The technique of intestinal 
slice preparation was obtained from Ruben de Kanter of the Groningen 
University Institute for Drug Exploration (publication reporting evaluation 
of viability of these slices is submitted).    
Slices (10-14 mg for kidney and liver slices, 25-30 mg for lung slices 
and 10-12 mg (1-2 mg without agarose) for small intestinal slices were 
prepared subsequently using a Krumdieck tissue slicer (Alabama R&D, 
Munford, AL, USA), filled with oxygenated (95% O2, 5% CO2) ice-cold KH 
buffer, supplemented with NaHCO3 (25 mM) and CaCl2 (2.5 mM). After 
preparation, slices were washed and kept on ice in WME with 10% FCS 
until use.  
 
Cryopreservation and thawing of slices and hepatocytes 
Slices were cryopreserved according to the method developed by de Kanter 
and Koster (1995) and optimized by de Graaf et al. (2000b). After storage in 
liquid nitrogen for 1-12 weeks, slices were thawed by placing the cryovials 
in a 37°C waterbath. After visible ice had vanished, slices were washed 
shortly with WME, 10% FCS. Since in earlier studies (de Graaf et al., 2000b) 
cryopreservation success has appeared to be variable to some extent, 
cryopreserved slices were selected based on viability. Only slices from livers 
with successful cryopreservation results (viability of at least 70% of fresh 
slices of the same liver after 4 h incubation or/and 50% after 24 h 
incubation) were selected. Viability was measured by estimating the 
percentage viable cells in a slice cross section upon histomorphological 
examination as described previously (de Graaf et al., 2000b).     
Cryopreserved male Sprague-Dawly rat hepatocytes were obtained from 
Sanvertech (Heerhugowaard, The Netherlands). Hepatocytes were thawed 
according to recommendations of the supplier. Shortly, hepatocytes were 
quickly thawed by placing the cryovial in a 37°C water-bath until visible ice 
vanished. Subsequently, the cryoprotectant concentration was lowered by 
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dropwise addition of WME. Finally, the diluted cryoprotectant solution was 
removed from the hepatocytes after centrifugation and the pellet was 
resuspended in WME supplemented with FCS (5%), 0.1 µM insulin, 50 mg/l 
gentamycine and d-glucose (to a medium concentration of 25 mM).  
 
Incubation of S9-homogenate, microsomes, hepatocytes and tissue slices  
A volume S9-homogenate or microsomes containing 1 mg protein was 
incubated with 175, 110 and 104 µM compound A, B or C respectively. To 
the S9-homogenate UDPGA (final concentration 200 µM), PAPS (final 
concentration 100 µM), Acetyl Co-A (final concentration 0.25 mM) were 
added to a total volume of 900 µl. Subsequently the incubation mixtures 
were placed in a 37°C water bath for 10 min under air. The reaction was 
started subsequently by adding 100 µl NADPH-regenerating system 
(containing NADP+, NADH, isocitrate, isocitrate dehydrogenase and MgCl2 to 
a final concentration of 0.57, 0.57, 6.4 and 23.4 mM respectively). After 2 h 
the incubation was terminated by freezing the samples in acetone-CO2 ice.   
Fresh and cryopreserved slices were incubated with 175 or 110 µM 
compound A and B respectively or 21 µM compound C during 24 h at 37°C, 
while floating in 5 ml medium in a 25-ml Erlenmeyer flask (1 
slice/Erlenmeyer), placed in a shaking waterbath (110 strikes/min), under 
humid carbogen (95% O2, 5% CO2). This incubation system has proven to 
maintain viability of fresh liver slices for at least 24 h (Olinga et al., 1997b). 
As incubation medium WME was used, supplemented with FCS (5%), 
0.1µM insulin, 50 mg/l gentamycine and D-glucose (to a medium 
concentration of 25 mM).  
Thawed hepatocytes were diluted with WME supplemented with FCS 
(5%), 0.1 µM insulin, 50 mg/l gentamycine and d-glucose (to a medium 
concentration of 25 mM) to a concentration of approximately 1*106 living 
cells per ml. Subsequently, a 12-wells plate was filled with 1 ml of this 
solution per well. Hepatocytes were incubated for 6 h with 175 or 110 µM 
compound A or B or 21 µM compound C by placing the 12-wells plate in a 
shaking water-bath (37°C) under humid carbogen atmosphere.   
 
In vivo studies with compound A, B and C 
In vitro data were compared with data from various in vivo studies that were 
performed in the past. In vivo metabolism data of Compound A were from 
one male Wistar rat, orally dosed with 273 µmol/kg 14C-compound A. In 
vivo data about the metabolism of compound B were from one male
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Sprague Dawley (SD) rat that was dosed orally with 11 µmol/kg 14C-
compound B. In addition, one liver of a male Wistar rat was isolated and 
perfused with 172 µmol/kg 14C-compound B and bile was collected. In vivo 
data of Compound C were derived from 2 SD rats dosed with 1.6 µmol/kg of 
14C-Compound C. In addition, for compound C, an in vivo bile excretion 
study was performed. For this purpose, a male SD rat was dosed with 4 
times 31 µmol/kg (1 time per 12 h) 14C-compound C. 
Because both SD and Wistar rats were used for the various in vivo and 
in vitro studies, a study was done to assess possible differences in 
metabolism between the two strains. For this purpose, two Wistar rats were 
dosed with 110 µmol/kg Compound B or 12 µmol/kg 14C-Compound C. 
Metabolite patterns were compared with those of SD rats. 
 
Analysis by HPLC and LC-MS 
Metabolites of compound A, B and C were determined (after sonication of 
the slices in their incubation medium) in the homogenate, after de-
proteinization with methanol. For analysis by HPLC and LC-MS (both 
Hewlett Packard) an Inertsil ODS-3 column (150 x 2.1, 5µm) was used with 
an OPTI-GUARD 1mm C18 as pre-column. As eluens a gradient of 100% 3 
g/l aqueous ammonium acetate to 100% methanol with a flow of 0.2 
ml/min was used. UV-detection occurred at 320 nm for compound A and at 
236 and 254 nm for compound B and C respectively. The mass spectrum 
was taken at 100-800 m/z by Electron Spray Ionisation using ICL/ICIS 
software for data acquisition and processing.  
 
Quantification of metabolites 
Peaks occurring in the UV signal were identified by MS, by searching for 
expected MH+ signals of possible metabolites. UV peak areas (% of total of 
metabolite peak areas) were used to evaluate the relative abundance of the 
metabolites in the chromatograms.In some cases, 2 different metabolites 
were identified by MS representing one single UV-peak. In this case the 
relative amounts of the metabolites involved are estimated using their MS 
peak area, taking the difference in sensitivity of the MS for the different 
compounds into account. 
 
Criteria for judgment 
We considered the in vitro systems to be adequate for the prediction of in 
vivo metabolism if they met two criteria: 1) they should produce the same 
metabolites as the intact animal 2) they should produce these metabolites 
Prediction of in vivo metabolism by in vitro preparations 
 139
in approximately the same relative amount as in vivo. To evaluate the latter, 
only metabolites that were formed in considerable amounts in vivo (i.e. with 
a peak area of at least 10% of the major metabolite) were taken into 
account. Of these metabolites, the percentage that they made up of the total 
amount of metabolites was calculated. The in vitro / in vivo ratio of this 
percentage should lie between 0.5 and 2. For example, if a metabolite made 
up 15% of the total amount of metabolites in vivo and 10% in vitro, the in 
vitro/ in vivo ratio was 0.66, so in this case the in vitro system was 
considered to adequately predict the relative in vivo amount of the 
metabolite. The marginsof 0.5 and 2 were chosen arbitrarily but reflect the 
intuitive way in vitro data are perceived as reasonably predictive for the in 
vivo situation.  
 
Up-scaling 
The combined in vitro metabolite profile of the different organ slices and 
liver slices was calculated as follows: First, the metabolism of the different 
slices was scaled up to the whole organ. For this purpose, the ratio of the 
organ weight and the slice weight was multiplied with the percentage of 
parent compound that was metabolized by the slices of that particular 
organ. Subsequently, these organ contributions were summed and 
normalized to 1. Thus, the relative contribution of each organ to the 
metabolism of the drug was obtained and used as a scaling factor. Then, for 
each organ, the relative abundance of the metabolites formed were 
multiplied with the scaling factor of that organ (giving the predicted relative 
contribution of that organ in the formation of the metabolites). Finally, for 
each of the metabolites, the relative contribution of each organ was 
summed to give the in vivo metabolite pattern. 
For example: both liver and kidney slices metabolize compound X. For 
liver slices, a scaling factor of 0.4 is calculated (so, 40% of the in vivo 
metabolites is predicted to be made by the liver) and for kidney slices this 
factor is 0.6. Liver slices make metabolite 1 (10%), metabolite 2 (30%) and 
metabolite 3 (60%). Kidney slices make respectively 40, 20 and 40% of 
metabolite 1, 2 and 3. The combined metabolite pattern is calculated as 
follows: metabolite 1: 0.4*10 + 0.6*40= 28%, metabolite 2: 0.4*30 + 0.6*20 
= 24% and metabolite 3: 0.4*60 +  0.6*40= 48%.   
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Table 1 Viability as determined by studying histomorphology of fresh and cryopreserved liver slices 
after 4 or 24 h in culture 
 
 
 
4 h 
 
24 h 
 
  
4 h  
 
24 h  
 
Liver 1 
  fresh 
  cryopreserved 
  % of fresh 
Liver 2 
  fresh 
  cryopreserved 
  % of fresh 
Liver 3 
  fresh 
  cryopreserved 
  % of fresh 
 
 
68a ±  3 
57 ± 2 
84 ± 4 
 
70 ± 0  
38 ± 3 
54 ± 5 
 
78 ± 2 
58 ± 3 
73 ± 4 
 
 
 
68 ±
 
3 
40 ± 2 
60 ±
 
5 
 
60 ±
 
3 
20 ± 5
 
 
 33 ±
 
9 
 
65 ±
 
3 
43 ± 4 
67 ±
 
7 
 
Liver 4 
  fresh 
  cryopreserved 
  % of fresh  
Liver 5 
  fresh 
  cryopreserved 
  % of fresh 
Liver 6 
  fresh 
  cryopreserved 
  % of fresh 
 
 
77 ±
 
2 
65 ± 2 
85 ±
 
4 
 
67 ±
 
2
 
 
27 ±
 
3 
40 ±
 
5 
 
ND 
ND 
ND 
 
 
72 ± 2 
62 ±
 
2 
86 ±
 
3 
 
 55 ±
 
3 
 8 ±
 
3
 
 
15 ±
 
6 
 
68 ±
 
2
 
 
48 ±
 
2 
70 ± 4 
 
a % intact cells in slice cross section 
Mean values are given +/- SEM from 3 slices per liver 
ND=not determined 
 
 
Results 
 
Viability of cryopreserved liver slices 
In previous studies we have noticed that viability of slices of different livers 
after cryopreservation varies considerably (de Graaf et al., 2000b). For this 
reason, in the present study we decided to select slices from experiments 
with the best cryopreservation results for further use in the drug 
metabolism studies. The results are shown in Table 1. The viability of fresh 
liver slices did not vary much between the different livers with 67-78% of 
the cells in a slice histomorphologically intact after 4 h of culturing and 55-
72% after 24 h. (Note that in all slices 1 or 2 outer cell layers are always 
damaged because of the slicing procedure, so that, even in very good slices, 
normally no more then approximately 80% of the cells are intact). In 
contrast with fresh slices, the quality of cryopreserved slices varied 
considerably, with 27-65% of the cells intact after 4 h of culturing and 8-
62% after 24 h. For this reason, slices of liver 1, 3, 4 and 6 were thawed to 
be used in the drug metabolism studies.  
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Table 2 Relative activities of the in vitro systems in metabolism of compound A, B and C  
 
 
 
% Parent compound metabolized 
 Compound A Compound B Compound C 
 
Microsomes 
S9-homogenate 
Cryopreserved hepatocytes 
Cryopreserved liver slices 
Fresh liver slices 
Fresh lung slices  
Fresh kidney slices  
Fresh intestinal slices 
 
0 
13 (3) 
24 (16) 
21 (3) 
17 (6) 
<1 
7 (6) 
10 (6) 
 
10 (2) 
8 (2) 
23 (2) 
20 (5) 
26 (10) 
<1 
3 (2) 
<1 
 
11 (5) 
5 (1) 
16 (5) 
36 (1) 
37 (4) 
<1 
<1 
16 (8) 
 
Values are given with SD in parentheses 
Note that with compound C the initial concentration was 104 µM for microsomes and S9-
homogenate, but 21 µM for other in vitro systems 
For all systems, >75% of the HPLC metabolites-peaks were identified 
 
Comparison of metabolism between Sprague Dawley and Wistar rats 
For logistic reasons, in the present study different rat strains (Sprague 
Dawley (SD) and Wistar) were used for the various in vitro and in vivo 
studies. A study was undertaken to study possible differences in 
metabolism between the strains regarding compound B and C. The relative 
abundance of the metabolites of these compounds appeared to be well 
comparable for SD and Wistar rats (data not shown).  
 
In vivo metabolism of Compound A, B and C 
Of compound A, 75% of the radioactivity was excreted by the Wistar rat 
within 24 h: 12% in feces and 63% in urine. Ca. 69% of the radioactivity in 
urine originated from the parent compound as well as ca. 50% in the feces. 
Of compound B, 74% of the radioactivity was excreted by the SD rats within 
48 h: 63% in feces and 11% in urine. In feces, 5% of the radioactivity was 
found to be the unchanged parent compound, in urine 25%. In bile, 3% of 
the radioactivity was represented by the parent compound B. The SD rats 
dosed with compound C excreted 95 % of the dose within 72 h, mainly in 
feces. Of the total dose, 50% was found to be metabolized. In bile, all 
administered Compound C was found to be metabolized.  
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Fig. 1 Identified metabolic pathways of compound A. A1: molecular fragment attached to the part 
that is acetylated. (1)-(2): metabolites referred to in the text 
 
In vitro metabolism of compounds A, B and C.  
The various preparations used varied in their activity of metabolism of the 
three compounds (Table 2). All three compounds were most actively 
metabolized by intact liver cell preparations, whereas intestinal slices also 
metabolized compounds A and C. Kidney slices had some activity but lung 
slices hardly produced metabolites. 
 
In vivo and in vitro metabolite patterns of compound A 
The major routes of biotransformation of compound A are given in Fig. 1. As 
shown in Fig. 2, by far the most important metabolite in the rat in vivo is 
the product of N-acetylation (metabolite no. 1). Another, still unknown 
metabolite was found in vivo (no. 2). All in vitro preparations with intact 
cells (organ slices and hepatocytes) produced the major N-acetyl metabolite, 
but lung slices only in negligible amounts. Metabolite no. 2 was only formed 
in vitro by the intact cell systems derived from the liver. Of the subcellular 
systems, S9 homogenate did acetylate compound A, while microsomes did 
not, because they lack the enzyme required for this reaction. Of the slices 
from the various organs, liver slices were the most active in the metabolism 
of compound A (Table 2). There is not much difference between the 
amounts of metabolites formed by fresh or cryopreserved slices. 
Cryopreserved hepatocytes were only incubated for 6 h with compound A, 
but metabolized the same amount of this compound as liver slices did in 24 
h.  
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Fig. 2 Relative amounts of identified metabolites of Compound A formed by various test systems.  
1: acetylated A 
2: unknown metabolite  
For all test systems >75% of the metabolites were identified. Slices were from 3 livers; Microsomes 
from 2 livers; S9-homogenate from 2 livers; hepatocytes from 1 batch. In vivo data were from 1 rat. 
*
  
<1% of the mother compound was metabolized 
a relative amounts of metabolites are calculated as described in materials and methods section, with 
data in Table 3 
 
Clearly, only intact cellular systems derived from liver made both important 
in vivo metabolites of Compound A. Therefore, to calculate a combined 
metabolite pattern taking extra-hepatic metabolism into account to predict 
the in vivo metabolite profile of compound A, data of liver slices and kidney 
and small intestinal slices were used. The scaling factors for the organ 
slices are shown in Table 3. Both metabolites are predicted but the amount 
of metabolite no. 2 is underestimated (Fig. 2). This is also seen when the 
ratios of the relative amounts of metabolites formed in vitro and in vivo are 
compared (Table 4); for all intact liver cell preparations, the ratio for this 
metabolite is below 0.5 and, when all organ slices are combined, this is 
even lower. However, the major metabolite, N-acetyl A, was predicted 
correctly; all ratio’s were close to 1. 
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Table 3 Calculation of scaling factors for compound A 
 
   
Organ weight (A)a 
 
Slice weight (B) 
 
Fraction 
metabolized (C)b 
 
 (A / B) *C  Scaling factor 
 
Liver  
Lung  
Kidney  
Small intestine  
 
15.3 g 
6.9 g 
2.9 g 
7.2 g 
 
14 mg 
30 mg 
14 mg 
2 mg 
 
0.21 
<0.01 
0.07 
0.10 
 
230 
0 
14.5 
360 
 
0.38 
0 
0.02 
0.60 
 
a
 derived from the Kanter et al., 2002 (in press) 
b
 data from Table 2 
 
 
 
Table 4 Semi-quantitative prediction of in vivo metabolism of compound A, B and C by various in 
vitro systems 
 
  
In vivod 
  
In vitro/in vivo e 
 
Metabolite 
 
 
  
Hepatocytes  
 
Liver slices (fresh) 
 
Liver slice (cryo) 
 
All organ slices 
 
Compound Aa 
1 
2 
 
Compound Bb 
1 
2 
3 
4 
5 
6 
7 
8 
 
Compound Cc 
1 
2 
4 
 
urine 
82.4 
17.6  
 
bile+urine 
3.2 
8 
15 
3 
1.5 
19.5 
2.5 
47 
 
bile 
87.1 
0.7 
12.1 
 
 
 
1.2 
0.23 
 
 
2.6 
0.9 
1.2 
3.1 
7 
0.8 
2.1 
0.5 
 
 
0.06 
0 
4.75 
 
 
1.1 
0.4 
 
 
2.6 
0.7 
0.6 
3.6 
2.0 
0.7 
0.6 
1.0 
 
 
0.18 
0 
4.17 
 
 
1.2 
0.3 
 
 
0.8 
0.6 
0.42 
3.0 
2.5 
0.9 
0 
1.2 
 
 
0.15 
0 
3.29 
 
 
1.2 
0.10 
 
 
f 
 
 
 
 
 
 
 
 
 
0.75 
0 
1.72 
 
bold: ‘important’ metabolites 
a for the metabolic route see Fig. 1 
b for the metabolic route see Fig. 3 
c for the metabolic route see Fig. 5 
d % of the total amount of metabolites in vivo 
e ratio of the % of the total amounts of metabolites predicted in vitro and the % of the total amounts of 
metabolites actually formed in vivo 
f extra-hepatic metabolism was insignificant 
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Fig. 3 Identified metabolic pathways of  compound B. The molecular fragments attached to the part 
that is metabolized are indicated as B1 through B7. (1)-(8): metabolites referred to in the text. 
 
In vivo and in vitro metabolite patterns of compound B  
Compound B is metabolized in vivo via a wide range of metabolic pathways 
(Fig. 3), the major metabolite being the sulfate conjugate, no. 8. This 
metabolites was produced in considerable amounts by fresh and 
cryopreserved liver slices, cryopreserved hepatocytes, S9 homogenate and 
in small amount by kidney slices (Fig. 4). Only intact cell systems derived 
from liver formed all metabolites of compound B that are produced by the 
rat in vivo. Some conjugates (i.e. no. 3 and 7) produced in vitro were only 
found in bile and not in other excreta. Microsomes only formed phase I 
metabolites of compound B (i.e. no. 1, 4, 5 and 6). S9 homogenate produced 
all phase I metabolites except for no. 4, and it produced both sulfate 
conjugates (no. 3 and 8), but not the glucuronide conjugates (no. 2 and 7).  
These results show that only the intact-cell systems can be used for up-
scaling to predict in vivo metabolite pattern.  
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Fig. 4 Relative amounts of identified metabolites of compound B   
1: hydroxy-B 
2: [hydroxy-B]-O-glucuronide 
3: [hydroxy-B]-O-sulfate 
4, 5: fragments after N-dealkylation 
6: B-carboxylic acid 
7: B-glucuronide 
8: B-sulfate 
For all test systems >75% of the metabolites were identified.  
Slices were from 3 livers; Microsomes from 2 livers; S9-homogenate from 2 livers; hepatocytes from 
1 batch. In vivo data were from 1 rat, bile from 1 rat. 
* <1% of the mother compound was metabolized 
** in some in vitro incubations a second hydroxyl metabolite was found in small amounts  
a metabolite pattern is calculated as described in materials and methods section, with data in Table 5 
 
In vitro metabolite patterns are compared with those in bile+ urine. This is a 
more adequate comparison than that with feces+urine since in feces, some 
metabolites are found to be deconjugated (Fig. 4). Slices from kidney, lung 
and the small intestines metabolized small amounts of compound B and, 
therefore, the combined metabolite pattern based on metabolism by all 
organ slices (scaling factors given in Table 5) resembles that of liver slices 
(Fig. 4). Since cryopreserved hepatocytes and fresh and cryopreserved liver 
slices all give a similar metabolite profile, these preparations all predict in 
vivo metabolite patterns of Compound B well, with in vitro / in vivo ratios all 
being between 0.5 and 2 (Table 4).  
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Table 5 Calculation of scaling factors for compound B. 
 
  
Organ weight (A)a 
 
 
Slice weight (B) 
 
Fraction 
metabolized (C)b  
 (A / B)*C  Scaling factor 
 
Liver  
Lung  
Kidney  
Small intestine 
 
15.3 g 
6.9 g 
2.9 g 
7.2 g 
 
14 mg 
30 mg 
14 mg 
2 mg 
 
0.26 
<0.01 
0.03 
0 
 
284 
0 
6 
0 
 
0.98 
0 
0.02 
0 
 
a
 derived from the Kanter et al., 2002 (in press) 
b
 data from Table 2 
 
In vivo and in vitro metabolism of compound C 
Compound C was metabolized in vivo to four major metabolites, notably an 
N-glucuronide (metabolite no. 1 in Fig. 5) and three hydroxylated 
metabolites excreted in feces in unconjugated form (no. 2, 5 and 7). In bile, 
the N-glucuronide was prominent, but also the glucuronidated hydroxy 
metabolite (no. 4) was seen. The sulfate conjugate (no. 3) was detected with 
the MS in bile, but the amount was too small to be quantified by HPLC/UV. 
The N-glucuronide was only one of the minor metabolites in in vitro 
systems with intact cells derived from liver (Fig. 6). Subcellular fractions did 
not make this glucuronide conjugate at all. However, the N-glucuronide was 
formed in considerable amounts by slices of the small intestine. In fact, 
intestinal slices (1-2 mg tissue) produced approximately three times more of 
this metabolite than liver slices (10-15 mg tissue). A number of metabolites 
was formed by all systems with intact cells from liver, but not found in in 
vivo (no. 3, 6 and 8, Fig. 6). A considerable amount of a metabolite with the 
same molecular weight as the parent drug was found in vitro but not in vivo.  
Presumably, this metabolite was a C-N-oxide that was converted to the 
original drug by the mass spectrometer. Unconjugated hydroxy metabolites 
were not detected in (liver) slices or hepatocyte incubations. With 
microsomes and S9 homogenate, however, substantial amounts of these 
metabolites were found. Fresh liver slices and hepatocytes converted the 
same amount of compound C during incubation (Table 3). Cryopreserved 
liver slices and intestinal slices were a little less active. Negligible amounts 
of metabolites were found after incubation of compound C with lung and 
kidney slices.     
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Fig. 5 Identified metabolic pathways of compound C. The molecular fragments attached to the part 
that are metabolized are indicated as C1 through C5. (1)-(8): metabolites referred to in the text. 
 
Since only the intact cell preparations predicted all major in vivo 
metabolites, the data from these preparations were used for up-scaling. 
These preparations produced only conjugated hydroxyl metabolites (that 
were found to be deconjugated in feces) and, therefore, comparison was 
made with the combined bile and urine data. The results in Table 4 show 
that the liver preparations underestimate the N-glucuronide and 
overestimate the glucuronidated hydroxyl metabolite. When the relatively 
large contribution of intestinal slices to the N-glucuronidation of compound 
C is taken into account in the calculation of the combined metabolite 
pattern of the various organ slices, the obtained pattern closely resembles 
in vivo metabolism. (Table 4, last column; scaling factors are given in Table 
7). 
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Fig. 6 Relative amount of identified metabolites of compound C formed by various test systems.  
1: [C]-N-glucuronide 
2: 3-hydroxy-C 
3: [4-hydroxy-C]-O-sulfate 
4: [4-hydroxy-C]-O-glucuronide 
5: 3-hydroxy-C 
6: [3-hydroxy-C]-O-sulfate 
7: dihydroxy-C 
8: C-N-oxide  
For all test systems >75% of the metabolites were identified. Slices were from 3 livers; Microsomes 
from 2 livers; S9-homogenate from 2 livers; hepatocytes from 1 batch. In vivo data were from 2 rats, 
bile from one rat. 
* <1% of the parent compound was metabolized. 
** An hydroxy-C and [hydroxy-C]-O-sulfate were found at the same retention time because the 
sulfate was split off by the mass spectrometer.  
*** A metabolite with the same mass as the parent was found, presumably because C-N-oxide was 
converted to the original drug by the mass spectrometer. 
a Metabolite pattern is calculated as described in materials and methods section, with data in Table 6. 
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Table 6 Calculation of scaling factors for compound C 
 
  
Organ weight (A)a 
 
Slice weight (B) 
 
Fraction 
metabolized (C)b 
 (A / B)*C  Scaling factor 
 
 
 
Liver  
Lung  
Kidney  
Small intestine 
 
15.3 g 
6.9 g 
2.9 g 
7.2 g 
 
14 mg 
30 mg 
14 mg 
2 mg 
 
0.37 
<0.01 
<0.01 
0.16 
 
404 
0 
0 
576 
 
0.41 
0 
0 
0.59 
 
a
 derived from the Kanter et al., 2002 (in press) 
b
 data from Table 2 
 
 
Discussion 
 
In the present study we compared in vitro metabolism by preparations from 
rat liver with increasing structural organization and by slices from other 
metabolizing organs (rat lung, kidney, intestines) with in vivo biotransfor-
mation. It appeared that there are substantial differences in metabolism, 
both qualitatively and quantitatively, between the different systems.  
Microsomes and S9-homogenate produced considerable amounts of 
phase I metabolites of the drugs tested. However, as microsomes possess 
only inaccessible UDP-Glucuronyltransferases and no other phase II 
enzymes, this preparation did not produce the phase II metabolites formed 
in vivo from compounds A, B and C. S9-homogenate formed only the sulfate 
and acetyl conjugates since cytosolic enzymes phase II enzymes as acetyl-
transferases and sulfo-transferases are present, but glucuronyl-
transferases are inaccessible, like in microsomes. With compound C, small 
amounts of an O-glucuronide metabolite were found with S9-homogenate 
nevertheless. In contrast with the other compounds, compound C was 
dissolved in DMSO (medium concentration 1%). Possibly, DMSO disturbed 
the ER membrane, making it more permeable and activating the glucuronyl 
transferases.  These results clearly show that intact cell preparations are 
required to reliably predict the metabolites formed in vivo.   
In general, fresh and cryopreserved slices and cryopreserved hepato-
cytes produced the various metabolites in approximately the same relative 
amounts. Liver slices, containing approximately the same amount of 
hepatocytes per slice as were used for the hepatocyte incubations, however, 
needed a 24-h incubation to produce the same absolute amount of 
metabolites as hepatocytes in 6 h. The lower drug metabolizing activity of 
liver slices, which is also shown by Ekins et al. (1995) may be caused by 
slow drug transport into the center of the slice, limiting its metabolism.
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Our results indicate that cryopreserved liver slices are as good to be used as 
in vitro tool to study drug metabolism as fresh liver slices are. However, 
selection of slices by viability is in our opinion necessary, because the 
success of cryopreservation differs between livers (de Graaf et al., 2000b). In 
previous studies, we noticed that cryopreserved liver slices with a low 
viability did not only produce smaller amounts of metabolites, but also the 
relative amounts of the metabolites changed (unpublished observations). 
Particularly conjugation activity decreases in unsuccessfully cryopreserved 
slices, possibly by cofactor loss, while phase I biotransformation is 
preserved longer (Maas et al., 2000b; Vanhulle et al., 2001). The selection of 
slices on the base of their histomorphological appearance after thawing and 
culturing, as done in the present study, appeared to be useful. 
Slices from extra-hepatic origin produced metabolites that were also 
formed by liver slices or hepatocytes, but the relative amount in which the 
various metabolites were formed differed considerably. With compound C 
the major metabolite in vivo was the N-glucuronide, while in liver slices and 
hepatocytes this was the O-glucuronide. Similar results were reported by 
Sandker et al. (1994) with Org 3770 and by Pahernik et al. (1995) with 
pimobendan. It was suggested that the N-glucuronide was mainly formed 
extra-hepatically (Sandker et al. 1994). In the present study, small 
intestinal slices appeared to be very active producers of the N-glucuronide 
conjugate of compound C in comparison to liver slices, indicating that the 
intestines indeed are important in the in vivo metabolism of compound C. 
Differences in relative activities of various biotransformation pathways 
between liver, lung and kidney slices were also reported with 
ethoxycoumarin and testosterone by de Kanter et al. (1999 and 2002). 
These results indicate that for a reliable prediction of in vivo metabolism of 
some compounds, the use of both hepatical and extra-hepatical slices is 
required. 
The up-scaling procedure we applied combines the contribution of each 
of the organs by a scaling factor based on the amount of metabolism per 
slice of the various organs, the slice weights and the organ weights.  This 
procedure assumes that the relative rates of metabolism of the various 
organs is the same in vitro and in vivo, as well as the relative amounts of 
metabolites formed by an organ. These assumptions are only valid when the 
degree of saturation of metabolism is similar in vitro and in vivo. This factor 
was not examined however in the present study. Nevertheless, in vivo 
metabolism was found to be well predicted by either intact liver cells and/or 
the combined organ slices. The predicted relative in vivo amounts of 
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metabolites were in most cases within the set limits of 0.5 and 2 of the 
amounts that were actually formed in vivo. So, this approach could be 
useful in a prospective study, predicting metabolite patterns of various 
animal species and humans for proper selection of an animal model for 
human drug toxicity studies.   
In conclusion, in vitro systems with intact cells (slices and hepatocytes) 
from liver produced the same metabolites of the three compounds studied 
as the rat in vivo and for that reason seem to be a valuable tool to predict 
drug metabolism in vivo. Deconjugation of biliairy conjugates in feces 
should be taken into account when comparing in vitro metabolite patterns 
with that in feces and urine. Since phase I metabolites were found in only 
small amounts with intact cells, microsomes and S9-homogenate can be 
adequately used to study phase I metabolism, but are unsuitable to predict 
in vivo metabolite patterns. Extra-hepatic organ slices produced metabolites 
that were also formed by liver cells, but the relative amount of the various 
metabolites differed considerably. For compounds that are metabolized by 
N-glucuronidation, the small intestine may be an important metabolizing 
organ and the amount of N-glucuronides formed may be underestimated 
when only liver cell preparations are used. Therefore, for the prediction of 
the relative amounts of metabolites formed in vivo, the use of intestinal 
slices in combination with liver slices can be required. 
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Introduction 
 
In this chapter, the most important results and conclusions of this thesis as 
well as future perspectives of tissue slice cryopreservation for application in 
drug metabolism research are discussed. 
 
 
Slice histomorphology, ATP, GSH and K+ content and phase II biotrans-
formation capacity are very sensitive parameters to determine cryo-
preservation outcome 
 
Various end-points are used to determine whether cryopreservation of slices 
has been successful or not (see chapter 1). In chapter 2, it appeared that in 
practice, the judgement ‘viable’ or ‘not viable’ depends on the parameter 
used for evaluation. Of course, if damage by cryopreservation is severe 
enough, most (if not all) parameters will point this out ultimately, but a 
sensitive viability parameter will indicate loss of cell integrity within a short 
period after thawing. It was shown that slice histomorphology, potassium, 
ATP and GSH content and phase II biotransformation met this criterium. 
Other parameters tested (LDH retention, testosterone metabolism, enzyme 
activity, and urea synthesis) were less affected by cryopreservation. It 
should be noted that time is required for cryopreservation damage to 
become expressed: directly after thawing, viability of cryopreserved slices 
did not differ much of that of fresh slices.  
These findings are in agreement with those of other authors who studied 
the viability of thawed slices (see chapter 1). Particularly phase II biotrans-
formation has been found repeatedly to be severely affected by cryopreser-
vation (Wishnies et al., 1991; Ekins, 1996a; Ekins et al., 1996a; Ekins et 
al., 1996b; de Kanter et al., 1998; Day et al., 1998; Maas et al., 2000a; 
Maas et al., 2000b; Sohlenius-Sternbeck et al., 2000; Vanhulle et al., 2001). 
Several reasons can account for this observation. Enzymes may have been 
lost due to induced membrane leakage, cofactor availability may be limited 
or enzyme activity may be lost by denaturation. Enzyme activity is not 
prone to be affected by cryopreservation (Glö ckner et al., 1998 and chapter 
2). Vanhulle et al. (2000) have shown that the content of enzymes 
responsible for phase II biotransformation (particularly those enzymes that 
are associated to cellular membranes) was not affected by cryopreservation, 
even 24 h post-thawing. However, the sulfation and glucuronidation of a 
model compound were decreased markedly. In chapter 2 we have shown 
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that while conjugation of CDNB with GSH decreased in cryopreserved slices 
after 4 h of culturing after thawing, conjugation in the slice homogenate 
after addition of GSH was barely affected. All these results indicate that not 
the enzyme content, nor the enzyme activity but the cofactor content limits 
conjugation in thawed slices. The low GSH content we have found in the 
thawed slices supports this. Contrary to the direct conjugation of model 
compounds, the conjugation of 7-HC to 7-HC-glucuronide and 7-HC-sulfate 
after O-deethylation of 7-EC has been shown to be much less affected by 
cryopreservation (Ekins, 1996a; Ekins et al., 1996a). However, this might be 
explained by the fact that the O-deethylation step rather than the cofactor 
content is rate-limiting in this reaction. The fact that this assay is actually 
overestimating the ability of thawed slices to conjugate can be illustrated by 
the observation that thawed slices from the same experiments, directly 
incubated with 7-HC, produced its conjugates in small amounts compared 
to fresh slices (Ekins, 1996a; Ekins et al., 1996a ). 
Remarkably, we have found that testosterone metabolism (as indicator 
for the capability of slices to perform phase I biotransformation) was well 
preserved in thawed slices, even when almost all other parameters used 
indicated severe loss of slice integrity. Several other authors have reported 
similar results (Wishnies et al., 1991; Ekins, 1996a; Ekins et al., 1996a; 
Ekins et al., 1996b; de Kanter et al., 1998; Glö ckner et al.,1998; Glö ckner et 
al.,1999; Maas et al., 2000a; Sohlenius-Sternbeck et al., 2000; Vanhulle et 
al., 2001). These observations are surprising because also phase I 
biotransformation is dependent on cofactors and we have shown that 
particularly these molecules were lost by unsuccessful cryopreservation. We 
can speculate that for the phase I biotransformation not the cofactor 
content, but the transport of the compounds into the slice is rate-limiting 
and that damage of slices by cryopreservation increases substrate 
availability. Indeed, Ekins et al. (1995) have shown that substrate transport 
into slices inhibited metabolism compared to isolated hepatocytes. However, 
not only phase I, but also phase II biotransformation was found to be 
inhibited in slices, so enhanced transport cannot explain the different 
sensitivity of these parameters to cryopreservation damage.       
 Another observation in chapter 2, difficult to explain, is the relative 
insensitivity of urea synthesis to cryopreservation. Again, this reaction is 
directly dependent on cofactor availability (ATP). Potassium content, which 
is also directly related to ATP content, was found to correlate very well with 
ATP content and was low in unsuccesfully cryopreserved slices. However, 
regulation of intracellular ion concentrations requires by far the greatest 
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part of the cellular energy. It could well be, that the small amount of ATP 
left in a unsuccessfully cryopreserved slice is just enough to keep urea 
synthesis going on. This assumption is supported by the fact that in fresh 
slices, the ATP content directly after slice preparation was low and 
increased during culturing, while urea synthesis was linear from t=0 and 
did not increase at later time-points.  
  The relative insensitivity of LDH content to cryopreservation damage can 
be explained in correspondence to the maintenance of biotransformation 
enzymes found by Vanhulle et al. (2001): after cryopreservation the 
membranes apparently did not become leaky enough to become easily 
permeable for relatively large molecules. Also other authors have concluded 
that large molecules like LDH are only lost when a cell has reached ‘a point 
of no return’ (Danpure, 1984). With milder damage, it has been found that 
the leakage depends on the size of the molecule and small molecules are 
much easier lost than the large ones (Schmidt and Schmidt, 1967). 
In chapter 2, histomorphology was found to be a sensitive and important 
parameter to determine slice viability, similarly to ATP and potassium 
content. Essentially, this is not surprising because depletion of energy and 
subsequent deregulation of ion concentration is known to directly lead to 
necrosis. But, more importantly, we have found that the percentage of 
intact cells in a slice after cryopreservation strongly correlated with phase II 
biotransformation (unpublished results). Furthermore, in chapter 7 we have 
shown that rapidly frozen slices, selected on the basis of their intact slice 
histomorphology, were capable to biotransform drugs to the same extent as 
fresh slices.   
Summarizing, appropriate parameters should be used to evaluate 
cryopreservation outcome to be able to assess whether thawed slices can be 
used for drug metabolism studies. Amongst the parameters used for this 
purpose, we have found slice histomorphology, potassium, ATP and GSH 
content and phase II biotransformation of a model compound to be the 
most adequate. 
 
  
Rapid freezing preserves liver slices viability better than slow freezing  
 
In chapter 2 we have found that slices were better preserved by the rapid 
freezing method of de Kanter and Koster (1995) than by the slow 
freezingprotocol published by Maas et al. (2000a). Freezing rate was found 
to explain a great part of the differences in viability between the methods. 
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Comparable results have been reported by de Kanter et al. (1995) and 
Glö ckner et al. (1996) with rat liver slices. Rapid freezing has also been 
shown to be successful with other tissue; For example Zieger et al. (1996) 
have found that skin tissue, rapidly frozen in the presence of 2M DMSO has 
a high post-thaw viability.  
The preference of liver slices for rapid freezing is remarkable because 
isolated rat hepatocytes require slow freezing for survival (Powis et al., 
1987; Condouris et al., 1990; Diener et al., 1993; Maas et al., 2000a). The 
most plausible explanation for this discrepancy concerns the most 
important difference between isolated cells and complex tissue, which is 
their susceptibility to damage by extracellular ice. Single cells can escape 
from the damaging effect of extracellular ice by ranging into unfrozen canals 
of the cryoprotectant (CPA) medium. Closely packed cells are more 
susceptible to extracellular ice than cells suspended in a low concentration 
(Pegg, 1981). Correspondingly, organs and tissues are more prone to be 
damaged by extracellular ice, which piles up between the cells and in the 
vascular space (Bischof et al., 1997; Pegg, 1987). Rapid freezing probably 
protects slices from extensive extracellular freezing by preventing cell 
dehydration. Although Fisher et al. (1991) also reported low viability of rat 
liver slices after slow freezing, they obtained very good viability of slow 
frozen human, pig and dog liver slices (Fisher et al., 1991; Fisher et al., 
1993; Fisher et al., 1996), measured with the same sensitive viability 
parameters. The cause of this species difference is not known.     
The viability of rapidly frozen slices was increased by using higher DMSO 
concentrations (18% instead of 12%) (chapter 3). It appeared that post-thaw 
slice potassium content and histomorphology and phase I and II biotrans-
formation activity was maintained in this manner for at least during 4 h 
after thawing. Even more important, cryopreserved slices were shown to 
predict the in vivo phase I and II biotransformation of newly developed 
drugs as good as fresh liver slices (chapter 7). Others have applied this 
method on liver slices and found results that were just as promising 
(Sohlenius Sternbeck et al., 2000). The improving effect of higher DMSO 
concentrations can be explained by its capability to inhibite ice crystal 
formation, which is increased with increasing concentration (Baudot et al., 
2000). In chapter 3, it was also found that slice thickness determined 
cryopreservation outcome, but not the survival of fresh slices. A possible 
explanation is that the glycogen content of slices is decreased in the 
centerof thick fresh slices (Lupp et al., 2001; and own unpublished 
observations), but is also lowered after cryopreservation by rapid freezing 
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(Vanhulle et al., 2000). So, cells in the center of thick slices may be deprived 
from their stored energy source after cryopreservation and become necrotic.      
 
 
Intracellular vitrification is not the mechanism explaining the success 
of rapid freezing  
 
A bulk solution of 18% DMSO will not vitrify with a cooling rate of 
200°C/min (Baudot et al., 2000). So, in first instance, it is not very likely 
that slice vitrification, preventing inter- and intracellular ice formation, is 
the mechanism explaining the success of rapid freezing for the 
cryopreservation of rat liver slices. Indications exist however, that the 
intracellular matrix, because of the high concentrations of proteins, has 
less tendency to crystallize than extracellular medium because it more or 
less behaves as a CPA (Rapatz and Luyet, 1960; Takahashi and Hirsh, 
1991). Besides this, the compartmentization of water (occurring in and 
between cells) is known to increase supercooling and inhibit crystal 
formation (Yamane et al., 1992; Peridieu et al., 1995). This knowledge made 
de Kanter and Koster (1995) hypothesize, that upon rapid freezing, water 
only crystallizes in the cryopreservation medium outside the slice, but 
vitrifies within the slice. Furthermore they speculated, that cells in the slice, 
not facing the extracellular medium would be protected from damage by ice 
formation by the outer cellayers. This speculation was based on the fact 
that they found that slices with a lower protein content (which were 
probably thin slices, with relatively many ‘surface cells’ compared to ‘inner 
cells’) have a low viability. 
In chapter 5, this hypothesis was tested by performing differential 
scanning calorimetry (DSC). In this manner, the heat of crystallization, 
which is proportional to the amount of ice formed, was compared between 
slices pre-incubated with 18% DMSO and bulk 18% DMSO medium. If 
water in a slice indeed has less tendency to crystallize than bulk medium, 
one would expect a lower fraction of water within the slice to be quantified 
as ice than in the medium. This was not the case: both the total amount of 
ice formed and the dependency of ice formation on the cooling rate did not 
differ between slices and medium. So, slice vitrification was eradicated as 
possible explanation for rat liver slices surviving rapid freezing. However, 
the tendency of slices pre-incubated with high molarity mixtures of CPAs to 
devitrify was inhibited similar to literature data. The latter observation is 
discussed further onwards.  
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Slices are to some extent resistant to ice formation  
 
The question remains what then is the mechanism explaining the success 
of rapid freezing. If the prevention of intracellular ice formation (IIF) truly is 
a prerequisite for cell survival after cryopreservation, the only explanation 
remaining is that cells lose enough water to concentrate intracellular CPAs 
in such a way, that vitrifiable concentrations are reached. This explanation 
is not in conflict with the DSC measurements in chapter 5. After all, the 
DSC only measures the total amount of ice formed within a sample and 
does not distinguish between ice formed intra- or extracellularly. It is 
debatable however, whether with the cooling rates used for rapid freezing of 
200°C/min there is time enough for cells permeated with 18% v/v DMSO to 
lose enough water to reach vitrifiable DMSO concentrations. To achieve 
this, intracellular DMSO concentrations of approximately 45% w/w (Baudot 
et al., 2000) should be reached, so slices should lose at least 35% of their 
initial volume as pure water by dehydration. Bischof et al. (1997) calculated 
that cells in non-DMSO treated human liver slices retain 95% of their 
original volume when they are cooled with 100°C/min. Although we used 
rat liver slices permeated with 18% DMSO, it is even less likely that a 35% 
volume loss occurs in these slices during rapid freezing since non-DMSO 
treated human hepatocytes have a higher membrane permeability to water 
than DMSO-treated rat hepatocytes (compare cell permeability parameters 
of Bischof et al., 1997 and Karlsson, 1993). So it is very unlikely that cell 
dehydration is the mechanism explaining the success of rapid freezing.    
So, with rapid freezing of 18% DMSO permeated slices, it is very likely 
that intracellular crystallization occurs. Although many authors have 
reported a direct relation between IIF and cell death (e.g. Mazur, 1972), 
there also exist evidence that cells can survive IIF (MacKenzie, 1970; Mazur, 
1977; Zieger et al., 1996; Acker and McGann, 2000). A pre-requisite seems 
to be, that thawing is rapid as well. The thought is, that with slow warming 
rates, the small intracellular ice crystals that are formed during rapid 
freezing, recrystallize to form energetically favourable bigger sized ice-
crystals, deleterious to the cell (Mazur, 1977; MacKenzie,1970). By rapid 
warming, keeping intracellular ice crystals small, cells are probably 
“rescued” from damage by these crystals. Mazur et al. (1972) have shown 
for example, that chinese hamster cells exhibit high survival when they 
were cooled with rates higher than required to prevent IIF by equilibrium 
freezing (“supra-optimal” rates), as long as the warming rate was high as 
well. Cells that were cooled with supra-optimal rates and warmed rapidly 
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even had a higher survival rate than cells that were cooled at equilibrium 
freezing rates. The authors suggested that freezing with supra-optimal rates 
protects cells from the effects of high salt (and CPA) concentrations, 
induced by cell dehydration upon slow freezing. Probably, with rapidly 
frozen liver slices, a similar mechanism plays a role. In addition, rapid 
freezing probably protects liver slices from potential deleterious large ice 
crystals formed between cells. We have noticed that with slow warming, 
slices have a very low viability (unpublished observations), which is an 
indication that the mechanism of survival from IIF in rapidly frozen liver 
slices indeed plays a role. 
 Still, it is an unanswered question why we have found that in some 
cases slices do not, or to lesser extent, survive rapid freezing. In chapter 3, 
for example, we found that the variability in survival between slices from 
different rat livers is high. In chapter 4, we found that kidney and intestinal 
slices can not be successfully cryopreserved by rapid freezing. Furthermore, 
in chapter 5 it was shown that slices pre-incubated with high VS4 
concentrations do not survive rapid freezing, while these solutions are non-
toxic to fresh slices. And, finally, in chapter 6, we obtained very low viability 
of slices that were first pre-incubated at 37°C prior to cryopreservation by 
rapid freezing. Factors that may explain these observation can be extrinsic 
(or physical-chemical) of nature, i.e. associated with cryopreservation (CPA 
toxicity, size and location of ice crystals) or intrinsic, associated with the 
tissue to be cryopreserved (for example the sensitivity to damage by ice 
crystals).  
  The low survival of kidney and intestinal slices compared to liver slices, 
observed in chapter 4, may be explained by possible differences in water 
permeability and surface to volume ratios of cells from the different organs. 
Because of this, the extent to which cells are dehydrated during rapid 
freezing and consequently, the size and location of ice in the different tissue 
slices may not be similar. The variability of survival rates of liver slices, 
observed in chapter 3 are difficult to explain from the point of view of 
extrinsic factors playing a role. After all, slices were all from rat liver and 
pre-incubated with 18% DMSO and frozen and thawed in the same way, so 
differences in CPA toxicity or size or location of ice crystals can not explain 
for the found variability. It is reported however, that differences in storage 
time of slices at 4°C could determine cryopreservation outcome (chapter 3 
and Glö ckner et al., 1996). Possibly, variation in the storage time at 4°C of 
liver slices during preparation caused the observed variation. 
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In chapter 5, different CPA concentrations were used, so extrinsic factors 
associated with cryopreservation did differ between the slices. However, 
lower viability after rapid freezing was obtained with slices that were pre-
incubated with higher (but non-toxic to fresh slices) CPA concentrations. 
This is remarkable, because the use of higher CPA concentrations leads to 
the formation of less or smaller (intra- and intercellular) ice crystals and 
hence, it would be expected that higher survival is yielded with higher non-
toxic CPA concentrations. So, again, extrinsic factors are unlikely to explain 
the low viability of slices observed in this chapter. Could intrinsic factors 
play a role in low survival of slices rapidly frozen after pre-incubation with 
higher CPA concentrations? Possibly: CPAs have a number of (largely 
unidentified) effects on cell membranes and cellular structures (Baxter and 
Lath, 1971; Fahy et al., 1990; Anchordoguy et al., 1992), which may not 
necessarily lead to death of unfrozen, CPA-treated cells, but possibly 
enhance susceptibility of slices to subsequent damage by ice crystals during 
freezing. 
 A similar mechanism may play a role in chapter 6: by pre-incubating 
slices prior to cryopreservation, at 37°C, we possibly introduced a mild 
‘reperfusion effect’. This phenomenon is known from cold preservation and 
is caused by re-introducing oxygen in tissue formerly deprived from oxygen 
during ischemia. Slices endure ischemia during preparation. Reperfusion 
injury is associated with all kinds of cellular alterations, which may again 
be sublethal to fresh slices, but renders the slices more susceptible to ice 
crystal damage. Our assumption that such a mechanism indeed plays a 
role in the development of this ‘pre-incubation effect’ is strengthened by the 
observation that this effect did not occur when slices were vitrified, hence 
no ice-crystals were formed during cryopreservation. 
 Resuming, as pointed out in the foregoing, rapid freezing possibly 
protects cells from the deleterious effects of extracellular freezing and from 
the damaging effects associated with cell dehydratation, but (small) 
intracellulair ice crystals are formed. Using indirect evidence, we have 
discussed to which extent we expect the resistance of cells to IIF could 
explain our observations. Future studies should compare the occurrence 
and size of ice crystals between the different organ slices and between slices 
frozen after various pre-treatments. In this manner, a definitive statement 
about the role of extrinsic and intrinsic factors in determining the outcome 
of cryopreservation by rapid freezing can be formulated. 
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Slices of extra-hepatic origin can be successfully cryopreserved by 
vitrification 
 
In chapter 4 it was found that rapid freezing after pre-incubation with 18% 
DMSO did not preserve viability of kidney and intestinal slices. So, we chose 
another approach for the cryopreservation of these slices, i.e. vitrification. 
Intra- and extracellular ice formation in a slice are avoided by vitrification, 
overcoming the potentially deleterious effects of rapid and slow freezing.  
For the development of a vitrification protocol two factors should be kept 
in mind 1) the pre-incubation period should be short enough to avoid CPA 
toxicity, but long enough to ensure complete equilibration with the CPA, 2) 
the applied cooling and warming rates should be higher than the critical 
cooling and warming rates of the tissue. Particularly with VS4, the warming 
rate was found to be a critical issue. Bulk VS4 medium of the same weight 
as a slice had a Vcrw of approximately 2500-3500°C/min. This rate is not 
feasible for the warming of slices. However, by DSC measurements we have 
found that with a few exceptions, the Vcrw of tissue slices is much lower (50-
1500°C/min) than that of bulk VS4 (chapter 4 and 5), probably due to 
partitioning of the solution in the tissue. These results are in agreement 
with those of other authors (Takahashi and Hirsh, 1991; Peridieu et al., 
1995). Since the tissue slices could be warmed with a rate of approximately 
800°C/min, in some slices devitrification could be avoided, but not in some 
other slices. The DSC was found to be very helpful to monitor this: first of 
all, the DSC was used to ensure that the Vcrw of a tissue slice was not 
increased by decreasing pre-incubation duration with a CPA and secondly, 
DSC measurements were used to certify that a slice, used as a represen-
tative for a particular organ, had a Vcrw below the feasible warming rates. 
A major problem to be resolved with vitrification is the toxicity of the 
CPAs, that have to be applied in high concentrations. With several CPAs 
(DMSO, 1,2-propanediol and glycerol) it was already noticed that extra-
hepatic organ slices were much more sensitive to CPA toxicity than liver 
slices (unpublished results). In chapter 4, relatively non-toxic high molarity 
mixtures of CPAs were used (i.e. VS4 and VM3). It was found that the 
toxicity of these mixtures could be avoided for the greatest part by 
optimizing the pre-incubation and washing-out protocols. Particularly the 
shortening of the last pre-incubation step with the undiluted vitrification 
solutions and the addition of trehalose in the washing medium reduced 
toxicity. With intestinal slices, we had the least succes: due to the high 
sensitivity of these slices to VS4, attempts to vitrify them were ceased. 
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Eventually, after optimization of the pre-incubation protocol, we found that 
liver slices, kidney cortical and kidney medulla slices could be successfully 
cryopreserved after treatment with VM3, but to much lesser extent with 
VS4. Unexpectedly, contrary to prevailing thoughts, it was found that 
cooling rate was an important factor determining survival of slices, even 
when no ice crystals were formed. This indicates that thermal stress in a 
sample is a issue to be considered upon developing a vitrification prototcol. 
 
 
Slices of both hepatic and extra-hepatic origin should be used to 
reliably predict in vivo drug metabolism  
 
When an animal species is selected to serve as a model for human drug 
toxicity, it is necessary that this species produces comparatively the same 
(in some cases harmful) metabolites of the drug as humans. When an in 
vitro tool is used for the selection of such animals, metabolism should be 
adequately predicted. In chapter 7, it was shown that subcellular fractions 
do not meet this prerequisite. In contrast, intact cell systems from liver 
(hepatocytes and slices) were found to not only produce the same 
metabolites of two out of three tested drugs as intact animals, but in 
approximately the same relative amounts as well. Of the third drug, 
however, the major metabolite in vivo (an N-glucuronide) was only produced 
in small amounts by these systems. It was found that intestinal slices 
produced this metabolite in relatively large amounts.  
The relative contribution to drug metabolism by different metabolizing 
organs differs between compounds and between animal species (Vickers et 
al., 1995; de Kanter et al., 1999; de Kanter et al., in press). Some 
hypothethical situations as an example to stress the importance of these 
findings: suppose rats are selected as a model for human drug toxicity 
based on the fact that rat liver slices produce the same metabolites as 
human liver slices. When a toxic metabolite is actually produced by the 
human kidney, but not by the rat kidney, the choice of rats to model 
human toxicity will be proven further onwards to be inadequate. Likewise, 
when the parent drug is actually toxic, but is conjugated rapidly in the 
intestinals of rats, but not in those of humans, the toxicity of this drug may 
be underestimated in the rat model. Consequently, to rightfully predict in 
vivo metabolism for proper animal species selection, slices of both liver and 
extra-hepatic metabolising organs should be used. 
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Future perspectives 
 
The questions that should be answered in this section are whether it is 
convenient to continue with the develpoment of cryopreservation methods 
for organ slices and which approach is most likely to lead to an “universal” 
method, i.e. a method applicable for various organ slices of various animal 
species. 
Obviously, the results of chapter 7 only emphasize the need for adequate 
cryopreservation methods for tissue slices: from a logistically point of view, 
it would be very convenient when one is able to withdraw the material that 
is required for a certain experiment from a stored pool of tissue slices, at 
any desired time-point. Which cryopreservation method should be used for 
this purpose is a question that is more difficult to answer. In this thesis it is 
shown that rapid freezing, because it preserves viability to a high level and 
because of its simplicity, is a very convenient method to cryopreserve liver 
slices. Like with slow freezing, however, the results are not extrapolatable to 
all tissue slices of all animal species. We have suggested that the relative 
sensitivity of different slices to ice crystals formed by rapid freezing may be 
the cause of this problem. More insights in the size and location of ice 
crystals and the factors determining susceptibility of cells to these crystals 
will help to further develop rapid freezing protocols for extra-hepatic organ 
slices. 
Because vitrification prevents the formation of ice during freezing, it may 
overcome the problems that came across with equilibrium slow freezing and 
rapid freezing. Indeed, it was shown in this thesis that kidney and liver 
slices can be successfully preserved by vitrification. Toxicity of the highly 
concentrated CPAs required for vitrification is a major concern, however we 
have shown that these problems can be overcome for a great part by using 
mixtures of CPAs like VM3 and VS4 and by adequately designing protocols 
for impregnation and out-washing of these compounds. DSC may be of help 
for this purpose. CPA mixtures are still being optimized to combine the 
lowest possible toxicity with the highest tendency to vitrify. So, from a 
future perspective, vitrification as a starting point should offer the highest 
chance to develop  “universal” cryopreservation methods for tissue slices. 
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Veiligheid van nieuwe medicijnen wordt doorgaans getest met behulp van 
proefdieren. Om als goed model te dienen voor de mens, dient voor zulke 
veiligheidsstudies een proefdiersoort geselecteerd te worden die dezelfde 
omzettingsproducten (metabolieten) maakt van het medicijn als de mens. 
Deze metabolieten kunnen namelijk, net als het medicijn zelf, giftig zijn. 
Het proefdiergebruik kan sterk verminderd worden als de boven-
genoemde selectie ‘in vitro’ kan worden uitgevoerd in plaats van in een 
intact dier. Het feit dat er in deze (vroege) fase van het veiligheidsonderzoek 
nog nauwelijks gegevens over het metabolisme van de nieuwe medicijnen in 
de mens bekend zijn, is een andere belangrijke reden om dit soort 
onderzoek in vitro uit te voeren: er kan namelijk wèl relatief gemakkelijk 
gebruik worden gemaakt van menselijk orgaan materiaal (restanten van 
operaties en donororganen).   
Omdat de lever voor een groot deel verantwoordelijk is voor het 
metabolisme van lichaamsvreemde stoffen (zoals medicijnen) ligt het voor de 
hand om voor in vitro onderzoek leverpreparaten te gebruiken. Een 
voorbeeld van een leverpreparaat waarmee vaak gewerkt wordt zijn 
leverslices: dunne plakjes lever met dezelfde structurele organisatie en 
voorkomende celtypes als een intacte lever. Er zijn echter aanwijzingen dat 
sommige medicijnen door andere organen dan de lever worden omgezet. 
Een belangrijk doel van het onderzoek dat beschreven is in dit 
proefschrift was na te gaan of het metabolisme van medicijnen door een 
intact dier inderdaad goed voorspeld kan worden met behulp van in vitro 
preparaten. Het bleek dat het metabolisme van sommige medicijnen prima 
voorspeld kan worden met leverpreparaten met intacte cellen zoals 
leverslices, maar dat ook slices van andere organen (met name dunne darm) 
nodig zijn om een goede voorspelling te doen van het metabolisme van 
andere medicijnen (hoofdstuk 7).  
Vaak kunnen veel meer slices van een orgaan worden gemaakt dan 
nodig zijn voor een bepaald in vitro experiment. Om optimaal gebruik te 
kunnen maken van de voordelen van het gebruik van orgaanslices is een 
manier nodig om ze te kunnen opslaan. Idealiter zou men gebruik moeten 
kunnen maken van een ‘orgaanslice-bank’: op elk willekeurig tijdstip 
kunnen daaruit slices worden verkregen van verschillende proefdiersoorten 
en de mens, zodat een op een makkelijke manier diersoortvergelijkend 
metabolsime onderzoek van een nieuw medicijn kan worden gedaan.
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Het grootste deel van het in dit proefschrift beschreven onderzoek is gewijd 
aan het zoeken naar een manier om orgaanslices voor langere tijd op te 
slaan door middel van cryopreservatie. Cryopreservatie houdt in dat 
biologisch materiaal wordt afgekoeld tot een zeer lage temperatuur (-196°C). 
Op deze temperatuur staan biologische en chemische processen vrijwel stil, 
zodat veranderingen in het materiaal (zoals ‘bederf’ of ‘veroudering’) kunnen 
worden voorkomen. Als cryopreservatie succesvol verloopt, zijn de orgaan- 
slices na ontdooien nog levensvatbaar en inzetbaar voor in diersoort-
vergelijkende in vitro studies (zie hoofdstuk 1).  
Het bleek moeilijk te zijn om het begrip ‘levensvatbaar’ te definiëren. 
Bepaalde cellulaire processen in de orgaanslices bleken veel gevoeliger te 
zijn voor beschadiging door cryopreservatie dan andere (hoofdstuk 2). 
Veranderingen in de histomorphologie (structuur van weefsels en cellen 
zoals met een microscoop te bestuderen valt) bleek één van de gevoeligste 
indicatoren van beschadiging door cryopreservatie te zijn. Verder bleek dat 
gecryopreserveerde slices met een intacte histomorphologie net zo goed als 
niet-gecryopreserveerde slices in staat waren tot het metaboliseren van 
medicijnen (hoofdstuk 7). Om die reden is histomorphologie in de meeste 
experimenten die in dit proefschrift beschreven zijn gebruikt om het succes 
van cryopreservatie te bepalen. 
In hoofdstuk 2, 3 en 4 is aandacht besteed aan verschillende manieren 
om orgaanslices te cryopreserveren. Het uitgangspunt van cryopreservatie 
is het voorkomen van schade door ijskristallen tijdens het afkoelen en 
ontdooien. Een veel gebruikte methode is om cellen zeer langzaam in te 
vriezen. Tijdens dit proces drogen cellen langzaam uit en worden alleen 
ijskristallen buiten de cel gevormd. Deze ‘extracellulaire ijskristallen’ 
worden als relatief onschadelijk voor de cellen beschouwd. Als te snel wordt 
afgekoeld worden echter ijskristallen in de cel gevormd (‘intracellulaire 
ijskristallen’), waardoor de cel kan sterven.  
Hoewel langzaam invriezen heel goed blijkt te werken voor ‘losse cellen’ 
(bijvoorbeeld bloedcellen), is in hoofdstuk 2 gebleken dat langzaam 
invriezen minder geschikt is voor slices. Waarschijnlijk worden de cellen in 
de slice toch beschadigd door de kristallen die tussen (buiten) de cellen 
ontstaan. ‘Losse cellen’ hebben geen last van dit soort kristallen, omdat ze 
kunnen rangschikken in onbevroren kanaaltjes tussen de ‘extracellulaire’ 
ijskristallen. Een betere methode bleek om de slices te ‘vitrificeren’ (=het 
vormen van een glas, zie hoofdstuk 4). Hierbij worden slices eerst 
geïmpregneerd met hoge concentraties ‘cryoprotectantia’ (CP’s, vaak 
organische oplosmiddelen, zoals DMSO) en daarna afgekoeld. Op deze 
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manier worden in de slice geen intra- of extracellulaire ijskristallen gevormd 
maar ontstaat er een ‘glas’, in feite een vloeistof met een zeer hoge 
viscositeit. Door te vitrificeren worden slices gevrijwaard van beschadiging 
door ijskristallen, maar er ontstaat wel een nieuw probleem: de hoge 
concentraties CP’s zijn zo giftig dat de slices het impregneren vóór het 
invriezen vaak al niet overleven. De oplossing bleek om gebruik te maken 
van mengsels van CP’s. Deze mengsels bestaan uit CP’s die elkaars 
giftigheid ‘opheffen’. Resultaten verkregen met dit soort mengsels waren 
hoopgevend: nier- en leverslices van de rat bleken na vitrificatie en 
ontdooien bijna net zo vitaal te zijn als niet-behandelde slices (hoofdstuk 4). 
De derde cryopreservatiemethode waarmee geëxperimenteerd is in ons 
onderzoek, ‘rapid freezing’, is een verhaal apart: leverslices die 
gecryopreserveerd zijn met deze methode zijn vitaal na ontdooien, ondanks 
het feit dat ijskristallen zowel intra- als extracellulair gevormd worden 
(hoofdstuk 2 en 5).  Het is heel waarschijnlijk dat de hoge invriessnelheid 
en de middelmatig hoge concentraties DMSO (dat de vorming van 
ijskristallen remt) waarmee gecryopreserveerd wordt ervoor zorgen dat er 
slechts kleine ijskristallen kunnen ontstaan waardoor de beschadiging door 
cryopreservatie gering is. Een bewijs hiervoor is dat de slices alsnog 
doodgaan als langzaam wordt ontdooid waarbij kleine kristallen de kans 
krijgen om tot grotere kristallen uit te groeien. Een opvallend resultaat 
beschreven in hoofdstuk 6 is dat voorbehandeling van de slices bepaalt hoe 
groot hun weerstand is tegen intra- en extracellulair ijs gevormd tijdens 
‘rapid freezing’. Verder bleek ‘Rapid freezing’ niet geschikt voor de 
cryopreservatie van nier- en dunne darm slices: na ontdooien daalde de 
vitaliteit van deze slices drastisch (hoofdstuk 4).  
De twee belangrijkste eindconclusies (hoofdstuk 8) van dit proefschrift 
zijn 1) dat de voorselectie van proefdieren voor veiligheidsonderzoek van 
medicijnen ‘in vitro’ kan worden uitgevoerd met behulp van orgaanslices en 
dat het dus loont dit soort onderzoek te vergemakkelijken door het 
aanleggen van een orgaanslice-bank en 2) dat vitrificatie van slices na 
impregnatie met relatief weinig giftige CP mengsels het beste uitgangspunt 
is om ‘universele’ (dwz werkend voor verschillende orgaanslices van 
verschillende diersoorten) methodes voor de cryopreservatie van 
orgaanslices te ontwikkelen.      
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gesprekken over ‘het (gezins)leven’ zal ik missen. Ik laat nog wel even 
weten of we (zonder ruzie) Rome halen: het zal je verbazen. 
- Bas Blaauboer en Willem Seinen: in het begin hebben we elkaar wat 
weinig gezien, maar aan het eind van mijn promotietijd hebben we 
dat toch een beetje goed gemaakt, dacht ik. Bedankt voor jullie 
positieve kritiek.  
- André, René en Engelina, jullie waren altijd bereid om (op het laatste 
nippertje) nog wat analyses uit te voeren om mij van nog wat 
Onmisbare Data te voorzien of computerprobleempjes te verhelpen 
(André). Jùllie waren onmisbaar! 
- Studenten: Daniëlle, Frans, Cokky, Alexander, Fatma en Olaf, jullie 
aanwezigheid zorgde voor een (broodnodige?) verlaging in de 
gemiddelde leeftijd van de Drug Safety medewerkers. Naast 
gezelligheid (en het uitwisselen van persoonlijk lief en leed met een 
aantal van jullie) bracht jullie stage vaak ook nog productiviteit: 
boven de meeste publicaties die zijn voortgekomen uit ons project 
prijkt wel één van jullie namen. En Frans, als je dit leest: we krijgen 
nog een verslag van je…. 
- Joop, jouw ongelofelijke oog voor detail heeft mijn proefschrift weer 
net ietsje beter gemaakt. 
- Alle niet bij naam genoemde collega’s en ex-collega’s van het 
(voormalige) Drug Safety Department (nu PLO?, BLO?, CDU?, 
PCDVU? of PDU?): de nu verworven vrijheid heeft zijn voordelen, 
maar ik zal de druk bijgewoonde thee- en koffiepauzes (vooral die met 
taart) en afdelingsuitjes en de wat minder druk bezochte ‘nawerkse 
borrels’ toch erg missen. Wat mij betreft houden we contact.
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- Anne Baudot and Pierre Boutron, you were both of great help, 
learning me the ins-and-outs of DSC measurements. Anne, when I 
see you again, I’ll teach you how to inline skate (so, beware!). 
- (Paranimf) Ruben, door jouw tip ben ik aan mijn ‘baantje’ bij Solvay 
gekomen. Onze bezoeken aan de kroeg/restaurant liepen steevast uit 
op een gedreven uitwisseling van projectresultaten en (Solvay/ 
promotie) frustraties, vaak tot ergernis van ons gezelschap. Als ik je 
kom opzoeken in Milaan praten we alleen nog over dingen die niets 
met het werk te maken hebben (beloofd!).     
- (Paranimf) Wilfred, de andere frustatie-uitwisselaar en partner-in-
leverslices. Wat ik kan, kun jij zeker! (Je moet er alleen even de tijd 
voor hebben, hè). De laatste loodjes, zet hem op! 
- Andere TNO-ers, met name André Wolterbeek: je hebt wel eens 
gegrapt dat je werkloze tijd de beste in je leven was: ik ga het nu ook 
proberen, ik ben benieuwd. 
- Erwin, papa en mama, Marike en Ingmar, Manon, Mildred, Adillah, 
Arja, schoonfamilie en andere, niet bij naam genoemde ‘dierbaren’: 
jullie verwachten geen bedankjes en die krijgen jullie dan ook niet. 
Het is gewoon fijn dat jullie er zijn! 
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